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ABSTRACT	  
B	   virus	   (Macacine	  herpesvirus	   1),	   subfamily	  Alphaherpesvirinae,	   causes	   a	   fatal,	   neuro-­‐
virulent	  infection	  in	  zoonotically	  infected	  humans.	  Macaques	  (Macaca	  sp.)	  serve	  as	  the	  natural	  
host	  for	  B	  virus	  and	  they	  are	  frequently	  seropositive	  for	  B	  virus	  antibodies	  without	  showing	  any	  
overt	  signs	  of	  disease.	  The	  global	  hypothesis	  of	  these	  studies	  is	  that	  B	  virus,	  a	  highly	  cytopathic	  
virus	  in	  macaques,	  subverts	  the	  innate	  immune	  responses	  in	  the	  host	  (macaques)	  that	  has	  co-­‐
evolved	  with	  it	  (the	  virus)	  differently	  than	  it	  does	  the	  foreign	  host	  (humans).	  The	  foreign	  host,	  
 
 
frequently	  fails	  to	  produce	  neutralizing	  antibodies	  early	  after	  infection	  and	  this	  may	  be	  due	  to	  a	  
dysregulation	  or	   inhibition	  of	  pathways	  known	   to	  play	  a	   role	   in	   the	   innate	   immune	   response	  
which	  directs	   the	  adaptive	  defense	  responses.	   	   	  Current	  knowledge	   is	   that	  at	   least	   five	  major	  
signaling	  pathways	  can	  be	  activated	  after	  a	  pathogen	  such	  as	  B	  virus	  enters	  a	  host	  cell	   (REF).	  
These	   include	   the	   IRF3	  pathway,	   the	  NFkB	  pathway,	   the	  NFAT	  pathway,	  and	   the	  MAPK	  path-­‐
way.	  Early	  stimulation	  of	  one	  or	  more	  of	   these	  pathways	   leads	   to	   the	   induction	  of	   the	  proin-­‐
flammatory	   response	   and	   subsequent	   induction	   of	   cytokines	   such	   as	   IL6,	   IL8	   and	   IL10,	   and	  
apoptosis.	  Cytokine	  induction	  and	  apoptosis	  play	  important	  roles	  in	  host-­‐pathogen	  interactions,	  
innate	   defense	   induction	   and	   subsequent	   adaptive	   immune	   responses.	   Using	   a	   primary	   cell	  
model	  that	  is	  representative	  of	  the	  first	  target	  cells	  of	  B	  virus	  in	  the	  natural	  and	  foreign	  host,	  we	  
investigated	  one	  of	   the	   key	   signaling	  pathways,	   the	  MAPK	  pathway,	   induced	  by	  B	   virus	  early	  
after	  infection	  (Farah-­‐Abraham	  and	  Hilliard,	  unpublished	  data).	  	  My	  data	  suggest	  that	  macaque	  
and	  human	  cells	  differ	  in	  the	  induction	  kinetics	  of	  MAPK	  (JNK	  and	  p38)	  activation.	  	  These	  data	  
reveal	  differences	  between	  foreign	  and	  natural	  host	  cells	   in	  how	  each	  controls	  apoptosis,	  and	  
demonstrate	  that	  inhibition	  of	  p38	  activation	  reduced	  and	  with	  high	  dose	  inhibition	  terminated	  
B	  virus	  replication	  in	  human	  cells,	  and	  played	  a	  role	  in	  reduction	  of	  apoptosis-­‐associated	  media-­‐
tors.	  The	  importance	  of	  each	  component	  in	  the	  MAPK	  pathway	  is	  investigated	  with	  respect	  to	  
virus	   replication	   in	  macaque	  and	  human	  cells	   that	   represent	   the	  primary	   target	  cells	   in	  acute	  
infection.	  Knowledge	  of	  these	  events	  provides	  an	  understanding	  of	  how	  the	  innate	  immune	  re-­‐
sponses	  can	  be	  modulated	  by	  B	  virus	  to	  shape	  the	  adaptive	  immune	  response	  to	  limit	  how	  the	  
virus	  replicates	  and	  spreads.	  Further,	  these	  data	  may	  provide	  insight	  into	  a	  novel	  target	  for	  the	  
design	  of	  new	  antivirals	  to	   inhibit	   this	  deadly	  zoonotic	  virus.	  This	  research	  will	  help	  us	  under-­‐
 
 
stand	  how	  the	  early	  molecular	  mechanisms	  of	  host-­‐pathogen	  interactions	  result	  in	  modulation	  
of	  the	  innate	  immune	  responses	  and	  how	  certain	  aspects	  of	  a	  normally	  defensive	  (protective)	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1 INTRODUCTION	  (General	  Introduction)	  
1.1 Literature	  Review	  
Members	  of	  the	  family	  of	  viruses	  classified	  as	  Herpesviridae	  can	  be	  further	  divided	  into	  
three	   subfamilies:	  Alphaherpesvirinae,	  Betaherpesvirinae	  and	  Gammaherpesvirinae.	  Members	  
of	  subfamily	  Alphaherpesvirinae,	  commonly	  called	  alphaherpesviruses,	  are	  DNA	  viruses	  that	  can	  
be	  characterized	  by	  a	  short	  reproductive	  cycle,	  efficient	  destruction	  of	  the	  host	  cells,	  the	  ability	  
to	  replicate	  in	  a	  wide	  variety	  of	  host	  tissues	  and	  the	  ability	  to	  establish	  a	  lifelong	  latent	  infection	  
in	  the	  sensory	  ganglia	  of	  the	  peripheral	  nervous	  system	  (PNS)	  of	  the	  natural	  host	  (Fields,	  Knipe	  
et	  al.	  1996;	  Sandri-­‐Goldin	  2006;	  Weller	  2011).	  
1.2 Virus	  Characteristics	  	  	  
B	   virus	   (Cercopithecine	   herpesvirus	   1,	   Macacine	   herpesvirus	   1,	  McHV1)	   is	   an	   alpha-­‐
herpesvirus,	  native	  to	  Old	  World	  monkeys	  in	  the	  genus	  Macaca.	  	  It	  has	  a	  156k	  base	  pair	  double-­‐
stranded	   linear	  DNA	   genome	   that	   is	   contained	  within	   a	   160-­‐180	   nm	   icosahedral	   capsid.	   This	  
capsid	  is	  encapsulated	  firstly	  by	  a	  matrix	  of	  protein	  called	  the	  tegument,	  followed	  by	  an	  outer	  
lipid	  envelope	  that	  contains	  many	  previously	  described	  viral	  glycoproteins,	  some	  of	  which	  are	  
important	   for	   attachment	   and	   entry	   into	   permissive	   cells	   (Ruebner,	   Kevereux	   et	   al.	   1975;	  
Ludwig	  1983;	  Perelygina,	  Zhu	  et	  al.	  2003;	  Davison,	  Eberle	  et	  al.	  2009;	  Tregle,	  Loe	  et	  al.	  2010).	  
The	   sequenced	   B	   virus	   lab	   strain	   E2490	   used	   in	   this	   dissertation	  work	   has	   a	   genome	   size	   of	  
156789	  bp	  (Perelygina,	  Zhu	  et	  al.	  2003).	  There	  are	  74	   identified	  B	  virus	  genes	  that	  have	  26.6-­‐
87.7%	  amino	  acid	  homology	   to	  herpes	   simplex	  virus	   type	  1	   (HSV-­‐1)	  and	  Herpes	   simplex	  virus	  
type	  2	  (HSV-­‐2)	  proteins	  (Perelygina,	  Zhu	  et	  al.	  2003;	  Zao	  2007).	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In	  cell	  culture,	  B	  virus	  has	  replication	  kinetics	  that	  is	  similar	  to	  the	  replication	  kinetics	  of	  
HSV-­‐1	  and	  HSV-­‐2	  (Whitley	  2001).	  As	  described	  for	  HSV-­‐1	  and	  HSV-­‐2,	  adsorption	  and	  entry	  into	  
permissive	   cells	  occurs	  during	   the	   first	  hour	  post	   infection	   (p.i.),	   followed	  by	   shut	  off	  of	  host	  
macromolecular	   synthesis	   by	   a	   tegument	   protein	   referred	   to	   as	   virion	   host	   shutoff	   (vhs)	  
(Strelow	  and	  Leib	  1995).	  The	  shut-­‐off	  of	  host	  macromolecular	  synthesis	  is	  followed	  by	  a	  coordi-­‐
nated	  expression	  of	  three	  classes	  of	  viral	  genes	  referred	  to	  as	  immediate-­‐early	  (α),	  early	  (β)	  and	  
late	  (γ)	  genes	  (Honess	  and	  Roizman	  1974;	  Roizman,	  Kozak	  et	  al.	  1975).	  Viral	  DNA	  replication	  oc-­‐
curs	  by	  4	  hrs	  p.i.	  and	  infectious	  virus	  is	  detectable	  within	  6-­‐10	  hours	  p.i.	  (Hilliard,	  Eberle	  et	  al.	  
1987;	  Whitley	  2001).	  
1.3 Route	  of	  Transmission	  and	  Pathogenesis	  	  	  
As	  with	  other	  members	  of	   the	  Alphaherpesvirinae	   subfamily,	  primary	  B	  virus	   infection	  
occurs	  in	  mucosal,	  epithelial,	  or	  dermal	  cells,	  has	  a	  relatively	  short	  reproductive	  cycle	  followed	  
by	  retrograde	  transport	  of	  virus	  within	  the	  peripheral	  nervous	  system	  (PNS)	  from	  the	  site	  of	  in-­‐
fection,	  and	  is	  capable	  of	  establishing	  latency	  in	  the	  sensory	  ganglia	  of	  infected	  hosts	  (Roizman,	  
Carmichael	  et	  al.	  1981;	  Aderem	  and	  Ulevitch	  2000;	  Akira,	  Takeda	  et	  al.	  2001;	  Farah	  2005).	  Cer-­‐
tain	  stressful	  stimuli	  may	  lead	  to	  reactivation	  of	  virus,	  defined	  by	  replication	  of	  viral	  DNA	  and	  
assembly	  of	  new	  particles,	   followed	  by	  anterograde	  transport	  of	  virus	  particles	   from	  the	  sen-­‐
sory	  ganglia	   to	  epithelial	   sites	   (Strelow	  and	  Leib	  1995;	  Whitley	  2001;	  Scientific	  Committee	  on	  
Health	  and	  Environmental	  Risks	  2009).	  Shedding	  and	  transmission	  of	  infectious	  virus	  can	  occur	  
intermittently	  throughout	  the	  lifetime	  of	  the	  host.	  
3	  
	  
1.4 Natural	  Host	  and	  Scope	  of	  the	  Problem	  	  	  
Old	  World	  monkeys	  of	  the	  genus	  Macaca	  are	  the	  natural	  hosts	  of	  B	  virus,	  each	  having	  
co-­‐evolved	   together	  over	  30	  million	  years.	  This	  genus	  comprises	  at	   least	  a	  dozen	  species	  and	  
includes	  some	  of	  the	  earliest	  recorded	  non-­‐human	  primate	  species	  used	   in	  scientific	  research	  
due	  to	  the	  macaques	  genetic,	  anatomic	  and	  physiologic	  similarities	  to	  humans	  (Valerio,	  Ellis	  et	  
al.	  1969;	  Valerio,	  Pallotta	  et	  al.	  1969;	  Farah	  2005).	  Each	  year	  12,000-­‐15,000	  macaques	  are	  im-­‐
ported	   into	   the	   USA,	   and	   they	   make	   up	   63%	   of	   the	   non-­‐human	   primates	   used	   in	   research	  
(Capitanio	   1998;	   Council	   2002;	   Conlee	   KM	   2004;	   J.	   R.	   Held	   2005;	   (SCHER)	   2009;	   Scientific	  
Committee	   on	   Health	   and	   Environmental	   Risks	   2009;	   Suran	   and	   Wolinsky	   2009).	   Macaques	  
have	  been	  used	   in	  many	  types	  of	  research,	   including	  product	  design,	  safety	  testing	  and	   infec-­‐
tious	  agent	  research.	  Many	  major	  medical	  discoveries	  and	  research	  contributions	   in	  the	  areas	  
of	  life	  cycle,	  pathogenesis,	  drug	  efficacy	  and	  vaccine	  development	  have	  been	  based	  on	  research	  
using	  macaques	   (Landsteiner	   1940;	   Boen	  1964;	  Goodwin	   1970;	   Fridman	  1972;	  Areekul	   1979;	  
Hill	  1980;	  Palmer	  1987;	  Howson	  1996;	  Farah	  2005;	  (SCHER)	  2009).	  Macaques	  represent	  an	  in-­‐
valuable	   non-­‐human	   primate	   resource	   in	   the	   biomedical	   community	   for	   elucidating	   disease	  
processes	  in	  humans	  because	  the	  macaque	  immune	  system	  offers	  researchers	  an	  opportunity	  
to	  investigate	  responses	  to	  natural	  and	  foreign	  pathogens	  at	  cellular	  and	  molecular	  levels.	  The	  
recent	  publication	  of	  the	  rhesus	  macaque	  genome	  sequence	  will	  encourage	  an	  increased	  use	  of	  
macaques	  for	  biomedical	  research	  (Gibbs,	  Rogers	  et	  al.	  2007).	  	  
The	  similarity	  of	  pathogens	   that	   infect	  macaques	   to	   those	   that	   infect	  other	  closely	   re-­‐
lated	   primates	   such	   as	   humans	  will	   continue	   to	   encourage	   the	   use	   of	  macaques	   as	   research	  
models	  and	  the	  use	  of	  the	  pathogens	  that	  infect	  them	  as	  tools	  in	  research.	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In	  the	  wild	  73-­‐100%	  of	  macaques	  are	  known	  to	  be	  seropositive	  for	  B	  virus.	  The	  virus	  can	  
cause	   a	   similar	   disease	  manifestation	   in	   both	   humans	   (foreign	   host)	   and	  macaques	   (natural	  
host),	  but	  infections	  in	  macaques	  tend	  to	  be	  benign,	  whereas	  infections	  in	  humans	  often	  lead	  to	  
an	  acute	  infection	  of	  the	  central	  nervous	  system	  (CNS),	  which	  may	  result	  in	  fatal	  encephalitis	  or	  
serious	  neurological	  sequelae	  (Ostrowski,	  Leslie	  et	  al.	  1998;	  Huff	  and	  Barry	  2003;	  Farah	  2005).	  
Although	   symptomatic	   B	   virus	   infection	   in	   humans	   is	   uncommon,	   the	   availability	   of	   antiviral	  
drugs	  such	  as	  acyclovir,	  famciclovir	  and	  ganciclovir	  have	  allowed	  progression	  of	  the	  disease	  in	  
some	  zoonotically	   infected	  patients	  to	  be	  kept	  under	  control	  and/or	  some	  neurological	  symp-­‐
toms	  alleviated	  (Zuniga	  ;	  CDC	  1987;	  CDC	  1989;	  Holmes,	  Hilliard	  et	  al.	  1990;	  Ostrowski,	  Leslie	  et	  
al.	  1998;	  Tregle,	  Loe	  et	  al.	  2010).	  
1.5 Host	  Antiviral	  Response	  to	  B	  Virus	  Infection	  	  	  
As	  previously	  mentioned,	  B	  virus	  infection	  in	  macaques	  (natural	  host)	  is	  similar	  to	  that	  of	  
HSV-­‐1	  infection	  in	  humans	  (natural	  host).	  In	  most	  cases,	  when	  a	  virus	  such	  as	  B	  virus	  enters	  its	  
natural	  host,	  the	  host	  immune	  responses	  are	  able	  to	  control	  the	  infection	  with	  or	  without	  spo-­‐
radic	  reactivation	  throughout	  the	  lifetime	  of	  the	  host.	  Simplex	  viruses	  in	  their	  natural	  hosts	  are	  
cytopathic	  and	  the	  host	  and	  virus	  have	  selected	  for	  properties	  that	  will	  allow	  the	  two	  to	  coexist	  
together,	  i.e.	  the	  virus	  replicates	  periodically	  and	  the	  host	  continues	  to	  support	  this	  replication.	  
However,	  when	  a	  virus	  such	  as	  B	  virus	  enters	  a	  foreign	  host,	  the	  host	  innate	  and	  adaptive	  im-­‐
mune	   responses	   are	  unable	   to	   control	   the	   virus	   in	   a	  manner	   that	   prevents	   its	   entry	   into	   the	  
CNS.	  This	  phenomenon	  can	  also	  be	  seen	  with	  viruses	  such	  as	  Ebola	  or	  Marburg	  (Barreiro	  and	  
Quintana-­‐Murci	  2010).	   In	   these	  cases	   the	  human	  becomes	  a	   terminal	  host	   for	   the	  virus.	   	  Re-­‐
garding	  the	  adaptive	  immune	  response	  to	  B	  virus	  infection,	  in	  macaques	  an	  IgM	  response	  can	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be	  detected	  within	  three	  to	  ten	  days	  p.i.,	  followed	  by	  an	  IgG	  response	  around	  ten	  to	  fourteen	  
days.	  However,	  this	  response	  is	  induced	  to	  a	  relatively	  lower	  level	  than	  normally	  observed	  and	  
delayed	  in	  zoonotically	   infected	  humans,	   if	  detected	  at	  all.	  For	  some	  B	  virus-­‐infected	  humans,	  
detectable	   levels	  of	  B	  virus-­‐specific	   IgG	  antibodies	  can	  be	   intermittently	  observed,	   suggesting	  
periodic	  reactivation	  of	  B	  virus,	  as	  shown	  by	  work	  from	  the	  National	  B	  Virus	  Resource	  Center	  
(Hilliard	   2005).	   Neutralizing	   antibodies	   associated	  with	   the	   infection	   also	   appear	   in	   both	   hu-­‐
mans	  and	  macaques,	  although	  at	  lower	  levels	  in	  humans	  (Lees,	  Baskerville	  et	  al.	  1991;	  Whitley	  
2001).	  
Studies	   in	  our	   laboratory	  have	   shown	   that	  B	   virus	   counteracts	   the	   innate	   immune	   re-­‐
sponse	  by	  inhibiting	  protein	  kinase	  RNA-­‐activated	  (PKR)	  activity,	  inhibiting	  NF-­‐κB	  regulated	  im-­‐
mune	   responsive	  genes	  putatively	  by	   IκBζ	   and	   subverting	  natural	   killer	   (NK)	   cell	   activity	   (Zao	  
2007;	   Zhu	   2007;	   Vasireddi	   2009)	   (Figure	   1).	   Collectively,	   the	   information	   gained	   provides	   a	  
framework	  within	  which	  one	  can	  not	  only	  understand	  the	  pathogenesis	  of	  B	  virus	   in	  both	  the	  
foreign	  and	  natural	  hosts,	  but,	  more	  importantly,	  can	  also	  examine	  how	  closely	  related	  viruses	  
that	   have	   co-­‐evolved	  with	   their	   natural	   hosts	  modulate	   the	   innate	   and	   adaptive	   immune	   re-­‐





Figure	  1.	  Mechanisms	  by	  which	  B	  virus	  counteracts	  the	  innate	  immune	  response:	  A	  summary	  




Cellular	   signaling	  pathways	  known	   to	  be	  upregulated	  early	  after	   infection	  can	  be	  acti-­‐
vated	  at	  any	  and/or	  every	  step	  during	  virus	  entry	  and	  replication.	  However,	  it	  is	  still	  not	  known	  
how	  all	  of	  these	  inter-­‐related	  signaling	  pathways	  and	  their	  interaction	  with	  B	  virus	  effect	  B	  virus	  
replication	  and	  direct	  the	  observed	  adaptive	  immune	  responses	  characteristic	  of	  each	  host	  spe-­‐
cies.	   	   	   The	   fact	   that	   B	   virus	   did	   not	   co-­‐evolve	  with	   humans,	   coupled	  with	   evidence	   gathered	  
from	  the	  studies	  of	  other	  viruses,	  suggests	  that	  neither	  the	  virus	  nor	  the	  host	  has	  had	  the	  oppor-­‐
tunity	  to	  select	  for	  traits	  that	  allow	  the	  host	  and	  virus	  to	  co-­‐exist	  successfully,	   i.e.,	  an	  effective	  
adaptive	   immune	  response	  as	  seen	   in	  the	  natural	  host,	  capable	  of	  restricting	  virus	  replication	  
and	  entry	  into	  the	  CNS	  
In	  any	  cell	  type,	  the	  response	  to	  virus	  infection	  is	  equal	  to	  the	  sum	  of	  cellular	  signaling	  
events	  involved	  in	  the	  innate	  immune	  response	  and	  their	  downstream	  outcome,	  i.e.	  the	  secre-­‐
tion	  of	  inflammatory	  cytokines	  that	  direct	  the	  outcome	  of	  the	  adaptive	  responses.	  This	  down-­‐
stream	  inflammatory	  response	  then	  influences	  the	  adaptive	  response	  and	  thus	  determines	  the	  
overall	  fate	  of	  the	  host.	  In	  order	  to	  understand	  the	  immune	  modulation	  mechanisms	  of	  B	  virus	  
in	   cells	   from	   both	  macaques	   and	   humans,	   it	   is	   important	   to	   investigate	   the	  mechanisms	   by	  
which	  B	  virus	  directs	  a	  strong	  humoral	  defense	  in	  macaques,	  whereas	  in	  most	  humans,	  it	  rap-­‐
idly	  gains	  entry	  into	  the	  CNS,	  causing	  ascending	  paralysis	  and	  death	  while	  suppressing	  any	  ap-­‐
parent	  adaptive	  defenses.	  
1.6 Strategies	  Used	  by	  Alphaherpesviruses	  to	  Subvert	  the	  Innate	  Immune	  Response	  	  	  
As	  previously	  mentioned,	  HSV-­‐1	  is	  a	  closely	  related	  alphaherpesvirus,	  and,	  as	  with	  B	  vi-­‐
rus	  in	  the	  natural	  host	  macaques,	  HSV-­‐1	  is	  able	  to	  replicate	  and	  persist	  throughout	  the	  lifetime	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of	  its	  natural	  host,	  humans.	  It	  has	  been	  shown	  by	  in	  vitro	  studies	  that	  virally	  encoded	  proteins	  
of	  HSV-­‐1	  have	  antiviral	  functions.	  Among	  these	  proteins	  are	  the	  following:	  virion	  host	  shut	  off	  
(vhs),	   infected	  cell	  protein	  0	   (ICP0),	   infected	  cell	  protein	  27	   (ICP27),	   infected	  cell	  protein	  34.5	  
(ICP34.5)	  and	  US11	  (Vandevenne,	  Sadzot-­‐Delvaux	  et	  al.	  2010).	  	  	  
The	  HSV-­‐1	  vhs	  protein	  is	  present	  on	  the	  tegument	  of	  the	  virus	  and	  has	  endoribonuclease	  
activity	   which	   functions	   to	   inhibit	   the	   host	   cell’s	   translation	   machinery	   by	   degrading	   mRNA	  
(Kwong	  and	  Frenkel	  1987;	  Strom	  and	  Frenkel	  1987;	  Kwong,	  Kruper	  et	  al.	  1988;	  Whitley	  2001;	  
Vandevenne,	  Sadzot-­‐Delvaux	  et	  al.	  2010).	  Whether	  B	  virus	  vhs	  plays	  a	  similar	   role	   in	   infected	  
cells	  has	  not	  been	  determined	  at	  present.	  	  	  
Among	   the	   functions	   of	   HSV-­‐1	   ICP0	   protein	   there	   is	   a	   E3	   ubiquitin-­‐like	   ligase	   activity	  
which	  functions	  to	  inhibit	  the	  host	  cell’s	  interferon	  response	  by	  disrupting	  ND10	  structures	  and	  
sequestering	  transcription	  factors	  such	  as	   IRF3,	  and	  thus	  blocking	   interferon	  beta	  (IFNβ)	  gene	  
transcription	   (Gelman	  and	  Silverstein	  1986;	  Whitley	  2001;	  Vandevenne,	   Sadzot-­‐Delvaux	  et	   al.	  
2010)..	  Several	  aspects	  of	  ICP0	  may	  influence	  the	  role	  of	  MAPK	  in	  B	  virus	  infection:	  the	  ability	  to	  
ubiquitinate	  proteins	  targeted	  for	  presentation	  by	  the	  MHC	  I;	  ubiquitinate	  the	  cytoplasmic	  do-­‐
main	  of	  receptors	   important	   in	  the	   innate	   immune	  response	  to	   infection;	  and	  modification	  of	  
cellular	  proteins	  via	  ubiqutination	  for	  the	  activation	  or	  degradation	  of	  proteins,	  can	  all	  influence	  
the	  role	  of	  MAPK	  in	  B	  virus	  infection.	  	  	  
Another	  HSV-­‐1	  protein	  that	  has	  antiviral	  function	  is	  ICP27	  which	  inhibits	  the	  host	  cell’s	  
transcriptional	  machinery	  by	  inhibiting	  RNA	  splicing	  and	  it	  thus	  prevents	  the	  expression	  of	  inter-­‐
feron	   stimulating	   genes	   as	   well	   as	   inhibits	   STAT1	   phosphorylation	   and	   nuclear	   translocation	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which	   are	   important	   for	   interferon	   gene	   expression	   (Gelman	   and	   Silverstein	   1985;	   Sacks,	  
Greene	  et	   al.	   1985;	  Rice	   and	  Knipe	  1988;	   Sekulovich,	   Leary	  et	   al.	   1988;	   Estridge,	   Kemp	  et	   al.	  
1989;	  Bolovan,	  Sawtell	  et	  al.	  1994;	  Whitley	  2001;	  Vandevenne,	  Sadzot-­‐Delvaux	  et	  al.	  2010).	  The	  
alteration	  of	  the	  kinetics	  production	  and/or	  activation	  of	  proteins	  involved	  in	  the	  cytokine	  gene	  
expression	  influenced	  by	  MAPK	  could	  putatively	  increase	  cell	  survival	  times	  long	  enough	  for	  vi-­‐
rus	  replication	  and	  spread	  to	  neighboring	  cells	  and	  establishment	  of	  latency	  in	  neurons.	  	  	  
Similarly,	  HSV-­‐1	   ICP34.5	  protein	  prevents:	   type	   I	   interferon	  expression	   through	   inhibi-­‐
tion	  of	  IRF3	  activation	  and	  host	  cell	  antiviral	  PKR	  responses	  to	  infection.	  This	  is	  accomplished	  by	  
dephosphorylation	  of	   cellular	  protein,	  eukaryotic	   translation	   initiation	   factor	  2-­‐alpha	  kinase	  2	  
(eIF2α),	  thus	  driving	  host	  cell	  protein	  synthesis	  (Gelman	  and	  Silverstein	  1985;	  Bolovan,	  Sawtell	  
et	   al.	   1994;	  Whitley	   2001;	  Vandevenne,	   Sadzot-­‐Delvaux	   et	   al.	   2010).	   The	  MAPK	  pathway	  has	  
many	  functional	  targets	  that	  can	  play	  a	  role	  in	  the	  promotion	  of	  viral	  gene	  expression	  and	  con-­‐
tribute	  to	  the	  overall	  efficiency	  of	  viral	   replication	   in	  host	  cells,	   thus	  a	  potential	   role	  of	   ICP27	  
and	  other	   immediate	  early	  proteins	  could	  be	  to	  stabilize	  cellular	  transcripts	  necessary	   for	  cell	  
survival	  and	  enhance	  viral	  replication.	   	  B	  virus,	  however,	   lacks	  this	  protein	  and	  appears	  to	  re-­‐
place	  at	  least	  part	  of	  its	  function	  via	  the	  encoded	  US11	  protein.	  
HSV-­‐1	   US11	   protein	   is	   a	   tegument	   protein,	   which	   also	   inhibits	   the	   PKR	   response	   by	  
blocking	   its	   activation.	   Additionally	   it	   inhibits	   dsRNA	   activation	   of	   latent	   RNase,	   RNase	   L,	   by	  
blocking	  oligoadenylate	  synthase	  activity	  (OAS)	  (Roller	  and	  Roizman	  1990;	  Roller	  and	  Roizman	  
1992;	  Cassady,	  Gross	  et	  al.	  1998;	  Whitley	  2001;	  Vandevenne,	  Sadzot-­‐Delvaux	  et	  al.	  2010).	   	   In	  
HSV-­‐1	  US11	   is	  expressed	   late	   in	   infection;	  however	   the	  B	  virus	  homolog	  of	   this	  protein	   is	  ex-­‐
10	  
	  
pressed	  as	  an	  early	  gene	  product.	  Early	  expression	  of	  US11	  can	  be	  observed	  in	  ICP34.5	  deletion	  
mutants	  of	  HSV-­‐1	  (Cassady,	  Gross	  et	  al.	  1998).	  	  	  
In	  summary,	  simplexviruses	  encode	  a	  number	  of	  proteins	  that	  enable	  effective	  virus	  rep-­‐
lication	  by	  delaying	  cell	  death.	  	  However,	  these	  same	  proteins	  via	  their	  expression	  kinetics	  serve	  
to	  ultimately	  limit	  virus	  replication	  perhaps	  for	  the	  benefit	  of	  host	  survival,	  enabling	  a	  relatively	  
peaceful	  coexistence	  of	  these	  viruses	  within	  their	  natural	  hosts.	  	  	  
1.7 Cell	  Signaling	  Events	  that	  Occur	  In	  Response	  to	  a	  Pathogen	  	  	  
When	  host	  physical	  barriers,	  e.g.,	  skin,	  mucous,	  secretory	  antibodies,	  to	  infection	  have	  
been	   circumvented,	   cells	   then	   rely	   on	   the	   sensing	   of	   pathogens	   through	   a	   group	   of	   trans-­‐
membrane	   proteins	   including	   Toll-­‐like	   receptors	   (TLRs)	   (Aderem	   and	   Ulevitch	   2000;	   Akira,	  
Takeda	  et	   al.	   2001).	   These	  membrane	   receptors	   have	   a	  heterogeneous	   group	  of	   ligands	   that	  
can	  be	  cell-­‐type	  dependent	  and	  function	  on	  or	  within	  a	  cell	   to	  stimulate	  similar	  signaling	  cas-­‐
cades	  through	  their	  interaction	  with	  cytoplasmic	  adaptor	  molecules	  and	  other	  scaffold	  proteins	  
involved	   in	   the	   innate	   immune	  response	   (Kaisho	  and	  Akira	  2001).	   	  These	  receptors	  once	  acti-­‐
vated,	  especially	  TLRs	  play	  an	  important	  role	  in	  orchestrating	  the	  molecular	  signals	  through	  in-­‐
duction	   of	   a	   universal	   and/or	   specific	   response	   to	   the	   invading	   pathogen	   (Barreiro	   and	  
Quintana-­‐Murci	  2010).	  After	  molecular	  signals	  linked	  to	  the	  innate	  immune	  response	  have	  been	  
initiated,	  there	  are	  many	  cytoplasmic	  mediators	  that	  play	  key	  roles	  in	  the	  integration	  and	  pro-­‐
gression	  of	  the	  response	  for	  effective	  clearance	  of	  the	  pathogen	  and	  development	  of	  an	  anti-­‐
gen-­‐specific	  adaptive	  response.	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Of	   the	  many	   signaling	   pathways	   that	   exist	  within	   a	   cell,	   the	   stimulation	   of	   four	  well-­‐
known	   intracellular	  cascades	  can	  occur	  after	   infection	  to	  modulate	  cell	  death	   (apoptosis)	  and	  
trigger	  the	  release	  of	  cytokines	  (Figure	  2).	  	  They	  are	  the	  nuclear	  factor	  kappa-­‐B	  (NF-­‐κB)	  cascade,	  
the	   mitogen-­‐activated	   protein	   kinase	   (MAPK)	   cascade,	   the	   interferon	   regulatory	   factor	   (IRF)	  
pathway	  and	  the	  nuclear	  factor	  of	  activated	  T-­‐cells	  (NF-­‐AT)	  (Takeda,	  Kaisho	  et	  al.	  2003).	  	  
Some	  of	   these	   pathways	   rely	   on	   a	   feedback	  mechanism	  or	   biphasic	   response	  mecha-­‐
nisms	  to	  amplify	  the	  signaling,	  and	  collectively	  they	  allow	  for	  transcription	  factors	  such	  as	  IRF3,	  
NF-­‐κB	   and	   AP1	   to	   be	   upregulated	   for	   gene	   transcription	   (Vandevenne,	   Sadzot-­‐Delvaux	   et	   al.	  
2010).	  Since	  it	  is	  known	  that	  a	  common	  strategy	  of	  viruses	  to	  promote	  viral	  infection	  is	  to	  ma-­‐
nipulate,	  and	  or	  exploit	  preexisting	  intra-­‐cellular	  pathways,	  it	  is	  therefore	  important	  to	  investi-­‐
gate	  how	  certain	  aspects	  of	  a	  normally	  protective	  host	  responses	  are	  being	  re-­‐directed,	  modi-­‐
fied	  or	   inhibited	  to	   the	  advantage	  of	  a	  host	   that	  has	  co-­‐evolved	  with	  a	  specific	  virus	  –	   in	   this	  
case,	  macaques	  and	  B	  virus	  –	  and	  to	  its	  disadvantage	  in	  a	  foreign	  host,	  specifically	  humans	  in-­‐







Figure	  2	   	  A	   summary	  of	   the	  currently	  understood	  main	  early	   signaling	  pathways	  associated	  
with	  host	  cell	  detection	  of	  virus	  infection.	  
	  
1.8 Protein	  Complexes	  that	  Mediate	  Activation	  of	  Signaling	  Pathways	  	  	  
As	   previously	   mentioned,	   stimulation	   of	   PRRs	   can	   activate	   four	   intracellular	   protein	  
kinase	  cascades	  resulting	  in	  the	  induction	  of	  type	  I	  IFN’s,	  apoptosis	  and	  many	  inflammatory	  cy-­‐
tokines	  that	  collectively	  play	  a	  role	  in	  the	  innate	  immune	  response	  (Takeda,	  Kaisho	  et	  al.	  2003).	  
TLR	  signals	  are	  mediated	  by	  a	  conserved	  Toll−interleukin	  1	  (IL-­‐1)	  receptor	  domain	  (TIR)	   in	  the	  
cytoplasmic	   regions	   that	   recruits	   adaptor	   molecules	   such	   as	   myeloid	   differentiation	   factor	  
(MyD88),	  TIR-­‐associated	  protein	  (TIRAP)	  (also	  called	  MAL),	  Toll	  receptor-­‐associated	  activator	  of	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interferon	  (TRIF)	  and	  Toll	  receptor-­‐associated	  molecule	  (TRAM)	  (Su	  2005).	  These	  adaptor	  mole-­‐
cules	  function	  to	  recruit	  and	  assemble	  additional	  intracellular	  signaling	  molecules,	  including	  IL-­‐1	  
receptor-­‐associated	   kinases	   (IRAK)	   and	   tumor	   necrosis	   receptor	   factor	   6	   (TRAF6),	   into	   com-­‐
plexes	   (Su	   2005).	   Toll-­‐like	   receptor-­‐associated	   activator	   of	   interferon	   (TRIF),	   a	   multipurpose	  
adaptor	  protein	  that	  acts	  as	  a	  platform	  for	  the	  recruitment	  of	  several	  proteins	  (IKK,	  TBK1,	  VISA	  
and	  TRAF6),	  has	  been	  shown	  to	  be	   involved	   in	  the	  activation	  of	  the	   interferon	  (IFN)	  response	  
and	  the	  MAPK-­‐induced	  apoptotic	  response	  (Meylan,	  Burns	  et	  al.	  2004;	  Zhong,	  Tien	  et	  al.	  2006)	  
(Figure	  3).	  TRIF	  can	  also	   interact	  with	  an	  adaptor	  protein	  called	  Fas-­‐associated	  death	  domain	  
protein	  (FADD),	  which	  activates	  caspase	  8	  leading	  to	  the	  subsequent	  activation	  of	  caspase	  3	  and	  
induction	   of	   apoptosis	   (Kreuz,	   Siegmund	   et	   al.	   2004;	   Yoneyama,	   Kikuchi	   et	   al.	   2004;	   Kato,	  
Takeuchi	  et	  al.	  2006;	  Zhong,	  Tien	  et	  al.	  2006)	  (Figure	  3).	  	  
Another	  functionally	  important	  adaptor	  protein,	  TIRAP/MAL,	  has	  been	  shown	  to	  interact	  
with	   the	   TLR-­‐mediated	  MyD88-­‐dependent	   pathway	   for	   inflammatory	   cytokine	   production	   as	  
well	   as	   NF-­‐κB	   and	   JNK	   activation	   (Takeda	   and	   Akira	   2004).	  Within	   this	   pathway,	   the	   TIRAP-­‐
MyD88	  complex	  activates	  TRAF6	  through	  the	  IL1	  receptor	  kinases	  (IRAK’s).	  Activated	  TRAF6	  is	  
linked	   to	   TAK1	   (MAP3K7)	   through	   adaptor	   protein	   TAK1	   binding	   protein	   (TAB2)	   leading	   to	  
stimulation	  of	  the	  JNK	  pathway	  and	  cellular	  activator	  protein-­‐1	  (AP1)	  activation	  (Silverman	  and	  
Fitzgerald	  2004;	  Kishida,	  Sanjo	  et	  al.	  2005)	  (Figure	  3).	   In	  the	  studies	  described	  in	  this	  disserta-­‐
tion,	  an	  initial	  goal	  was	  to	  identify	  the	  adaptor	  molecules	  upstream	  of	  the	  MAPK	  pathways	  that	  
were	  critical	  to	  the	  activation	  of	  MAPK	  following	  B	  virus	  infection	  of	  macaque	  and	  human	  cells	  
and	  to	  verify	  whether	  cells	  from	  each	  species	  responded	  similarly	  following	  B	  virus	  infection.	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Several	  members	  of	  the	  MAP3K	  family,	  including	  TAK1	  (MAP3K7),	  tumor	  progression	  lo-­‐
cus-­‐2	  (Tpl2)	  and	  ASK1,	  have	  been	  shown	  to	  be	  essential	  in	  mediating	  TLR-­‐activated	  kinase	  cas-­‐
cades.	  Because	  the	  activation	  of	  a	  MAPK	  is	  downstream	  of	  a	  MAP2K	  and	  MAP3K,	  it	  is	  possible	  
that	  one	  or	  more	  MAP3Ks	  are	  required	  for	  activation	  of	  the	  MAPK	  cascades	  after	  TLR	  stimula-­‐
tion	  (Su	  2005).	  Two	  such	  MAP3Ks,	  called	  ASK1	  (apoptosis-­‐inducing	  signaling	  kinase	  1)	  and	  TAK1,	  
are	  capable	  of	  activating	  both	   the	  p38	  and	   JNK	  pathways	   (Ichijo,	  Nishida	  et	  al.	  1997;	  Kishida,	  
Sanjo	  et	  al.	  2005)	  (Figure	  3)	  and	  these	  were	  investigated	  in	  this	  dissertation.	  
Other	  proteins	  that	  function	  independently	  of	  the	  TLR	  pathways,	  but	  are	  able	  to	  act	  as	  
dsRNA	   detectors	  within	   the	   cytoplasm,	   are	   the	   retinoic	   acid	   inducible	   gene	   I	   (RIG-­‐I)	   and	   the	  
melanoma	   differentiation-­‐associated	   gene	   5	   product	   (MDA5/helicard).	   Both	   RIG-­‐I	   and	  MDA5	  
contain	   two	   caspase-­‐recruitment	   domains	   (CARDs),	  which	   recruit	   a	   CARD-­‐containing	   adaptor	  
protein	  called	  VISA	  (also	  known	  as	  MAVS,	  IPS-­‐1	  or	  Cardif)	  (Kato,	  Takeuchi	  et	  al.	  2006;	  Takeuchi	  
and	   Akira	   2008).	   VISA	   relays	   the	   signal	   to	   kinases	   TBK1,	   IKK,	   receptor-­‐interacting	   protein	  
kinase1	  (RIP	  1)	  and	  TRAF6	  for	  the	  phosphorylation	  of	  downstream	  transcription	  factors	  that	  are	  
involved	   in	   the	   expression	   of	   type-­‐I	   interferons,	   proinflammatory	   cytokines	   and	   apoptotic	  








Figure	  3	  	  	  Protein	  complexes	  that	  mediate	  activation	  of	  signaling	  pathways	  
	  
1.9 Activation	  of	  Intracellular	  Pathways	  	  	  
To	  detect	  an	  invading	  pathogen,	  the	  innate	  immune	  response	  depends	  on	  many	  differ-­‐
ent	   evolutionally	   conserved	   recognition	   mechanisms.	   Collectively,	   these	   recognition	   mecha-­‐
nisms	  rely	  on	  molecular	  patterns	  known	  as	  pattern	  recognition	  receptors	  (PRRs)	  that	  recognize	  
specific	  pathogen-­‐associated	  molecular	  patterns	  (PAMPs)	  that	  are	  not	  present	  in	  host	  cells.	  Ex-­‐
amples	   of	   PAMPs	   are	   viral	   DNA,	   single-­‐stranded	   ssRNA,	   dsRNA	   and	   glycoproteins	   of	   varied	  
pathogens	  (Kato,	  Takeuchi	  et	  al.	  2006).	  Four	  main	  families	  of	  PRRs	  have	  been	  shown	  to	  initiate	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proinflammatory	   signaling	   pathways:	   the	   Toll-­‐like	   receptors	   (TLRs),	   the	   NOD-­‐like	   receptors	  
(NLRs),	  the	  RIG-­‐I-­‐like	  receptors	  (RLRs)	  and	  the	  DNA	  sensors.	  	  
The	  TLRs	  were	   the	   first	   identified	  and	   remain	   the	  best-­‐characterized	   receptors	  among	  
the	  signaling	  PRRs.	  They	  initiate	  key	  inflammatory	  responses	  by	  recognizing	  a	  variety	  of	  exoge-­‐
nous	  PAMPs	  from	  bacteria,	  fungi,	  parasites,	  and	  viruses,	  such	  as	  lipopolysaccharide	  (LPS),	  flag-­‐
ellin,	   and	  CpG	  DNA,	   and	  also	  assist	   in	  directing	   specific	   aspects	  of	   	   the	  adaptive	   immune	  de-­‐
fenses.	  	  
RIG-­‐I-­‐like-­‐receptors	   (RLRs)	   belong	   to	   a	   family	   of	   inducible	   cytoplasmic	   RNA	   helicases	  
thought	   to	  be	  essential	   for	  host	   antiviral	   responses.	   Two	  well-­‐known	  RNA	  helicases	  are	  RIG-­‐I	  
(retinoic-­‐acid-­‐inducible	   protein	   1)	   and	   MDA-­‐5	   (melanoma-­‐differentiation-­‐associated	   gene	   5).	  
They	   function	   to	  sense	   the	  endogenous	  PAMPs,	   such	  as	   the	   replication	   intermediate	   for	  RNA	  
viruses	  which	   is	   double-­‐stranded	  RNA	   (dsRNA),	   and	   are	   capable	   of	   amplifying	   the	   innate	   im-­‐
mune	   response	   to	   infection	   (Onoguchi,	   Yoneyama	   et	   al.	   2011).	   Laboratory	   of	   genetics	   and	  
physiology	  2	  (LGP2)	  represents	  a	  third	  RLR	  which	  functions	  as	  a	  negative	  regulator	  of	  RIG-­‐I	  and	  
MDA-­‐5	  (Onoguchi,	  Yoneyama	  et	  al.	  2011;	  Technologies	  2011).	  
Recently,	  another	  group	  of	  PRRs	  called	  NOD-­‐like	   receptors	   (NLRs)/CATERPILLERs,	  have	  
been	  identified.	  NLRs	  have	  more	  than	  20	  members	  in	  mammals	  and,	  though	  not	  clearly	  under-­‐
stood,	  their	  primary	  role	  is	  to	  recognize	  cytoplasmic	  PAMPs	  as	  with	  the	  TLRs	  (Takahashi,	   Ip	  et	  
al.	  2009;	  Technologies	  2011).	  NLRs	  can	  be	  further	  sub-­‐divided	   into	  two	  categories:	   those	  that	  
signal	  via	  NF-­‐κB	  and	  MAPK	  pathways	  and	  those	  (NALPs)	  that	  play	  a	  role	  in	  the	  assembly	  of	  the	  
inflammasome	  (Inohara	  and	  Nunez	  2001;	  Takahashi,	  Ip	  et	  al.	  2009).	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Other	   important	  players	   that	   associate	  with	  PRRs	  either	   to	   initiate	   a	  proinflammatory	  
response	  to	  infection	  or	  to	  induce	  phagocytosis	  are	  the	  inflammasome,	  peptidoglycan	  recogni-­‐
tion	  proteins	  (PGRP),	  C-­‐type	  lectin	  families,	  also	  called	  C-­‐type	  lectin	  receptors	  (CLRs),	  and	  Dam-­‐
age	  Associated	  Molecular	  Patterns	  (DAMPs)	  (Kerrigan	  and	  Brown	  2009;	  Technologies	  2011).	  
Inflammasomes	  are	   large	  caspase	  1	  activating	  complexes	  formed	  within	  the	  cytoplasm	  
after	  NLR	  engagement	  of	  PAMPs.	  	  	  These	  function	  to	  cleave	  prototype	  inflammatory	  cytokines	  
proIL-­‐1β	  and	  pro	  IL18	  into	  their	  active	  forms	  (Takahashi,	  Ip	  et	  al.	  2009).	  Currently	  there	  are	  four	  
known	   inflammasomes,	  NLRP1	  (NALP1),	  NLRP3	  (NALP3	  or	  PYPAF1	  or	  cryopyrin),	  NLRC4	  (IPAF)	  
and	  AIM2,	  whose	  components	  and	  stimuli	  differ	  (Stutz,	  Golenbock	  et	  al.	  2009).	  Little	  is	  known	  
about	  which	  of	  these	  plays	  a	  role	  in	  simplexvirus	  infections,	  including	  B	  virus.	  	  	  
PGRP	   and	   CLRs,	   such	   as	   mannose	   receptor,	   dectin-­‐1,	   DNGR-­‐1	   and	   mannose	   binding	  
lectin,	  recognize	  PAMPs	  and	  act	  as	  phagocytic	  receptors	  to	  mediate	  or	  regulate	  the	  uptake	  of	  
pathogens	  via	  phagocytosis	  by	  binding	  microbial	  carbohydrate	  moieties	  (glycan	  structures)	  not	  
present	   in	  the	  host	  (Zelensky	  and	  Gready	  2005;	  Kerrigan	  and	  Brown	  2009;	  Takahashi,	   Ip	  et	  al.	  
2009;	  Dam	  and	  Brewer	  2010).	  	  
Danger	   Associate	  Molecular	   Patterns	   (DAMPs)	   are	   endogenously	   upregulated	   nuclear	  
and	   cytoslolic	   signaling	  molecules	   that	   activate	   TLRs	   and	   innate	   immune	   cells	   via	   a	   not-­‐yet-­‐
clarified	  mechanism	  that	   is	  distinct	  from	  the	  co-­‐receptors	  and	  accessory	  molecules	  utilized	  by	  
PAMPs	  (Rubartelli	  and	  Lotze	  2007;	  Piccinini	  and	  Midwood	  2010).	  DAMPs	  may	  activate	  positive	  
feedback	   loops	   that	  allow	   for	   increased	  TLR	  activation,	   thus	  contributing	   to	   increased	   inflam-­‐
mation	  (Piccinini	  and	  Midwood	  2010).	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1.10 Mitogen-­‐Activated	  Protein	  Kinase	  Pathway	  	  	  
The	  key	  focus	  of	  the	  studies	  reported	  in	  this	  dissertation	  involve	  mitogen-­‐activated	  pro-­‐
tein	  kinase	  (MAPK)	  cascade,	  which	  is	  highly	  conserved	  and	  is	  involved	  in	  many	  cellular	  functions	  
including	  cell	  proliferation,	  cell	  differentiation,	  cell	  migration,	   inflammation	  and	  apoptosis	   fol-­‐
lowing	  cell	   infection.	  External	  stimuli,	   such	  as	  growth	   factors,	   inflammatory	  cytokines,	   ligands	  
for	  G-­‐protein	   coupled	   receptors	   (GPCR),	   as	  well	   as	   cellular	   and	  environmental	   stress	   and	   the	  
presence	  of	  dsRNA,	  have	  been	  shown	   to	   induce	   the	   sequential	  activation	  of	   the	  MAPK	  phos-­‐
phorylation	   cascade.	   This	   cascade	   begins	   with	   activation	   of	   the	   most	   membrane-­‐proximal	  
MAPK	  enzyme	  commonly	  referred	  to	  as	  a	  MAP	  kinase	  kinase	  kinase	  (MAP3K)	  and	  ends	  at	  the	  
terminal	   mitogen	   activated	   protein	   kinase	   (MAPK),	   which	   phosphorylates	   many	   substrates.	  
These	  substrates	   include	   transcription	   factors	   such	  as	  AP1	  heterodimers	   (activating	   transcrip-­‐
tion	  factor-­‐2/ATF2),	  Fos,	  Jun	  and	  other	  protein	  kinases	  such	  as	  MAPK-­‐activated	  protein	  kinases	  
(MAPKAPKs)	  (Perelygina,	  Zhu	  et	  al.	  2003;	  Ashwell	  2006).	  The	  overall	  regulation	  of	  downstream	  
events	   that	   are	   influenced	   by	   MAPK	   pathways	   involves	   successive	   phosphorylation	   and	  
dephosphorylation	  events	  of	  MAPKs.	  Subsequent	  nuclear	  translocation	  events	  and	  modulations	  
of	  transcription	  factors	  can	  then	  lead	  to	  stimulus-­‐dependent	  modifications	  of	  gene	  expression	  
to	   regulate	   the	   antiviral	   response	  which	   involves	   the	   induction	  of	   type	   I	   IFN's,	   cytokines	   and	  

















Currently	   14	   MAP3K	   isoforms	   and	   seven	   MAP2K	   isoforms	   have	   been	   identified.	   The	  
fourteen	  MAP3K	  isoforms	  are	  diverse,	  and	  can	  be	  regulated	  in	  a	  differentially	  depending	  on	  the	  
initial	   stimuli,	  whereas	  the	  seven	  MAP2K	   isoforms	  are	  highly	  specific	   to	   their	  substrates,	  with	  
little	  variation	  in	  the	  MAP2K-­‐to-­‐MAPK	  level	  of	  the	  cascade	  (Zhang	  and	  Dong	  2005).	  The	  MAPKs	  
may	  be	  regulated	  by	  MAP	  kinase	  phosphatases	  (MKP)	  or	  dual-­‐specificity	  phosphatases	  (DUSP)	  
that	  act	  as	  antagonists	  (negative	  regulators)	  to	  control	  the	  magnitude	  and	  duration	  of	  their	  ac-­‐
tivation.	  To	  date,	  13	  MKPs	  have	  been	  identified,	  each	  of	  which	  having	  a	  specific	  sub-­‐cellular	  lo-­‐
cation,	  substrate	  specificity	  and	  mode	  of	  regulation	  (Zhang	  and	  Dong	  2005).	  
The	   MAPK	   family	   consists	   of	   four	   sub-­‐families:	   extracellular-­‐signal-­‐related	   kinase	   1/2	  
(ERK1/2),	   extracellular-­‐signal-­‐related	   kinase	   5	   (ERK5),	   p38	   MAPK,	   and	   Jun	   N-­‐terminal	   kinase	  
(JNK).	  Of	  these	  four	  MAPK	  families,	  the	  p38	  and	  JNK	  pathways	  are	  commonly	  referred	  to	  as	  the	  
stress-­‐activated	  MAP	  kinase	  pathways	  (SAPK)	  because	   inflammatory	  cytokines,	  environmental	  
stresses,	  DNA	  damaging	  agents	  and	  viral	   infection	  can	   induce	   their	  activity	  and	   these	  are	   the	  
targets	  of	  the	  studies	  presented	  in	  the	  following	  sections.	  
The	  p38	  MAPK	  pathway	  is	  activated	  by	  MAP3Ks	  (MTK1,	  ASK1,	  TAK1)	  that	  exist	  upstream	  
of	   p38.	   These	  MAP3Ks	   then	  phosphorylate	   and	   activate	   the	  MAP2Ks	   (MAP2K3	   and	  MAP2K6)	  
(Ashwell	   2006).	   Once	   activated,	   p38	   acts	   on	   transcriptional	   targets	   such	   as	   c-­‐Jun	   and	   c-­‐Fos.	  
There	  are	  four	  isoforms	  of	  the	  p38	  MAPK	  (p38α,	  p38β,	  p38γ	  and	  p38δ)	  which	  may	  be	  differen-­‐
tially	   regulated	   under	   certain	   circumstances	   and	   differ	   in	   tissue	   distribution,	   regulation	   of	  
kinase	   activation	   and	   subsequent	   phosphorylation	   of	   downstream	   substrates	   (Dominguez,	  
Powers	  et	  al.	  2005).	  MAPK	  p38α	   is	  the	  most	  thoroughly	  studied	  MAPK	  p38	  isoform,	  and	  both	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p38α	  and	  p38β	  respond	  to	  many	  of	  the	  same	  agonists	  (Tibbles	  and	  Woodgett	  1999).	  Hence,	  the	  
p38	  MAPK	  pathway	  represents	  a	  point	  of	  convergence	  for	  multiple	  signaling	  processes	  that	  are	  
activated	  during	  any	  cellular	  stress,	  infection	  by	  a	  pathogen	  and	  inflammation.	  The	  pathway	  is	  
involved	   in	   the	   induction	   of	   apoptotic	   events	   and	   the	   biosynthesis	   of	   tumor	   necrosis	   factor-­‐
alpha	   (TNFα),	   interleukin-­‐1beta	   (IL-­‐1β),	   IL-­‐6	   and	   IL-­‐12	   at	   the	   transcriptional	   and	   translational	  
level	  (Dominguez,	  Powers	  et	  al.	  2005)	  (Figure	  3	  and	  Figure	  5).	  
The	  second	  SAPK	  pathway	   is	   the	   JNK	  pathway.	  The	   JNK	  pathway	   is	  evolutionarily	  con-­‐
served	  and	  can	  be	  activated	  in	  many	  cell	  types	  in	  response	  to	  inflammatory	  cytokines,	  cellular	  
stress	  and	  viral	  infection	  (Chu,	  Ostertag	  et	  al.	  1999;	  Zhang	  and	  Dong	  2005).	  JNK	  has	  three	  iso-­‐
forms,	   JNK1,	   2	   and	   3,	   where	   JNK3	   is	   brain-­‐specific	   (Davis	   1994;	   Hu,	   Qiu	   et	   al.	   1997;	  Mielke,	  
Damm	  et	  al.	  2000).	  JNKs	  can	  phosphorylate	  transcriptional	  targets	  c-­‐Jun	  and	  ATF2,	  leading	  to	  an	  
induction	  of	  type	  I	  IFN’s,	  production	  of	  inflammatory	  cytokines	  (IL-­‐1,	  IL-­‐6,	  IL-­‐12	  and	  TNFα)	  and	  
apoptosis	   (Chu,	  Ostertag	   et	   al.	   1999;	   Zhang	   and	  Dong	   2005).	   A	   number	   of	   upstream	   kinases	  
have	   been	   implicated	   in	   the	   activation	   of	   JNK:	   ME2K1;	   ME2K4;	   apoptotsis	   signal-­‐regulating	  
kinase	  (ASK1);	  mixed	  lineage	  kinases	  (MLK);	  and	  TGFβ	  activating	  kinase	  (TAK1).	  Scaffolding	  pro-­‐
teins,	  such	  as	  JNK	  interacting	  protein	  (JIP),	  β-­‐arrestin	  and	  JNK	  stress-­‐activated	  protein	  (JSAP1),	  
have	  also	  been	  identified.	  The	  overall	  function	  of	  scaffolding	  proteins	  is	  to	  tether	  signaling	  pro-­‐
teins	  in	  the	  vicinity	  of	  each	  other,	  allowing	  the	  assembly	  of	  specific	  complexes	  that	  further	  di-­‐





Figure	  5.	  A	  representation	  of	  Stress	  Activated	  Protein	  Kinases	  (SAPK’s)	  signaling	  pathway	  
	  
The	   activities	   of	   both	   the	   JNK	   and	  p38	  pathways	   can	  be	   regulated	  positively	   or	   nega-­‐
tively	  by	  a	  number	  of	  phosphatases	  called	  MAPK	  phosphatases	   (MKPs),	  or	  by	  protein-­‐protein	  
interactions	   that	   prevent	   nuclear	   translocation	   events	   (Tibbles	   and	  Woodgett	   1999;	   Lin	   and	  
Dibling	  2002).	  	  
The	  extracellular	  signal-­‐regulated	  kinase	  pathways	  ERK1/2	  and	  ERK5	  are	  similar	  in	  acti-­‐
vation	  modes	  and	  functions,	  as	  they	  are	  stimulated	  by	  growth	  factors	  and	  mitogens.	  These	  two	  
pathways	  are	  essential	  in	  cellular	  growth,	  differentiation	  and	  development.	  As	  with	  the	  SAPKs,	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the	  ERKs	  can	   interact	  with	  regulatory	  elements	  such	  as	  scaffold	  proteins	  and	  MAPK	  phospha-­‐
tases	  that	  regulate	  their	  activity.	  
1.11 MAPK-­‐Dependent	  Apoptosis	  	  	  
Apoptotic	   induction	   and	   regulation	   is	   important	   in	   host-­‐pathogen	   interactions	   and	   in	  
immune	  responses	  to	  infection.	  Studies	  have	  suggested	  that	  the	  evolutionary	  conserved	  MAPK-­‐
dependent	  apoptosis	  plays	  a	  critical	   role	   in	   innate	   immune	  responses	   to	  viral	   infection	   in	  eu-­‐
karyotic	  cells	  (Sumbayev	  and	  Yasinska	  2006).	  The	  MAPK	  family	  commonly	  referred	  to	  as	  SAPKs	  
(p38	  and	  JNK)	  are	  known	  to	  play	  a	  critical	  role	  in	  mediating	  the	  decision	  of	  cell	  fate	  by	  regulat-­‐
ing	  apoptosis.	  Apoptosis	  signal-­‐regulating	  kinase	  (ASK1)	  is	  a	  ubiquitously	  expressed	  MAP3K	  that	  
activates	   the	  SAPKs	  p38	  and	   JNK	  pathways	  by	  phosphorylating	   their	  upstream	  MAP2K.	   In	   the	  
case	  of	  inactivated	  JNK	  (non-­‐phosphorylated	  JNK),	  JNK	  is	  complexed	  with	  p53,	  which	  is	  unstable	  
and	  degraded	  by	   the	  proteosome	   (Sumbayev	  and	  Yasinska	  2006).	  Activated	  p38	  and	   JNK	  are	  
able	  to	  phosphorylate	  transcription	  factors	  c-­‐Jun	  and	  ATF-­‐2.	  The	  Jun	  protein	  may	  then	  form	  a	  
homodimer	   (Jun-­‐Jun)	   or	   it	   may	   form	   heterodimers	   with	   ATF2	   to	   form	   Jun-­‐ATF2	   (AP1)	  
(Sumbayev	  and	  Yasinska	  2006).	  Later	  transcription	  factors	  and	  other	  nuclear	  transcription	  fac-­‐
tors	  can	  lead	  to	  increased	  expression	  of	  the	  c-­‐Fos	  protein,	  which	  is	  able	  to	  dimerize	  with	  c-­‐Jun	  
to	  further	  enhance	  overall	  AP1	  levels	  (Tibbles	  and	  Woodgett	  1999).	  	  As	  a	  result,	  the	  apoptotic	  
and	   innate	   immune	   response	   to	  viral	   infection	   initiated	  by	  ASK1	  activation	  of	   the	  SAPK	  path-­‐
ways	   can	   lead	   to	   downstream	   effects	   that	   involve	   caspase	   3	   activation	   and	   apoptosis	  
(Sumbayev	  and	  Yasinska	  2006).	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1.12 Virus	  Stimulation	  of	  MAPK	  Pathways	  	  	  
As	  previously	  mentioned,	  B	  virus	  is	  an	  alphaherpesvirus,	  indigenous	  to	  Old	  World	  mon-­‐
keys	  in	  the	  genus	  Macaca.	  Following	  B	  virus	  entry	  into	  host	  cells,	  uncoating,	  transport	  and	  viral	  
replication	   occurs	   to	   permit	   a	   triphasic	   (temporal)	   transcription	   of	   the	   immediate-­‐early	   (α),	  
early	  (β),	  and	  late	  (γ)	  genes.	  When	  a	  pathogen	  such	  as	  B	  virus	  infects	  a	  cell,	  it	  sets	  off	  a	  program	  
of	  gene	  expression	  by	  conveying	  a	  signal	  along	  one	  or	  more	  pathways,	  some	  of	  which	  can	  be	  
protein	   kinase	  pathways,	   to	  act	  on	  downstream	   transcription	   factors.	   It	   is	   known	   that	   innate	  
immune	  response	  plays	  a	  large	  role	  in	  the	  initial	  ability	  of	  a	  host	  to	  eliminate	  a	  pathogen.	  This	  
initial	  response	   leads	  to	  the	  activation	  of	  cell-­‐mediated	  cytotoxic	  responses	  that	  are	  triggered	  
by	   varied	   pattern	   recognition	   receptors	   (membrane-­‐bound	   or	   cytoplasmic)	   and	   involves	   the	  
stimulation	  of	  multiple	  pathways	  for	  the	  secretion	  of	  type	  I	  IFN’s,	  cytokines	  and	  the	  upregula-­‐
tion	  of	  transcription	  factors	  involved	  in	  cell	  survival,	  cell	  proliferation	  and	  cell	  death	  (apoptosis).	  
Of	  these	  pathways,	  the	  mitogen-­‐activated	  protein	  kinase	  (MAPK)	  signaling	  pathways	  have	  been	  
shown	  to	  play	  an	  essential	  role	  in	  the	  innate	  immune	  response	  to	  viral	  infection	  (Chu,	  Ostertag	  
et	  al.	  1999;	  Young	  and	  Dillin	  2004;	  Cooray,	  Jin	  et	  al.	  2005;	  Zhang	  and	  Dong	  2005;	  Sumbayev	  and	  
Yasinska	  2006).	  	  
MAPKs	  represent	  a	  molecular	  signaling	  network	  present	  in	  all	  cell	  types	  that	  is	  altered	  in	  
immunological,	  inflammatory	  and	  degenerative	  diseases.	  Studies	  have	  shown	  that	  all	  three	  sub-­‐
families	  of	  the	  herpesviruses	  can	  activate	  one	  or	  more	  of	  the	  MAPK	  pathways	  during	  infection;	  
however,	  it	  is	  not	  known	  which	  events	  within	  signaling	  pathways	  regulate	  the	  induction	  of	  tran-­‐
scription	  factors	  that	  mediate	  the	  innate	  immune	  response	  (Xie,	  Pan	  et	  al.	  2005;	  Sloan,	  Han	  et	  
al.	  2006).	  With	  herpesvirus	  infections,	  the	  cell-­‐cycle	  regulatory	  machinery	  and	  other	  intracellu-­‐
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lar	  signaling	  pathways	  of	  the	  host	  cell	  are	  altered	  not	  only	  to	  promote	  cell-­‐cycle	  progression	  but	  
also	  to	  facilitate	  viral	  replication	  and	  spread.	  	  
As	  with	  any	  pathogen	  that	  enters	  a	  host	  (natural	  or	  foreign),	   induction	  of	  host	  cell	  sig-­‐
naling	  pathways	  and	  other	  biochemical	  changes	  occur	  that	  can	  be	  characterized	  as	  a	  molecular	  
signature	  which	  is	  a	  direct	  result	  of	  the	  specific	  invading	  pathogen.	  This	  signature	  begins	  at	  the	  
initiation	  of	  infection	  and	  varies	  depending	  on	  the	  pathogen	  and	  the	  host.	  The	  ability	  of	  the	  in-­‐
fected	  cell	   to	   sense	  an	   invading	  pathogen	  and	   stimulate	   the	   immune	   response	  or	   induce	  cell	  
death	  is	  thus	  of	  great	  importance.	  Without	  the	  ability	  of	  the	  cell	  to	  recognize	  invasion,	  either	  as	  
a	   result	   of	   pathogen-­‐associated	   inhibitors	   or	   the	   absence	   of	   pathogen	   recognition	   receptors	  
results	  in	  the	  ability	  of	  the	  virus	  to	  replicate	  unfettered	  and	  untoward	  consequences	  for	  the	  de-­‐
fenseless	  host.	  	  	  
In	  summary,	  we	  know	  that	  viral	  infections	  are	  detected	  by	  pathogen	  recognition	  recep-­‐
tors	  and	  this	  detection	  results	  in	  the	  activation	  of	  intracellular	  signaling	  pathways,	  such	  as	  pro-­‐
tein	  kinase	  cascades,	  that	  are	  modulated	  or	  inhibited	  to	  affect	  cellular	  function	  and	  to	  enhance	  
viral	   replication.	  We	   also	   know	   that	  many	   viruses	   inclusive	   of	  herpesviruses	   generally	   induce	  
different	  components	  of	  the	  MAPK	  pathway.	  At	  the	  onset	  of	  this	  research,	  no	  data	  were	  avail-­‐
able	  that	  described	  what	  pathways	  were	  induced	  in	  cells	  infected	  with	  B	  virus,	  much	  less	  what	  
differences	  existed	  in	  different	  cell	  species’	  responses	  to	  B	  virus	  infection.	  Without	  this	  knowl-­‐
edge,	  little	  headway	  can	  be	  made	  with	  respect	  to	  development	  of	  successful	  antiviral	  interven-­‐
tions	  that	  minimize	  morbidity	  and	  mortality	  during	  zoonotic	  infections.	  To	  begin	  this	  research,	  
experiments	  were	  designed	  to	  test	  the	  hypothesis	  that	  B	  virus	  induces	  specific	  innate	  immune	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responses	  when	  it	  enters	  the	  initial	  target	  cells	  populating	  epidermal	  and	  dermal	  layers	  of	  skin	  
from	  humans	  versus	  macaques	  and	  that	  these	  responses	  affect	  virus	  replication	  levels	  that	  ul-­‐
timately	  lead	  to	  differential	  induction	  of	  cytokines	  and	  chemokines	  that	  direct	  the	  adaptive	  de-­‐
fenses	  observed	  in	  each	  host	  system.	  Hypothesis:	  Host-­‐specific	  innate	  immune	  responses	  trig-­‐
gered	  by	  B	  virus	   infection	  are	  modulated	  in	  a	  host-­‐dependent	  manner	  that	  results	   in	  modula-­‐
tion	  of	  virus	  replication.	  
	  The	  mitogen-­‐activated	  protein	  kinase	  (MAPK)	  pathway	  was	  the	  rational	  choice	  for	  study	  
as	  the	  components	  of	  the	  pathway	  act	  as	  multifunctional	  networks	  that	  play	  a	  role	   in	  cellular	  
responses	   to	   cell	   growth	   and	   differentiation,	   stress,	   apoptosis	   and	   proinflammatory	   cytokine	  
secretion.	  Activation	  of	  one	  or	  more	  MAPKs	  has	  been	  shown	  to	  occur	  in	  all	  three	  subfamilies	  of	  
human	  herpesviruses,	   and	   the	  MAPKs	   can	  provide	  an	  alternate	   route	   for	   the	   induction	  of	   in-­‐
flammatory	  cytokines	  after	  infection	  that	  distinct	  from	  that	  of	  IRF3	  and	  NFkB	  induction	  (Meusel	  
and	  Imani	  2003;	  Hargett,	  McLean	  et	  al.	  2005).	  Because	  we	  know	  that	  viruses	  depend	  on	  host	  
cells	   for	  their	  replication	  and	  that	  they	  tend	  to	  reorganize	  or	   inhibit	  cellular	  functions	  such	  as	  
the	  MAPK	  pathway	  to	  modulate	  cellular	  and	  viral	  gene	  expression,	   I	   focused	  these	  studies	  on	  
the	  induction	  and	  regulation	  of	  the	  MAPK	  pathway	  and	  its	  components	  to	  identify	  specific	  cellu-­‐
lar	  defenses	  and	  the	  effect	  of	  these	  on	  virus	  replication.	  
I	  tested	  this	  hypothesis	  by	  investigating	  the	  following	  areas:	  (1)	  identification	  and	  com-­‐
parison	  of	  B	  virus	  signaling	  in	  target	  cells	  from	  the	  natural	  and	  foreign	  host,	  (2)	  quantification	  of	  
the	  effect	  of	  signaling	  on	  virus	  replication	  and	  (3)	  analysis	  of	  the	  outcomes	  in	  adaptive	  host	  re-­‐
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sponses	   induced	  as	   a	   result	   of	   specific	   signaling	  events.	   The	   following	   specific	   aims	  were	  de-­‐
signed	  to	  test	  the	  previously	  stated	  hypothesis:	  
Aim	  1:	  Establish	  in	  vitro	  target	  cell	  models	  representing	  the	  cells	  that	  are	  initially	  	  
	   infected	  during	  acute	  infection	  in	  order	  to	  study	  early	  virus:host	  interactions.	  	  
Aim	  2:	   Identify	  the	  specific	  MAPK	  responses	  induced	  by	  B	  virus	  in	  acutely	  infected	  cells.	  
Aim	  3:	  Measure	  MAPK-­‐induced	  gene	  products	  and	  proinflammatory	  mediators	  that	  are	  	  
	   upregulated	  in	  response	  to	  MAPK-­‐adaptor	  molecule	  activation	  to	  establish	  	  
	   whether	  these	  events	  correlate	  with	  observed	  adaptive	  responses	  character-­‐	  
	   ristic	  of	  each	  host	  species	  defenses	  against	  B	  virus	  infection.	  
	  
2 Aim	  1:	  Establish	  in	  vitro	  target	  cell	  models	  representing	  the	  cells	  that	  are	  initially	  infected	  
during	  acute	  infection	  in	  order	  to	  study	  early	  virus:host	  interactions.	  	  
2.1 Introduction	  
Typically	  with	  zoonotic	  (macaque	  to	  human)	  infection	  with	  B	  virus	  direct	  animal	  to	  hu-­‐
man	  contact	  occurs	  through	  of	  a	  bite	  or	  scratch.	  Indirect	  human	  exposure	  can	  involve	  situations	  
in	  which	  contaminated	  water	  or	  other	  solutions	  comes	  into	  contact	  with	  an	  open	  skin	  wound,	  
or	  a	  work-­‐related	  accidental	   injury	   (such	  as	  a	  scratch	   from	  the	  metal	  door	  of	  a	  cage).	   	   In	  any	  
case	  where	  the	  initial	  barrier	  of	  the	  skin	  was	  broken	  and	  an	  infection	  occurred,	  one	  of	  the	  first	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cell	  populations	  that	  the	  virus	  encounters	  and	  can	  infect	  is	  either	  epidermal	  cells	  in	  the	  epider-­‐
mal	   skin	   layers	   and/or	   fibroblasts	   in	   the	   dermal	   layers	   of	   the	   skin.	   	   Replication	  may	  occur	   in	  
these	  cell	   types	  prior	   to	   the	  retrograde	  transport	  of	  virus	  by	  sensory	  neurons	   innervating	  the	  
region.	  Virus	  may	  reach	  the	  dendrites	  and	  axons	  without	  replication,	  but	  replication	  at	  the	  ini-­‐
tial	  site	  of	  contact	  ensures	  a	  robust	  population	  of	  virus	  that	  can	  come	  into	  contact	  with	  the	  pe-­‐
ripheral	  nerves.	   	  This	   initial	   virus	   replication	  also	   results	   in	  activation	  of	   innate	  host	  defenses	  
which	  in	  turn	  direct	  adaptive	  defense	  responses.	  	  Without	  virus	  replication	  there	  is	  no	  opportu-­‐
nity	   for	   the	   induction	   of	   immunological	   defenses,	   leaving	   the	   host	   defenseless	   during	   reacti-­‐
vated	  infections.	  	  	  
The	  skin	  is	  our	  largest	  organ	  and	  comprises	  varied	  cell	  types,	  nerves,	  glands	  and	  layers.	  
Generally	  it	  is	  described	  as	  being	  made	  up	  of	  three	  layers:	  epidermis,	  dermis	  and	  subcutis	  (sub-­‐
cutaneous)	   (Figure	  6).	  Each	   layer	  contains	  essential	   cell	   types	  characteristic	  of	   that	   layer.	  Cell	  
types	  are	  found	   in	  two	  forms:	   immature	  cell	   types	  (whose	  names	  end	   in	  “-­‐blast”)	  secrete	  the	  
fibers	   and	   ground	   substances	   of	   the	   matrix;	   mature	   and	   terminally	   differentiated	   cell	   types	  




Figure	  6	  Anatomy	  of	  the	  layers	  of	  the	  skin	  (a)	  
	  
The	  skin	  is	  the	  largest	  organ	  and	  comprises	  of	  a	  complete	  mixture	  of	  cell	  types,	  nerves,	  glands	  
and	  layers	  (epidermis,	  dermis	  and	  subcutis/subcutaneous	  tissue).	  	  
Reference:	  File:HumanSkinDiagram.xcf	  	  
	  
It	  is	  within	  the	  layers	  of	  the	  epidermis	  and	  dermis	  that	  keratinocytes	  and	  fibroblasts	  re-­‐
side,	   respectively	   (Figure	   7).	   They	   represent	   the	   largely	   distributed	   population	   of	   cells	   that	  
comprise	  the	  majority	  cell	  type	  of	  their	  respective	  dermal	  layer	  and	  play	  a	  role	  in	  the	  skin’s	  in-­‐
nate	  immune	  response	  to	  any	  pathogen	  (McGrath	  2004).	  These	  cell	  types	  play	  a	  key	  role	  in	  skin	  
innate	   immunity	   by	   first	   recognizing	   pathogens	   via	   their	   membrane-­‐bound	   and	   intracellular	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pattern	   recognition	   receptors	   and	   then	   by	   secreting	   cytokines,	   growth	   factors,	   antimicrobial	  
peptides	   and	  other	   inflammatory	  mediators.	   The	   secretion	  of	   cytokines	   is	   critical	   to	   the	  host	  
cell’s	  inflammatory	  responses,	  the	  recruitment	  of	  macrophages	  and	  neutrophils,	  and	  the	  devel-­‐
opment	  of	  the	  adaptive	  response.	  	  
	  
Figure	  7	  	  	  Anatomy	  of	  the	  layers	  of	  the	  skin	  (b)	  
	  




The	  epithelial	  layer	  of	  the	  skin	  serves	  as	  a	  protective	  barrier	  against	  pathogens	  from	  the	  
outside	   environment.	   It	   is	   a	   four-­‐layered	   stratified,	   non-­‐vascularized	   structure.	   Its	   thickness	  
ranges	  from	  0.1	  mm	  to	  1.4	  mm	  (Weston	  2007)	  (Gawkrodger	  2002;	  Kanitakis	  2002;	  Akgun	  2010)	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The	  upper	  (outermost)	  layer	  of	  cells	  are	  continuously	  renewed	  from	  cells	  of	  the	  innermost	  layer	  
of	  the	  epithelium	  (basal)	  as	  the	  cells	  divide	  and	  are	  pushed	  upward	  to	  the	  surface	  (outermost	  
layer)	  (Gawkrodger	  2002;	  Kanitakis	  2002;	  Weston	  William	  L	  2007;	  Akgun	  2010).	  Differentiated	  
cells,	  called	  keratinocytes	  because	  they	  produce	  keratin,	  comprise	  the	  majority	  cell	  type	  of	  the	  
epidermis.	  Preliminary	  experiments	  (unpublished)	  have	  shown	  that	  keratinocytes	  are	  suscepti-­‐
ble	  to	  B	  virus	  infection.	  Keratinocytes	  are	  present	  in	  the	  four	  layers	  of	  the	  epidermis,	  each	  layer	  
consisting	  of	  cells	  that	  are	  at	  a	  different	  maturation	  stage	  (Fritsch	  2008).	  The	  uppermost	  layer	  
of	   the	   epidermis	   is	   continuously	   replenished;	   it	   takes	   approximately	   30	   days	   for	   the	   non-­‐
keratinized	  cells	  to	  become	  keratinized	  and	  move	  from	  the	  basal	  membrane	  to	  the	  uppermost	  
layer	  (Weston	  William	  L	  2007).	  Other	  cell	  types	  distributed	  within	  the	  epidermis	  are	  Langerhans	  
cells	   (3-­‐6%),	  melanocytes	   (5-­‐10%),	  Merkel	   cells	   (least	   quantity)	   and	   T	   cells,	   all	   of	  which	   have	  
their	   specialized	   function	   (Gawkrodger	   2002;	   Kanitakis	   2002;	   Plonka,	   Passeron	   et	   al.	   2009;	  
Akgun	  2010).	  	  
Langerhans	  cells	  are	  a	  mobile	  dendritic	  cell	  subset	  of	  antigen-­‐presenting	  cells	  that	  take	  
up	  antigen	  and	  present	   it	   to	   resident	  naïve	  T	  cells	  within	   the	  epidermis,	  activating	   the	  T	  cells	  
and	  the	  immune	  response	  (Kanitakis	  2002;	  Tuchinda	  and	  Gaspari	  2010).	  
Melanocytes	  are	  specialized	  cells	  that	  synthesize	  the	  pigment	  melanin.	  These	  cells	  use	  
their	  dendritic	  processes	   to	   transfer	   the	  melanin	   to	  basal	  mitotically	   active	   keratinocyte	   cells	  
(Gawkrodger	  2002;	  Weston	  William	  L	  2007).	  The	  melanin,	  which	  rests	  like	  a	  cap	  over	  the	  nuclei	  
of	   keratinocytes,	   functions	   to	   protect	   cells	   from	  UV	   rays	   (Gawkrodger	   2002;	   Kanitakis	   2002;	  
Weston	  2007;	  Weston	  William	  L	  2007).	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Merkel	   cells	   are	   cells	   with	   neuroendocrine	   and	   endothelial	   features	   that	   are	   in	   close	  
contact	  with	  the	  innervating	  sensory	  nerves	  of	  the	  epidermis	  (Kanitakis	  2002).	  They	  appear	  to	  
play	  a	  role	  in	  sensation,	  acting	  as	  mechanoreceptors	  (Gawkrodger	  2002;	  Kanitakis	  2002).	  
T	  cells	  with	  various	  functions	  can	  be	  found	  circulating	  in	  the	  epidermis.	  The	  different	  T	  
cells	   types	  present	   are	   T	  helper	   (Th)	   cells,	   delayed	  hypersensitivity	   T	  helper	   cells,	   cytotoxic	   T	  
(Tc)	  cells	  and	  suppressor	  T	  (Ts)	  cells	  (Gawkrodger	  2002).	  
2.3 Keratinocytes	  
As	  mentioned	   previously,	   keratinocytes	   represent	   the	  majority	   (85%)	   cell	   type	   in	   the	  
epidermis	  (Figure	  8).	  Generated	  in	  the	  basal	  layer	  of	  the	  epidermis,	  keratinocytes	  produce	  kera-­‐
tin	  as	  they	  mitotically	  divide	  and	  move	  towards	  the	  apical	  surface	  of	  the	  skin	  (Reue	  and	  Glueck	  
2001;	   Tchkonia,	   Tchoukalova	   et	   al.	   2005).	   They	   have	   been	   shown	   to	   secrete	   a	   plethora	   of	  
growth	  factors	  and	  cytokines,	  such	  as	  fibroblast	  growth	  factor	  (FGF),	  colony-­‐stimulating	  factor	  
(CSF),	   TGF-­‐α,	   TGF-­‐β,	   amphiregulin,	  platelet-­‐derived	  growth	   factor	   (PDGF),	   IL-­‐1,	   IL-­‐3,	   IL-­‐6,	   IL-­‐8,	  
and	   TNF-­‐α	   (Reue	   and	  Glueck	   2001;	   Tchkonia,	   Tchoukalova	   et	   al.	   2005).	   They	   have	   also	   been	  
shown	   to	   express	  MHC	   class	   II	   antigens,	   to	   express	   intracellular	   adhesion	  molecule	   (ICAM-­‐1)	  
and	   to	  play	  a	   role	   in	   tissue	  homeostasis,	  wound	  repair	  and	  certain	  cancers	   (Reue	  and	  Glueck	  
2001;	  Tchkonia,	  Tchoukalova	  et	  al.	  2005).	   In	  the	  verification	  and	  characterization	  of	  fibroblast	  
primary	  cell	   lines,	  companies	  have	  consistently	  used	  immunofluorescencent	  methods	  with	  an-­‐
tibodies	  to	  cytokeratins.	  The	  cytokeratins	  group	  consists	  of	  approximately	  29	  different	  proteins	  
that	   are	   characteristic	   of	   epithelial	   cells	   and	   are	   intermediate	   filaments	   of	   epithelial	   cells	   in	  
keratinizing	  tissue	  (skin).	  Cytokeratin	  is	  a	  heterodimer	  of	  type	  I	  (acidic	  polypeptides)	  and	  type	  II	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(basic	  polypeptides)	  keratins;	  at	  least	  one	  member	  of	  the	  acidic	  and	  basic	  family	  is	  expressed	  in	  
all	   epithelial	   cells	   (Hudson	   2002).	   Commercially	   available	   fluorescent	   antibodies,	   which	   have	  
cytoplasmic	   staining,	   are	   frequently	   used	   to	   determine	   if	   neoplasms	   and	   other	   tumors	   origi-­‐




Figure	  8.	  Major	  cell	  type	  within	  the	  epidermis	  
	  
Keratinocytes	  produce	  keratin	  as	  they	  mitotically	  divide	  and	  move	  towards	  the	  apical	  surface	  of	  
the	  skin.	  Shown	  above	  are	  the	  layers	  within	  the	  epidermis.	  It	  is	  within	  these	  layers	  that	  the	  con-­‐
tinuous	   process	   of	   keratinization	   of	   the	   cells	   occurs	   as	   they	  move	   towards	   the	   surface.	   Thus	  






The	  dermis	  is	  a	  two-­‐layered	  supportive	  connective	  tissue	  structure	  that	  lies	  in	  close	  con-­‐
tact	  with	  the	  epidermis.	  Its	  thickness	  is	  between	  0.6-­‐3.0	  mm	  and	  it	  contains	  vascularized	  struc-­‐
tures,	  nerves,	  nerve	  endings,	  hair	   follicles,	  sebaceous	  glands	  and	  cells	  associated	  with	  the	   im-­‐
mune	   response	   (Phillip	   2001;	  Weston	   2007)(Figure	   9).	  Within	   the	   dermis,	   collagen	  makes	   up	  
70%	  of	  the	  matrix;	  fibroblasts	  constitute	  the	  majority	  cell	  type;	  dendritic	  cells	  are	  present;	  and	  
over	   90%	  of	   the	   circulating	   T	   cells	   associated	  with	   the	   skin	   are	   found	   (Bos	   JD	   and	  ML.	   1987;	  
Gawkrodger	   2002;	  Weston	  William	   L	   2007).	   The	  elasticity	  within	   the	  dermis	   is	   provided	  by	   a	  
matrix	  of	  elastin	  fibers	  loosely	  arranged	  in	  many	  directions,	  while	  the	  collagen	  (the	  major	  struc-­‐
tural	  protein)	   imparts	   some	  rigidity	  and	  accounts	   for	  70-­‐80%	  of	   the	  dry	  weight	  of	   the	  dermis	  
(Gawkrodger	  2002).	  The	  proteoglycans	  glycosaminoglycans	  (GAG),	  commonly	  referred	  to	  as	  the	  
‘ground	  substance’	  of	   the	  dermis,	   is	   thought	  to	  provide	  viscosity	  and	  hydration	  to	  the	  dermis	  
(Gawkrodger	  2002).	  Chondroitin	  sulphate	  represents	  the	  major	  GAG	  in	  the	  dermis	  followed	  by	  







Figure	  9	  	  Major	  cell	  type	  within	  the	  dermis	  
	  
Fibroblasts	  constitute	  the	  major	  cell	  type	  of	  the	  dermis	  and	  are	  generally	  the	  predominant	  cell	  
type	  of	  connective	  tissues.	  They	  secrete	  collagen,	  elastin,	  GAG	  and	  other	  connective	  tissue	  ele-­‐
ments	   to	   create	   a	  non-­‐rigid	   extracellular	  matrix.	  Within	   the	  dermis	  one	  will	   find	  other	   struc-­‐







As	  previously	  mentioned,	  fibroblasts	  constitute	  the	  majority	  cell	  type	  in	  the	  dermis	  and	  
are	   generally	   the	   predominant	   cell	   type	   of	   connective	   tissues	   (Bos	   JD	   and	   ML.	   1987;	  
Gawkrodger	  2002;	  Kanitakis	  2002;	  Weston	  William	  L	  2007)	  (Figure	  9).	  They	  are	  mesenchymal-­‐
derived	  cells	  that	  can	  be	  spindle-­‐	  (more	  common)	  or	  stellate-­‐shaped	  and	  are	  widely	  used	  for	  in	  
vitro	   studies	   of	   cellular	   and	   molecular	   events	   in	   hosts	   (Gabbiani	   1981;	   Kanitakis	   2002;	   Stair	  
2004).	  	  	  
Fibroblast	  primary	  cell	  lines	  for	  many	  species	  are	  currently	  available,	  and	  they	  are	  easy	  
to	  maintain	  in	  culture	  (Gabbiani	  1981;	  Stair	  2004).	  It	  has	  been	  suggested	  that	  fibroblasts	  in	  dif-­‐
ferent	  parts	  of	  the	  body	  are	  intrinsically	  different,	  and	  because	  of	  these	  differences	  care	  should	  
be	  taken	  in	  deciphering	  which	  anatomical	  location	  they	  are	  derived	  from	  when	  used	  in	  a	  study	  
(Gabbiani	  1981;	  Stair	  2004).	  Fibroblasts	  secrete	  collagen,	  elastin,	  GAG	  and	  other	  connective	  tis-­‐
sue	  elements	  to	  create	  a	  non-­‐rigid	  extracellular	  matrix	  (Gabbiani	  1981;	  Gawkrodger	  2002;	  Stair	  
2004).	  
In	  the	  verification	  and	  characterization	  of	  this	  type	  of	  primary	  cell	  line,	  fibroblast	  identi-­‐
fication	  and	  characterization	  has	  not	  only	  been	  done	  by	  microscopic	  visualization	  of	  their	  spin-­‐
dle-­‐shaped	   morphology,	   but	   also	   by	   immunofluorescencent	   methods	   with	   antibodies	   to	   fi-­‐
bronectin,	   vimentin	  and/or	  Te7	  antigen.	   Fibronectin	   is	   a	   glycoprotein	  present	   in	  a	   soluble	  di-­‐
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meric	   or	   multimeric	   (200	   kDa	   each	   subunit)	   form	   in	   the	   matrix	   and	   surface	   of	   fibroblasts	  
(Gabbiani	  1981;	  Stair	  2004).	  
Langerhans	  cells	  are	  cutaneous	  immune	  cells	  of	  the	  epidermis	  and	  dermis.	  They	  are	  col-­‐
lectively	   referred	   to	  as	   cutaneous	  dendritic	   cells	  or	  professional	   antigen	  presenting	   cells,	   and	  
are	  responsible	  for	  T-­‐lymphocyte	  mediated	  immunity	  within	  the	  skin	  (Nicolas	  and	  Schmitt	  1984;	  
Wu,	  Grouard-­‐Vogel	  et	  al.	  2000;	  Valladeau	  and	  Saeland	  2005).	  They	  have	  the	  ability	  to	  differen-­‐
tiate	   into	   mature	   dendritic	   cells,	   present	   protein-­‐dervived	   peptide	   antigens	   to	   naive	   T-­‐
lymphocytes,	   and	   are	   able	   to	   move	   between	   layers	   of	   the	   skin	   and	   draining	   lymph	   nodes	  
(Valladeau	  and	  Saeland	  2005)	  .	  
It	  is	  known	  that	  many	  viruses	  have	  co-­‐evolved	  with	  their	  natural	  host	  so	  that	  the	  host’s	  
immune	  system	  and	  other	   intra-­‐signaling	  networks	  are	  manipulated	   to	   favor	  virus	   replication	  
and	  not	  cause	  death.	  Therefore,	   it	   is	   reasonable	   to	  assume	  that	  different	  species	  would	  have	  
different	   responses	   to	   infection.	   To	   understand	   the	   influence	   virus-­‐host	   interactions	   have	  on	  
host	  range	  (natural	  versus	  foreign)	  and	  the	  extent	  of	  virulence	  observed	  within	  each	  potential	  
host	  it	  is	  necessary	  to	  have	  cell	  lines	  that	  are	  representative	  of	  similar	  sites	  of	  infection	  in	  both	  
the	  natural	  and	  foreign	  host.	  These	  cell	   lines	  should	  be	  representative	  of	  the	   in	  vivo	  situation	  
after	  infection	  (at	  the	  site	  of	  infection),	  so	  an	  accurate	  analysis	  and	  determination	  of	  genes	  that	  
are	  key	  regulators	  of	  virulence	  are	  identified.	  The	  use	  of	  comparable	  cell	   lines	  from	  each	  host	  
(macaque	   and	   human)	   that	   are	   from	   similar	   locations	   (epidermal	   or	   dermal	   origin)	   has	   two	  
benefits:	  it	  enables	  one	  to	  delineate	  transcriptional	  responses	  that	  occur	  in	  the	  host’s	  (foreign	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or	  natural)	  response	  to	  infection;	  and	  it	  allows	  one	  to	  identify	  potential	  points	  within	  the	  cas-­‐
cade	  of	  transcriptional	  responses	  that	  can	  be	  used	  as	  drug	  targets	  against	  infection.	  	  
Currently,	  unlike	  human	  fibroblasts,	  macaque	  fibroblasts	  are	  not	  available	  for	  purchase.	  
Thus,	  to	  effectively	  investigate	  host	  responses	  in	  primary	  fibroblast	  cells	  derived	  from	  the	  natu-­‐
ral	  (macaque)	  and	  foreign	  (human)	  host	  after	  B	  virus	  infection	  in	  vitro,	  it	  necessitated	  the	  estab-­‐
lishment	  of	  a	  primary	  macaque	   fibroblast	   cell	   line.	   	   These	  cells	  were	   then	  used	   for	  all	   subse-­‐
quent	  comparative	  analyses.	  
3 Specific	   Aim	   II:	   Identify	   the	   specific	  MAPK	   responses	   induced	   by	   B	   virus	   in	   acutely	   in-­‐
fected	  cells.	  	  
3.1 Introduction	  
The	  initiation	  of	  molecular	  pattern	  recognition	  events	  at	  the	  cell	  surface	  and	  in	  the	  cy-­‐
toplasm	  via	   the	  pattern	  associated	  molecular	  patterns	   (PAMPs)	  and	  pathogen	   recognition	   re-­‐
ceptors	   (PRRs)	  occurs	  when	  any	  pathogen	  enters	  a	  host	   (foreign	  or	  natural).	   The	   subsequent	  
induction	  of	  host	  cell	  signaling	  pathways	  and	  other	  biochemical	  changes	  involved	  in	  innate	  im-­‐
mune	  response	  can	  be	  characterized	  as	  a	  molecular	  signature.	  This	  signature	  begins	  at	  the	  time	  
of	  infection	  and	  varies	  depending	  on	  the	  pathogen	  and	  the	  host.	  The	  ability	  of	  an	  infected	  cell	  
to	  quickly	  sense	  the	  invading	  pathogen	  and	  stimulate	  the	  immune	  response	  or	  induce	  cell	  death	  
via	  interconnected	  downstream	  signaling	  pathways	  is	  thus	  of	  great	  importance.	  	  
The	  methods	  employed	  by	  pathogens	  such	  as	  viruses	  to	  manipulate	  cellular	  targets	  and	  
signaling	  pathways	   for	   their	  benefit	   to	  encourage	  a	  productive	   infection	   can	  be	   considered	  a	  
39	  
	  
molecular	  signature	  of	  that	  pathogen.	  The	  initial	  recognition	  of	  a	  virus	  by	  a	  host	  cell	  is	  usually	  
due	  to	  genetic	  and	  non-­‐genetic	  viral	  components	  that	  trigger	  cell	  signaling	  events	  of	  the	  innate	  
immune	   response.	   Three	   primary	  modes	   have	   been	   suggested	   for	   triggering	   the	   cellular	   re-­‐
sponse	  to	  infection:	  the	  binding	  of	  viral	  glycoproteins	  to	  cellular	  receptors,	  the	  presence	  of	  de	  
novo	  viral	  proteins	  or	  genomic	  material,	  and	  the	  expression	  of	  viral	  mRNA	  or	  viral	  genes	  during	  








3.2 The	  first	  line	  of	  defense:	  detection	  and	  activation	  	  
Two	  key	  events	  must	  occur	  to	  have	  an	  effective	   innate	   immune	  response:	   first,	  detec-­‐
tion	  of	  the	  pathogen	  via	  pattern	  recognition	  receptors	  (PRRs)	  and,	  secondly,	  initiation	  and	  acti-­‐
vation	  of	  protein	  signaling	  cascades,	  leading	  to	  cytokine	  secretion	  and	  apoptosis.	  	  
Pathogen	  associated	  molecular	  patterns	  (PAMPs)	  are	  evolutionary	  conserved	  structures	  
that	  are	  present	  on	  pathogenic	  and	  non-­‐pathogenic	  organisms	   (Medzhitov	  2007;	  Rasmussen,	  
Reinert	  et	  al.	  2009).	  Within	  cells	   they	  allow	  for	  cellular	   recognition,	  and	  discrimination	  of	  self	  
(Medzhitov	  2007).	  However,	  many	  pathogenic	  organisms	  share	  PAMPs	  that	  are	  recognized	  by	  a	  
specified	   group	   of	   nucleotide	   sensing	   receptors	   called	   pattern	   recognition	   receptors	   (PRRs)	  
(Medzhitov	  2007).	  	  
PRRs	  are	  constitutively	  expressed	  in	  host	  cells	  and	  are	  able	  to	  detect	  pathogens	  regard-­‐
less	  of	  their	   life-­‐cycle	  stage	  (Akira,	  Uematsu	  et	  al.	  2006).	  Unlike	  adaptive	   immune	  recognition	  
which	   is	  mediated	  by	   antigen	   receptors	   on	   varied	   cell	   types,	   PRRs	   are	   involved	   in	   innate	   im-­‐
mune	  recognition	  and	  have	  broad	  specificity	  as	  they	  function	  to	  sense,	  gather	  and	  relay	  mes-­‐
sages	  to	  downstream	  signaling	  pathways	   involved	  in	  the	   innate	   immune	  response	  (Medzhitov	  
2007).	   The	   cellular	   location	   of	   the	   PRR	   can	   be	   at	   the	   surface	   of	   cell	  membranes,	   within	   the	  
membranes	  of	  endosomes	  and	  within	  the	  cytoplasm	  of	  the	  cell.	  Toll-­‐like	  receptors	  (TLRs)	  repre-­‐
sent	  the	  membrane	  bound	  PRRs.	  Examples	  of	  cytoplasmic	  PRRs	  are	  TLRs,	   interferon-­‐inducible	  
dsRNA	  activated	  protein	  kinase/protein	  kinase	  R	  (PKR),	  2’5’	  Oligoadenylate	  synthase	  (2’5’OAS),	  
Nod-­‐like	  receptors	  (NLRs),	  retinoic	  acid-­‐inducible	  gene	  I	  (RIG	  I),	  melanoma	  differentiation	  asso-­‐
ciated	  gene	  5	  (MDA5),	  DNA-­‐dependent	  activator	  of	   IFN-­‐regulatory	  factors	  (DAI)	  and	  absent	   in	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melanoma	  2	   (AIM2)	   (Akira	   and	  Takeda	  2004;	  Akira,	  Uematsu	  et	   al.	   2006).	   Each	  of	  which	  has	  
ligand	  specificity	  within	  cells	  and	  is	  not	  necessarily	  present	  in	  all	  cells	  (Akira	  and	  Takeda	  2004;	  
Akira,	  Uematsu	  et	  al.	  2006).	  	  
Generally,	   viruses	   enter	   cells	   by	   directly	   binding	   to	   receptors	   on	   the	   cell	   surface	   and	  
then	  enter	  the	  cytoplasm,	  via	  a	  pH-­‐dependent	  mechanism	  involving	  the	  endocytotic	  pathway,	  
or	   involving	  endocytosis.	  Viral	   glycoproteins,	  proteins	  and	  nucleotide	   structures	  are	   the	  main	  
PAMPs	  detected	  by	  infected	  cells.	  Detection	  of	  the	  viral	  PAMP	  by	  early	  sensor	  systems	  leads	  to	  
many	  sequential	  and	  non-­‐sequential	  signaling	  events	  for	  genes	  involved	  in	  the	  innate	  and	  adap-­‐
tive	   immune	   response	   to	   be	   expressed	   (Akira	   and	   Takeda	   2004;	   Akira,	   Uematsu	   et	   al.	   2006;	  
Christensen	  and	  Thomsen	  2009).	  	  
3.3 Membrane	  bound	  pathogen	  recognition	  receptors:	  Toll-­‐like	  receptors	  (TLRs)	  
Present	  in	  plants,	  invertebrates	  and	  vertebrates,	  Toll-­‐like	  receptors	  (TLRs)	  represent	  one	  
of	  the	  most	  characterized	  signaling	  pathogen	  recognition	  receptors	  (PRRs).	  TLRs	  are	  membrane	  
bound	  PRRs	   that	  are	  able	   to	  detect	  PAMPs	  on	   the	  cell	   surface,	  within	   the	  extracellular	   space	  
and	  within	  endosomes	  (Rasmussen,	  Reinert	  et	  al.	  2009).	  In	  mammals,	  there	  are	  thirteen	  mem-­‐
bers	  of	  the	  TLR	  family,	  ten	  of	  which	  are	  conserved	  between	  humans	  and	  mice,	  and	  it	  has	  been	  
suggested	  that	  phagocytic	  cells	  such	  as	  macrophages,	  neutrophils	  and	  dendritic	  cells	  constitu-­‐









Structurally	   TLRs	   are	   transmembrane	   proteins	  with	   cytoplasmic	   domains	   that	   are	   ho-­‐
mologous	  with	  the	  interleukin	  (IL)-­‐1	  receptor	  super-­‐family	  and	  have	  leucine	  rich	  repeats	  (LRR)	  
that	  recognize	  the	  PAMP	  (Medzhitov	  2007)	  (Figures	  11	  and	  12).	  	  The	  homology	  within	  their	  cy-­‐
toplasmic	  domain	  is	  referred	  to	  as	  the	  Toll-­‐interleukin	  receptor	  (TIR)	  domain.	  Ligand	  binding	  to	  
TLRs	  leads	  to	  multimerization	  and	  receptor-­‐clustering,	  followed	  by	  the	  assembly	  of	  intracellular	  
adaptor	  molecules	  each	  of	  which	  has	  a	  TIR	  domain.	  The	  combination	  of	  the	  adaptor	  molecules	  






















Figure	  13	  Adaptor	  molecule	  combinations	  signaling	  that	  allow	  for	  TLR	  specificity	  in	  signaling	  
	  
3.3.1 Cytosolic	  pattern	  recognition	  receptors	  
Cytosolic	   PRRs	   can	   be	   divided	   into	   retinoic	   acid-­‐inducible	   gene	   I	   (RIGI)-­‐like	   receptors	  
(RLRs)	  and	  nucleotide-­‐binding	  oligomerization	  domain	  (NOD)-­‐like	  receptors	  (NLRs)	   (Mogensen	  
2009).	  RIGI	  and	  MDA5	  are	  two	  well-­‐studied	  RLRs	  that	  function	  as	  RNA	  heilcases	  to	  sense	  cyto-­‐
plasmic	  RNA	  by	  binding	  of	  dsRNA,	  5’triphosphate	  RNA	  or	  self-­‐derived	  small	  RNAs	  generated	  by	  
RNase	  L	  to	  their	  C-­‐terminal	  domain	  (Mogensen	  2009).	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   NLRs	  belong	  to	  a	  family	  of	  innate	  immune	  receptors	  that	  have	  an	  N-­‐terminal	  ef-­‐
fector	  domain	  (downstream	  signaling),	  central	  nucleotide-­‐binding	  NACHT/NAD	  domain	  (ligand	  
induced	  self-­‐oligomerization)	  and	  a	  C-­‐terminal	  LLR	  domain	  (recognition	  of	  PAMPs)	  (Mogensen	  
2009;	  Rasmussen,	  Reinert	  et	  al.	  2009).	  The	  NLRs	  can	  be	  further	  subdivided	  into	  the	  NODs	  and	  
Nalps	  (NACHT,	  LLR	  and	  pyrin	  domain	  (PYD)	  containing)	  (Rasmussen,	  Reinert	  et	  al.	  2009).	  NOD1	  
and	  NOD2	  represent	  the	  two	  best-­‐characterized	  NODs,	  whereas	  Napl1	  and	  Nalp3	  represent	  the	  
two	   best-­‐characterized	   Nalps	   (Mogensen	   2009;	   Rasmussen,	   Reinert	   et	   al.	   2009).	   	   Nalp1	   and	  
Nalp3	  play	  an	  important	  role	   in	  assembly	  of	  the	  inflammasome	  complex,	  which	  is	  responsible	  
for	  caspase-­‐1	  activation	  and	  the	  downstream	  production	  of	  IL-­‐1β	  and	  IL-­‐18	  (Rasmussen,	  Reinert	  
et	  al.	  2009).	  
The	  interferon	  inducible	  dsRNA	  protein	  kinase,	  PKR,	  is	  another	  well-­‐characterized	  cyto-­‐
solic	  sensor.	  Upon	  binding	  to	  dsRNA,	  5’triphosphate	  RNA	  or	  poly	  (I-­‐C),	  a	  conformational	  change	  
in	  PKR	  occurs	  that	  allows	  for	  its	  autophosohoylation,	  dimerization	  and	  subsequent	  phosphory-­‐
altion	  of	  eukaryotic	  initiation	  translation	  factor	  alpha	  (eIF2α),	  for	  the	  inhibition	  of	  protein	  syn-­‐
thesis	  in	  the	  cell	  (Mogensen	  2009).	  
Currently	   known	   cytoplasmic	   DNA	   sensors	   are	   DNA-­‐dependent	   activator	   of	   IFN-­‐
regulatory	   factors	   (DAI),	   absent	   in	   melanoma-­‐2	   (AIM	   2)	   and	   FI16	   (an	   AIM	   2-­‐like	   receptor)	  
(Rasmussen,	  Reinert	  et	  al.	  2009;	  Unterholzner,	  Keating	  et	  al.	  2010).	  DAI	  was	  the	  first	  identified	  
cytosolic	  DNA	  sensor	  that	  has	  been	  shown	  to	  activate	  the	  IRF-­‐family	  of	  transcription	  factors	  via	  
its	   C-­‐terminal	   region	   (Rasmussen,	   Reinert	   et	   al.	   2009).	  DAI	   activation	   involves	  DAI	   binding	   to	  
DNA	  in	  a	   length	  dependent	  manner	  and	   is	   independent	  of	  the	  form	  of	  the	  DNA	  (B	  or	  Z-­‐form)	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(Rasmussen,	  Reinert	  et	  al.	  2009).	  AIM	  2	  and	   IFl16	  are	  PYHIN	  proteins	  belonging	  to	   the	  PYHIN	  
protein	  family	  that	  contains	  a	  pyrin	  domain	  and	  two	  DNA-­‐binding	  HIN	  domains	  (Unterholzner,	  
Keating	  et	  al.	  2010).	  Upon	  sensing	  exogenous	  viral	  dsDNA,	  Aim	  2	  plays	  a	  role	  in	  inflammasome	  
complex	  formation	  for	  the	  activation	  of	  caspase-­‐1	  and	  Fl16	  plays	  a	  role	  in	  the	  induction	  of	  IFNβ	  
via	  IRF3	  and	  NFkB	  induction	  in	  addition	  to	  its	  regular	  role	  in	  cell	  proliferation	  and	  differentiation	  
(Unterholzner,	  Keating	  et	  al.	  2010).	  	  
Inflammasomes	   are	   considered	   caspase-­‐1	   activating	  molecular	   platforms	   that	   lead	   to	  
the	   activation	   downstream	   production	   of	   proinflamatory	   cytokines	   (Schroder	   and	   Tschopp	  
2010).	  	  Caspases	  are	  cysteinie	  proteases	  whose	  activity	  is	  regulated	  by	  proteolytic	  cleavage	  and	  
their	  activity	  can	  be	  divided	  into	  two	  categories:	  proinflammatory	  caspases	  (caspase-­‐1,	  -­‐11,	  -­‐12)	  
and	  pro-­‐apoptotic	  caspases	   (caspase-­‐1,	   -­‐4,	   -­‐5)	   (Schroder	  and	  Tschopp	  2010).	  Caspase-­‐1	   is	   the	  
most	   characterized	  proinflammatory	   caspase	   that	  plays	  a	   role	   in	   inflammasome	  complex	   for-­‐
mation.	   The	   inflammasome	   complex	   consists	   of	   self-­‐oligimerization	   proteins	   such	   NLRs	   and	  
AIM2	  (Schroder	  and	  Tschopp	  2010).	  The	  components	  (NLRP1,	  NLRP3	  IPAF	  and	  AIM2)	  within	  the	  
protein	   scaffold	   determine	   the	   activation	   mechanism	   of	   the	   inflammasome	   to	   mediate	   the	  
caspase-­‐1	  dependent	  processing	  of	  the	  inflammatory	  cytokines	  (Schroder	  and	  Tschopp	  2010).	  
3.4 Virus-­‐mediated	  PRR	  
Viruses	  have	  many	  PAMPs	  that	  may	  be	  present	  on	  the	  infecting	  virion	  (such	  as	  viral	  gly-­‐
coproteins)	   or	  may	   be	   produced	   during	   viral	   replication	  within	   the	   cell	   (such	   as	   nucleic	   acid	  
structures	  DNA	  or	  RNA).	  In	  general,	  research	  has	  shown	  that	  TLRs	  2,	  3,	  4,	  7,	  8	  and	  9	  are	  able	  to	  
detect	  nucleic	  acids	  or	  glycoproteins	  which	  are	  PAMPs	  associated	  with	  viral	  infection	  (Akira	  and	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Takeda	  2004;	  Christensen	  and	  Thomsen	  2009).	  HSV-­‐1	  and	  HSV-­‐2	  infection	  is	  known	  to	  activate	  
the	  innate	  immune	  response	  via	  TLR	  dependent	  pathways	  (TLR2,	  3	  and	  9)	  and	  TLR	  independent	  
pathways	  (RIG-­‐I,	  DAI,	  PKR)	  (Zhu	  2007;	  Daubeuf,	  Singh	  et	  al.	  2009).	  Though	  the	  mechanism	  is	  not	  
clearly	  understood,	  TLR2	  has	  been	  shown	  to	  recognize	  HSV	  viral	  surface	  glycoprotein,	  and	  the	  
recognition	   of	  HSV	  by	   TLR9	   appears	   to	   be	   due	   to	   the	   unmethylated	   CpG	  motifs,	   though	   this	  
recognition	  has	  been	  cell-­‐type	  specific	  (Mogensen	  2009).	  Cytosolic	  PRRs,	  such	  as	  RLRs,	  DAI	  and	  
PKR,	  have	  also	  been	  shown	  to	  play	  a	  role	  in	  the	  recognition	  of	  HSV	  (Malmgaard,	  Melchjorsen	  et	  
al.	  2004;	  Rasmussen,	  Sorensen	  et	  al.	  2007;	  Zhu	  2007;	  Mogensen	  2009).	  	  
3.5 Adaptor	  molecules	  linking	  pattern	  recognition	  receptors	  (PRRs)	  to	  signaling	  cascades	  
As	   previously	  mentioned,	   upon	   TLR	   stimulation	   by	   ligand	   binding	   or	   the	   detection	   of	  
PAMPs	  within	  the	  cytoplasm	  the	  induction	  of	  receptor	  dimerization	  and	  associated	  conforma-­‐
tional	  changes	  that	  occur	  allow	  for	  cytosolic	  adaptor	  proteins	  to	  be	  recruited	  to	  their	  TLR	  TIR	  
domains.	   The	   adaptor	  molecules,	  MyD88	   and	   TIR	   domain-­‐containing	   adaptor	   inducing	   IFN-­‐β	  
(TRIF),	  represent	  the	  two	  primary	  adaptors	  that	  are	  recruited	  to	  the	  TIR	  domains	  of	  TLRs	  (Akira,	  
Uematsu	  et	  al.	  2006;	  Zhong,	  Tien	  et	  al.	  2006;	  Mogensen	  2009;	  Rasmussen,	  Reinert	  et	  al.	  2009)	  
(Figure	  14).	  	  
Examples	  of	  TLRs	  that	  use	  different	  adaptors	  to	  connect	  to	  signaling	  cascades	  are	  TLR3,	  
TLR4	  and	  TLR9	  (Zhong,	  Tien	  et	  al.	  2006).	  To	  activate	  the	  IkB	  kinases	  (IKKs),	  MAPKs,	  TLR3	  utilizes	  
the	  MyD88-­‐independent	   and	   TRIF-­‐dependent	   pathways;	   TLR4	   utilizes	   the	  MyD88–dependent	  
and	  TRIF-­‐dependent	  pathways;	  and	  TLR9	  utilizes	  the	  MyD88-­‐dependent	  pathway	  (Zhong,	  Tien	  





Figure	  14.	  	  The	  two	  primary	  adaptor	  molecule	  responsible	  recruited	  to	  TLR	  TIR-­‐domains.	  
	  
The	  MyD88-­‐dependent	   pathway	   involves	   the	   interaction	   of	  MyD88	  with	   transforming	  
growth	   factor-­‐β-­‐activated	  kinase	   (TAK1),	   TAK	  binding	  protein-­‐1	   (TAB1),	   TAK	  binding	  protein-­‐2	  
(TAB2),	  and	  tumor	  necrosis	  factor	  (TNF)	  receptor-­‐associated	  factor	  6	  (TRAF6)	  (Zhong,	  Tien	  et	  al.	  
2006).	   The	   TRIF-­‐dependent	   pathway	   involves	   the	   interaction	   of	   TRAF	   family-­‐member-­‐
associated	  NFkB	  activator	  (TANK)	  binding	  kinase-­‐1	  (TBK1)	  and	  TRAF6	  to	  activate	  the	  IKKs,	  IRF3/7	  
and	  induce	  caspase	  8	  dependent	  apoptosis	  (Zhong,	  Tien	  et	  al.	  2006).	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Non-­‐TLR	  dependent	  adaptor	  molecule	  virus-­‐induced	  signaling	  adaptor	  (VISA)	  and	  TRAF6	  
are	  known	  to	  associate	  with	  PRRs	  within	  the	  cytoplasm	  such	  as	  the	  DNA	  sensor	  AIM2,	  and	  RIG-­‐
I-­‐like	  receptors	  (RLRs)	  RIG-­‐I	  and	  MDA5	  (Konno,	  Yamamoto	  et	  al.	  2009).	  Initially,	  VISA	  had	  been	  
identified	  by	   four	   independent	   groups,	   and	   as	   a	   result	   VISA	   can	   also	   be	   referred	   to	   as	   inter-­‐
feron-­‐β	  promoter	  stimulator	  1	  (IPS-­‐1),	  mitochondrial	  antiviral	  signaling	  (MAVS)	  or	  Cardif	  (Kawai,	  
Takahashi	  et	  al.	  2005;	  Seth,	  Sun	  et	  al.	  2005).	  	  
3.6 TNF	  receptor	  associated	  factor	  (TRAF)	  mediated	  signal	  transduction	  
TNF	  receptor-­‐associated	  factors	  (TRAFs)	  are	  a	  family	  of	  evolutionarily	  conserved	  multi-­‐
functional	  adaptor	  proteins	  found	  in	  mammals	  that	  bind	  to	  surface	  pattern	  recognition	  recep-­‐
tors	  (PRRs)	  (Arch,	  Gedrich	  et	  al.	  1998;	  Bradley	  and	  Pober	  2001;	  Chung,	  Park	  et	  al.	  2002).	  They	  
physically	  and	  functionally	  connect	  cell	  PRRs	  to	  signaling	  transduction	  pathways	  by	  the	  recruit-­‐
ment	  of	  additional	  proteins	  from	  within	  the	  cytoplasm	  (Bradley	  and	  Pober	  2001;	  Chung,	  Park	  et	  
al.	   2002).	   This	   leads	   to	   the	   formation	  of	  multiprotein	   signaling	   complexes	  on	   the	   cell	   surface	  
and	  within	  the	  cytoplasm	  that	  are	  capable	  of	  initiating	  cellular	  responses	  associated	  with	  inter-­‐
connected	  signaling	  cascades	  (Arch,	  Gedrich	  et	  al.	  1998;	  Bradley	  and	  Pober	  2001;	  Chung,	  Park	  
et	  al.	  2002).	  	  
All	  TRAF	  proteins	  have	  a	  carboxy-­‐terminal	  (C-­‐terminal)	  TRAF	  domain	  (Bradley	  and	  Pober	  
2001;	  Chung,	  Park	  et	  al.	  2002).	  The	  N-­‐terminal	  contains	  a	  RING	  finger	  with	  several	  zinc	  motifs,	  
which	  is	  absent	  only	  in	  TRAF1	  (Chung,	  Park	  et	  al.	  2002).	  It	  has	  been	  shown	  that	  the	  intracellular	  
location	  of	   TRAFs	   changes	  with	  PRR	  activation	   such	   that	   they	   are	  distributed	   throughout the	  
cytoplasm	   or	   to	   intracellular	   punctate	   structures	   in	   resting	   cells	   (Bradley	   and	   Pober	   2001;	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Chung,	  Park	  et	  al.	  2002).	  After	  PRR	  activation	  TRAFs	  can	  be	  rearranged	  within	  the	  plasma	  mem-­‐
brane,	  recruited	  to	  the	  membrane	  rafts	  within	  the	  plasma	  membrane,	  and	  recruited	  to	  the	  nu-­‐
cleus	   and	   perinuclear	   regions	   (Bradley	   and	   Pober	   2001;	   Chung,	   Park	   et	   al.	   2002).	   This	   rear-­‐
rangement	   and	   recruitment	   is	   speculated	   to	   allow	   for	   stabilization	   of	   the	   receptor-­‐adaptor	  
complexes	  near	  to	  cellular	  proteins	  necessary	  for	  signal	  transduction,	  sustained	  signaling	  of	  the	  
activated	   receptor	  and	  sequestering	   to	   regions	   to	  downregulate	   the	  signals	  being	   transduced	  
(Bradley	  and	  Pober	  2001;	  Chung,	  Park	  et	  al.	  2002).	  	  
Currently	   there	   have	   been	   six	   functionally	   divergent	   TRAFs	   identified	   (TRAF1-­‐6)	   that	  
have	  been	  shown	  to	  participate	  in	  the	  regulation	  of	  adaptive	  and	  innate	  immunity,	  embryonic	  
development,	  bone	  metabolism,	  cell	  survival,	  proliferation,	  differentiation	  and	  stress	  responses	  
(Bradley	  and	  Pober	  2001;	  Chung,	  Park	  et	  al.	  2002).	  	  
TRAF1	   is	  unique	  among	   the	  other	  TRAFs	  as	   it	  does	  not	  have	  an	  N-­‐terminal	   ring	   finger	  
and	  shows	  restricted	  tissue	  distribution.	  TRAF1	  can	  interact	  with	  many	  TNFR	  family	  members,	  
inclusive	  of	  herpes-­‐virus	  entry	  mediator	  (HVEM),	  CD30	  and	  CD40	  for	  the	  activation	  of	  NFkB,	  JNK	  
and	  the	  induction	  of	  apoptosis	  (Bradley	  and	  Pober	  2001;	  Chung,	  Park	  et	  al.	  2002).	  
TRAF2	  has	  been	  extensively	  studied	  in	  terms	  of	  structure	  and	  function	  and	  is	  the	  most	  
widely	  expressed	  TRAF	  in	  almost	  every	  tissue	  examined	  (Bradley	  and	  Pober	  2001;	  Chung,	  Park	  
et	  al.	  2002).	  	  It	  has	  been	  shown	  to	  play	  a	  cytoprotective	  role,	  mediating	  signals	  for	  the	  activa-­‐
tion	  of	  the	  transcription	  factors	  NFkB	  and	  activating	  protein-­‐1	  (AP-­‐1)	  (Bradley	  and	  Pober	  2001;	  
Chung,	  Park	  et	  al.	  2002).	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TRAF3	  has	  been	  shown	  to	  interact	  with	  members	  of	  the	  TNF	  receptor	  family	  members	  
and	  to	  be	  important	  in	  T-­‐cell	  dependent	  immune	  responses,	  NFkB	  activation	  and	  inhibition	  as	  
well	  as	  in	  the	  induction	  of	  apoptosis	  (Bradley	  and	  Pober	  2001;	  Chung,	  Park	  et	  al.	  2002).	  
TRAF4	  has	   been	   shown	   to	   be	   the	  only	   TRAF	   that	   localizes	   to	   the	   nucleus,	   and,	   unlike	  
other	  TRAFs,	   it	  does	  not	   regulate	   signaling	   through	  cell	   surface	   receptors	   (Bradley	  and	  Pober	  
2001;	  Chung,	  Park	  et	  al.	  2002).	  Though	  highly	  expressed	  during	  embryogenesis,	  TRAF4	  has	  been	  
shown	  to	  play	  a	  functional	  role	  in	  neural	  multipotent	  cells	  and	  in	  epithelial	  stem	  cells	  in	  adults	  
(Bradley	  and	  Pober	  2001;	  Chung,	  Park	  et	  al.	  2002).	  
TRAF5	   is	   functionally	  and	  structurally	  close	  to	  TRAF2	  (Bradley	  and	  Pober	  2001;	  Chung,	  
Park	  et	  al.	  2002).	  It	  has	  been	  shown	  to	  play	  a	  role	  in	  the	  activation	  of	  NFkB,	  AP-­‐1	  transcription	  
factors	  and	  of	  CD40-­‐	  and	  CD27-­‐mediated	  lymphocytes	  (Bradley	  and	  Pober	  2001;	  Chung,	  Park	  et	  
al.	  2002).	  
TRAF6,	   like	   TRAF2	   and	   TRAF5,	   predominantly	   localizes	   to	   the	  membrane	   regions	   and	  
contains	  a	   receptor	  binding	  specificity	   that	   is	   important	   for	   its	   role	  as	  a	  mediator	  of	  signaling	  
through	  the	  TNF	  receptor	  family	  and	  the	  TLR	  family	  (Bradley	  and	  Pober	  2001;	  Chung,	  Park	  et	  al.	  
2002).	  Functionally,	  TRAF6	  is	  important	  for	  the	  activation	  of	  NFkB,	  JNK,	  and	  p38	  as	  well	  as	  for	  
CD40	  mediated	  signaling	  (Bradley	  and	  Pober	  2001;	  Chung,	  Park	  et	  al.	  2002).	  
Pathogen	   sensing	   by	   PRRs	   that	   interact	   with	   functionally	   divergent	   adaptor	   proteins	  
such	  as	  the	  TRAFs,	  function	  to	  mediate	  incoming	  signals	  (PAMPS)	  and	  recruit	  other	  proteins	  for	  
the	  formation	  of	  signaling	  complexes.	  These	  complexes	  function	  as	  platforms	  for	  activation	  and	  
regulation	  of	  downstream	  signaling	  pathways	  known	  to	  be	   involved	   in	  the	   innate	   immune	  re-­‐
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sponse.	   Suggesting	   that	   the	   different	   adaptors,	   and	   their	   combinations	   utilized	   by	   the	  mem-­‐
brane	  bound	  and	  cytosolic	   sensors	  are	   indispensable,	  and	   form	  a	  major	  part	  of	   the	  early	   cell	  
sensing	  mechanisms	  within	  cells	  that	  function	  to	  detect	  pathogens	  and	  are	  tailored	  to	  influence	  
specific	  pathways,	  some	  of	  which	  may	  overlap	  or	  allow	  for	  cross-­‐talk	  to	  regulate	  the	  transcrip-­‐
tion	  of	  downstream	  genes.	  	  
The	  ability	  of	  TRAFs	  to	  serve	  as	  points	  of	  convergence	  from	  initial	  sensors	  of	  the	  cells,	  
and	  as	  points	  of	  divergence	  for	  downstream	  signaling	  pathways,	  allows	  for	  an	  appropriate	  and	  
tailored	  biological	  response	  to	  be	  mounted.	  
3.7 Major	  signaling	  pathways	  activated	  early	  in	  response	  to	  PRR	  recognition	  
The	  assembly	  of	  intracellular	  adaptor	  protein	  complexes	  after	  PRR	  engagement	  acts	  as	  a	  
platform	  for	  the	  recruitment	  of	  other	  proteins	  involved	  in	  the	  activation	  of	  downstream	  signal-­‐
ing	  cascades	  via	  phosphorylation	  events,	  ubiquitination	  or	  protein-­‐protein	   interactions	   to	  cul-­‐
minate	  with	  the	  activation	  of	  transcription	  factors	  involved	  in	  activating	  and	  regulating	  the	  in-­‐
nate	  immune	  response.	  
The	  main	  signaling	  cascades	  known	  to	  be	  activated	  after	  PRR-­‐adaptor	  engagement	  are	  
nuclear	  factor	  kappa-­‐light-­‐chain-­‐enhancer	  of	  activated	  B	  cells	  (NFkB),	  mitogen-­‐activated	  protein	  
kinase	  (MAPK)	  and	  interferon	  regulatory	  factors	  (IFRs)	  (Bradley	  and	  Pober	  2001;	  Chung,	  Park	  et	  
al.	  2002;	  Mogensen	  2009).	  The	  activation	  of	  the	  MAPK	  and	  NFkB	  pathways	  allows	  for	  induction	  
of	  a	  proinflammatory	  response	  involving	  the	  transcription	  factors	  activator	  protein-­‐1	  (AP-­‐1)	  and	  
NFkB,	   respectively.	   The	   activation	   of	   IRF	   pathway	   allows	   for	   the	   induction	   of	   IFN	   production	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through	   binding	   to	   their	   cognate	   IRF-­‐elements	   in	   promoter	   regions	   for	   IFN	   production	  
(Mogensen	  2009).	  	  
AP-­‐1	  activity	  is	  regulated	  by	  MAPKs	  (JNK	  and	  p38)	  via	  direct	  phosphorylation	  or	  through	  
the	   transcription	   of	   AP-­‐1	   components	   such	   as	   cJun,	   Fos	   and	   activating	   transcription	   factor-­‐2	  
(ATF2)	  (Chung,	  Park	  et	  al.	  2002).	  The	  activation	  of	  NFkB	  can	  be	  through	  adaptor	  complex	  inter-­‐
action	  with	  NIK,	  MEKK1	  and	  MEKK3	  whereas	  the	  activation	  of	  MAPKs	  can	  be	  through	  adaptor	  
complex	   interaction	   with	   upstream	  MAPKs	   such	   as	   apoptosis	   signal-­‐regulating	   kinase	   (ASK1)	  
and	  MEKK1	  (Chung,	  Park	  et	  al.	  2002).	  
3.8 Mitogen-­‐Activated	  Protein	  Kinase	  (MAPK)	  Cascade	  
As	  previously	  mentioned,	  the	  MAPK	  pathway	  consists	  of	  a	  three-­‐tiered	  module	  involving	  
sequential	   tyrosine	   and	   threonine	   phosphorylations	   of	   a	   MAP3	   kinase	   (MAP3K)	   to	   a	   MAP2	  
kinase	  (MAP2K)	  to	  a	  MAP	  kinase	  (MAPK),	  which	  translocates	  to	  the	  nucleus	  and	  acts	  on	  tran-­‐





Figure	  15.	  	  Three	  tiered	  module	  of	  MAPK	  activation	  
	  
MAPKs	  can	  be	  divided	   into	   three	  broad	  categories:	   c-­‐Jun	  NH2-­‐terminal	  kinases	   (JNKs),	  
p38	  MAPK	  and	  extracellular	  signal-­‐related	  kinases	  (ERKs).	   	  Commonly	  referred	  to	  as	  the	  mito-­‐
genic	  MAPKs,	  ERKs	  play	  a	  major	   role	   in	   cell	  division,	  migration	  and	   survival	  whereas	   JNK	  and	  
p38	  play	  important	  roles	  in	  regulating	  apoptosis,	  cell	  cycle	  control,	  and	  inflammatory	  gene	  tran-­‐
scription	   (Figure	  16).	   JNK	  and	  p38	  are	   commonly	   referred	   to	  as	   the	   stress	  associated	  protein	  
kinases	  (SAPKs)	  as	  their	  induction	  was	  initially	  found	  to	  be	  stress	  associated	  (Hargett,	  McLean	  et	  





Figure	  16.	  	  The	  three	  board	  categories	  of	  the	  MAPKs	  casacade	  	  
	  
It	   should	  be	  noted	   that	   though	   the	   canonical	  method	  of	  MAPK	  activation	   involves	   se-­‐
quential	  phosphorylation	   steps	  of	  a	  MAP3K	   to	  a	  MAP2K	   to	  a	  MAPK,	  MAP2K,	  an	   independent	  
method	  of	  activation	  of	  MAPKs	  has	  been	   indentified	  and	  demonstrated	   for	  p38.	  This	  method	  
involves	  p38	  auto-­‐phosphorylaton	  and	  subsequent	  activation	  via	   its	   interaction	  with	  the	  TAK1	  
binding	  protein	  TAB1	  (Jiang,	  Gram	  et	  al.	  1997;	  Ge,	  Gram	  et	  al.	  2002;	  Tanno,	  Bassi	  et	  al.	  2003).	  	  
JNK	   is	  encoded	  by	   three	  genes,	   JNK1,	   JNK2	  and	   JNK3,	   that	  are	  alternatively	   spliced	   to	  
give	  10	   isoforms,	  with	   JNK1	  and	   JNK2	  being	  ubiquitously	  expressed	  and	   JNK3	  being	  primarily	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expressed	   in	   brain,	   heart	   and	   testis	   (Bode	   and	  Dong	   2007;	   Rincon	   and	  Davis	   2009).	   The	   p38	  
gene	  can	  also	  be	  alternatively	  spliced	  to	  produce	  four	  isoforms:	  p38α	  (most	  expressed	  isoform),	  
p38β,	  p38γ	  and	  p38δ	  (Rincon	  and	  Davis	  2009).	  
JNK	  interacts	  with	  many	  cellular	  proteins	  such	  as	  Bcl-­‐2	  family	  member	  proteins,	  14-­‐3-­‐3,	  
MLK2,	  histone	  H3,	  c-­‐Myc	  and	  JIP	  (Bode	  and	  Dong	  2007).	  Transcription	  factors	  cJun,	  JunB,	  ATF2	  
and	  p53	  are	  also	  known	  to	  be	  regulated	  by	  JNK	  (Bode	  and	  Dong	  2007).	  JNK	  has	  been	  shown	  to	  
interact	  hydrophobically	  with	  cJun	  in	  an	  ATP	  independent	  manner	  and	  when	  bound	  to	  JNK,	  cJun	  
is	   targeted	   for	   ubiquitination	   and	   subsequent	   degradation	   (Fuchs,	   Xie	   et	   al.	   1997).	   However,	  
when	  cJun	   is	  serine	  phosphorylated	  by	  JNK	   it	   is	  protected	  from	  ubiquitination	  and	   its	  half-­‐life	  
increased	  (Fuchs,	  Dolan	  et	  al.	  1996;	  Fuchs,	  Xie	  et	  al.	  1997).	  	  
Mitogen-­‐activated	  protein	  kinase	  kinase	  4	  (MKK4)	  and	  mitogen-­‐activated	  protein	  kinase	  
kinase	   7	   (MKK7)	   are	  MAP2Ks	   that	   activate	   JNK	   by	   phosohorylating	   JNK	   on	   a	   tyrosine	   and	   a	  
threonine,	  respectively	  (Fuchs,	  Dolan	  et	  al.	  1996;	  Bode	  and	  Dong	  2007).	  Whereas	  JNK	  inactiva-­‐
tion	  involves	  serine	  and	  tyrosine	  phosphatases	  and	  other	  dual	  specificity	  MAP	  kinase	  phospha-­‐
tases	  (DUSPs/MKPs)	  (Bode	  and	  Dong	  2007).	  	  
The	  state	  of	  JNK	  (active	  or	  inactive)	  along	  with	  its	  interaction	  with	  cellular	  proteins	  tends	  
to	  dictate	  whether	  the	  associated	  protein	  is	  or	  is	  not	  protected	  from	  ubiquitination	  and	  subse-­‐
quent	  degredation	  (Fuchs,	  Dolan	  et	  al.	  1996;	  Fuchs,	  Xie	  et	  al.	  1997).	  	  One	  of	  the	  previously	  men-­‐
tioned	   transcription	   factors,	  p53	   is	   a	   known	   regulator	  of	   apoptosis.	  All	   three	   isoforms	  of	   JNK	  
have	   been	   shown	   to	   regulate	   p53	   activity	   either	   by	   phosphorylation	   for	   sustained	   activation	  
(active	   JNK)	  or	  by	  association	  with	   it	   for	  degradation	   (inactive	   JNK)	   (Fuchs,	  Adler	   et	   al.	   1998;	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Meylan,	  Burns	  et	  al.	  2004).	  Though	  the	  association	  of	   JNK	  with	  p53	  occurs	   in	  most	  cell	   types,	  
the	  regulation	  of	  p53	  has	  been	  shown	  to	  differ	  and	  sometimes	  to	  be	  opposing	  between	  JNK1	  
and	   JNK2	   isoforms	   in	   certain	   cell	   types	   such	   as	   fibroblasts	   (Fuchs,	   Dolan	   et	   al.	   1996).	   In	   this	  
study	   they	   showed	   that	   though	   p53	  was	   phosphorylated	   and	   activated	   under	   stress-­‐induced	  
conditions,	   JNK2	   inhibition	   led	   to	   reduced	   p53	   levels,	   whereas	   inhibition	   of	   JNK1	   led	   to	   in-­‐
creased	  p53	   levels	  and	  cells	  deficient	   in	  both	   isoforms	   led	  to	  no	  expression	  of	  p53	  suggesting	  
that	  cellular	  responses	  can	  be	  differentially	  regulated	  by	  the	  JNK	  isoforms	  (Fuchs,	  Dolan	  et	  al.	  
1996).	   JNK	   isoforms	  have	  also	  been	  shown	  to	  regulate	   the	  half-­‐life	  and	  stability	  of	  cJun,	  such	  
that	  JNK1	  is	  more	  efficient	  in	  phosphorylating	  cJun,	  and	  JNK2	  has	  a	  greater	  affinity	  for	  cJun	  thus	  
targeting	  it	  for	  ubiquitination	  and	  subsequent	  degradation	  (Fuchs,	  Dolan	  et	  al.	  1996).	  
Though	   the	   transcription	   factor	   cJun	   is	  not	  only	  a	   substrate	   for	   JNK	  but	  also	   for	  ERKs,	  
protein	  kinase	  C	  (PKC),	  COOH-­‐terminal	  Src	  kinase	  (CSK),	  DNA-­‐dependent	  protein	  kinase	  (DNA-­‐
PK)	  and	  glycogen	  synthase	  kinase-­‐3	  (GSK-­‐3),	  it	  may	  seem	  misleading	  that	  all	  functional	  models	  
investigating	   JNK	   activity	   within	   cells	   look	   at	   the	   regulation	   of	   cJun	   (Bode	   and	   Dong	   2007).	  
However,	  because	  cJun	  activity	  is	  tied	  to	  AP1	  activation	  and	  cJun	  is	  a	  major	  substrate	  of	  JNKs,	  
the	  correlation	  of	  JNK	  activation	  and	  cJun	  transcription	  remains	  (Bode	  and	  Dong	  2007).	  
	  JNKs	  themselves	  can	  be	  differentially	  regulated	  by	  their	  interaction	  with	  other	  proteins	  
such	  as	   JNK	   interacting	  proteins	   (JIPs).	   JIPs	   function	  to	   inhibit	   the	  kinase	  activity	  of	   JNKs	  such	  
that	  the	  phosohoryalted	  JNK	  is	  unable	  to	  activate	  downstream	  proteins	  that	  are	  influenced	  by	  
phosphorylated	  JNK	  (pJNK)	  (Morrison	  and	  Davis	  2003).	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SAPK	  p38	  activation	  has	  been	  linked	  to	  many	  cellular	  processes	  including	  inflammation,	  
cell	  cycle	  control,	  apoptosis,	  senescence	  and	  tumorigenesis.	  Like	  JNK,	  p38	  has	  been	  shown	  to	  
be	  differentially	  expressed	   in	  varied	  cell	   types,	   such	   that	  p38α	  and	  p38β	  are	   the	  only	  ubiqui-­‐
tously	  expressed	  isoforms;	  p38γ	  is	  predominant	  in	  skeletal	  muscle	  and	  p38δ	  is	  predominant	  in	  
lung,	   kidney,	   testis,	  pancreas	  and	   small	   intestine	   tissues	   (Ono	  and	  Han	  2000;	  Ge,	  Gram	  et	  al.	  
2002;	  Tanno,	  Bassi	  et	  al.	  2003).	  Many	   inflammatory	  diseases	  and	  apoptotic	  events	  have	  been	  
linked	  to	  p38	  activation,	  and	  it	  has	  been	  suggested	  that	  p38	  plays	  a	  major	  role	  in	  the	  secretion	  
of	  proinflammatory	  cytokines	  IL1β,	  TNFα	  and	  IL6	  (Zarubin	  and	  Han	  2005).	  	  
The	  MAPK	  known	  to	  selectively	  activate	  p38	  are	  MKK3	  and	  MKK6	  (Ge,	  Gram	  et	  al.	  2002;	  
Tanno,	  Bassi	  et	  al.	  2003).	  However,	  it	  has	  also	  been	  shown	  that	  MKK4,	  an	  upstream	  kinase	  for	  
JNK	  activation,	  is	  capable	  of	  activating	  p38	  in	  a	  cell-­‐type	  specific	  manner	  and	  may	  thus	  serve	  as	  
a	  site	  of	  integration	  of	  the	  p38	  and	  JNK	  pathways	  (Jiang,	  Gram	  et	  al.	  1997).	  	  
Though	   it	   was	   initially	   thought	   that	   activated	   p38	   (phosphorylated	   p38)	   translocated	  
into	  the	  nucleus,	  it	  has	  also	  been	  shown	  that	  inactivated	  p38	  is	  present	  in	  both	  the	  cytoplasm	  
and	  nucleus	  of	  cells	  and	  upon	  activation,	  translocation	  does	  occur,	  but	  activated	  p38	  can	  also	  
be	  found	  in	  the	  cytoplasm	  (Raingeaud,	  Gupta	  et	  al.	  1995;	  Ben-­‐Levy,	  Hooper	  et	  al.	  1998).	  
There	  are	  few	  defined	  convergent	  and	  divergent	  points	  originating	  from	  the	  sites	  of	  in-­‐
coming	   signal	   integration	  by	  PRRs	  and	   the	  downstream	  activation	  of	  MAPKs	   for	   specificity	   in	  
the	   transcription	   factors	   activated	   through	   different	   upstream	   regulators	   and	   their	   combina-­‐
tions.	  Points	  of	  convergence	  are	  in	  the	  adaptor	  TRAF6,	  and	  points	  of	  divergence	  can	  be	  seen	  in	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within	  the	  MAP3K	  where	  TAK1	  and	  ASK1	  are	  capable	  of	  activating	  both	  the	  p38	  and	  JNK	  path-­‐
way	  (Figures	  17	  and	  18)	  (Jiang,	  Gram	  et	  al.	  1997;	  Morrison	  and	  Davis	  2003).	  	  
	  
	  






Figure	  18.	  Points	  of	  divergence	  that	  allow	  for	  specific	  MAPK	  of	  transcription	  factors	  
	  
MAPK	  p38	  is	  has	  been	  shown	  to	  regulate	  MAP	  kinase-­‐activated	  protein	  kinase	  2	  (MK2),	  
MNK1,	   heat	   shock	   protein	   27	   (HSP27),	   cAMP-­‐response	   element	   binding	   protein	   (CREB),	  
ATF1/2/6,	   tristetraprolin	   (TTP),	   p53,	  MSK	   and	  nuclear	   factor	   of	   activated	   T	   cells	   (NFAT)	   (Ono	  
and	  Han	  2000;	  Zarubin	  and	  Han	  2005).	  It	  should	  be	  noted	  that	  of	  the	  previously	  mentioned	  pro-­‐
teins	  and	   transcription	   factors	   regulated	  by	  p38,	  many	  of	   them	  play	   roles	   that	   can	  affect	   the	  
host	  cell	  such	  that	  it	  is	  no	  longer	  a	  viable	  environment	  for	  virus	  replication	  (Ono	  and	  Han	  2000;	  
Zarubin	  and	  Han	  2005).	  Examples	  include	  the	  following	  effects:	  TTP	  involvement	  in	  mRNA	  de-­‐
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stabilization,	  MNK1	  role	  in	  translation	  initiation	  by	  phosphorylating	  eukaryotic	  initiation	  factor-­‐
4e	  (eIF4E),	  MSK1	  phosphorylates	  pro-­‐apoptotic	  protein	  Bad,	  and	  Sap-­‐1a	  phosphorylation	  which	  
is	   an	   important	   protein	   in	   the	   SRE	   dependent	   ternary	   complex	   factor	   (TCF)	   that	   is	   bound	  by	  
transcription	  factor	  cfos,	  an	  AP1	  component	  (Ono	  and	  Han	  2000;	  Zarubin	  and	  Han	  2005).	  	  
Dephosphorylation	  events	   are	   responsible	   for	   the	   control	   of	  MAPKs.	   The	  MAPK	  phos-­‐
phatases	   (MKPs),	  also	  referred	  to	  as	  dual	  specificity	  MAPK	  phosphatases	   (DUSPs),	   function	  to	  
dephosphorylate	   phosphothreonine	   and	   phosphotyrosine	   residues	   on	   activated	   MAPKs	  
(Theodosiou	  and	  Ashworth	  2002;	  Liu,	  Shepherd	  et	  al.	  2007).	  Ten	  mammalian	  MKPs/DUSPs	  have	  
been	   identified.	   They	   can	  be	  divided	   into	   two	  groups	  based	  on	   their	   subcellular	   location	  and	  
method	  of	   transcriptional	   regulation	  and	  are	   regulated	  by	   three	  main	  mechanisms:	   transcrip-­‐
tion,	   protein	   stability	   and	   enzymatic	   activity	   (Table	   2)	   (Theodosiou	   and	   Ashworth	   2002;	   Liu,	  




Table	  2	  MAPK	  phosphatases	  (DUSP)	  	  
	  
	  
MKP1,	  MKP2,	  DUSP2	  and	  DUSP5	  have	  been	  shown	  to	   localize	  primarily	   in	   the	  nuclear	  
compartment,	  whereas	  MKP3-­‐5	  (i.e.,	  DUSP	  6,	  9	  and	  10),	  MKP7,	  DUSP7	  and	  DUSP8	  are	  distrib-­‐
uted	  within	  the	  cytoplasm	  and	  the	  nuclear	  compartment	  (Theodosiou	  and	  Ashworth	  2002;	  Liu,	  
Shepherd	  et	  al.	  2007).	  It	  is	  thought	  that	  MKPs/DUSPs	  that	  are	  primarily	  localized	  to	  the	  nuclear	  
compartments	  function	  as	  efficient	  regulators	  of	  MAPK	  and	  their	  activated	  transcription	  factors	  
as	  they	  are	  in	  close	  proximity	  to	  the	  translocated	  (activated)	  MAPK	  and	  are	  readily	  induced	  by	  
many	   of	   the	   same	   stimuli	   that	   activated	   the	   MAPKs	   (Figure	   19)	   (Theodosiou	   and	   Ashworth	  
2002;	  Liu,	  Shepherd	  et	  al.	  2007).	  Unlike	  the	  JNK	  isoforms,	  each	  of	  which	  is	  regulated	  by	  MPKs,	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only	   the	  p38α	  and	  p38β	   forms	  are	   regulated	  by	  MKPs	   (Ono	  and	  Han	  2000;	   Zarubin	   and	  Han	  
2005).	  	  
MKP1/DUSP1	  is	  considered	  the	  prototype	  MKP	  and	  has	  been	  the	  most	  extensively	  stud-­‐
ied	   (Theodosiou	   and	   Ashworth	   2002).	   It	   has	   been	   shown	   that	  many	   downstream	   innate	   im-­‐
mune	  responses	  can	  be	  modulated	  by	  MKP	  regulation	  of	  MAPK	  activity	  and	  that	  MKP1	  has	  a	  
preference	  for	  regulating	  MAPKs	  p38	  and	  JNK,	  thus	  playing	  an	  important	  role	  in	  the	  regulation	  
of	  inflammatory	  cytokine	  biosynthesis	  (Theodosiou	  and	  Ashworth	  2002).	  
	  
	  




3.9 MAPK-­‐dependent	  apoptosis	  
As	  previously	  described,	  adaptor	  proteins	  TRAF2	  and	  TRAF6	  are	  known	  to	  directly	  acti-­‐
vate	  or	  associate	  with	  factors	  that	  activate	  upstream	  MAP3Ks:	  TAK1	  and	  ASK1.	  TAK1	  and	  ASK1	  
lie	  at	  the	  top	  of	  the	  MAPK	  proinflammatory	  cascade.	  TAK1	  associates	  with	  TAB1	  and	  TAB2	  to	  
form	  a	  complex	  that	  activates	  downstream	  MAP2K	  for	  activation	  for	  the	  terminal	  MAPKS:	  p38	  
and	  JNK.	  ASK1	  is	  also	  able	  to	  activate	  MAP2KS	  associated	  with	  both	  the	  p38	  and	  JNK	  pathway,	  
though	  its	  association	  has	  generally	  been	  with	  the	  JNK	  pathway.	  	  
Though	  the	  activation	  of	  p38	  and	  JNK	  seems	  to	  have	  some	  redundancy,	  their	  pathways	  
can	  be	  considered	  mutually	  exclusive	  for	  the	  control	  of	  defined	  cellular	  events,	  and	  they	  have	  
been	  shown	  to	  be	  important	  mediators	  of	   intracellular	  signaling	  during	  innate	  responses	  such	  
as	  inflammatory	  cytokine	  secretion	  and	  apoptosis.	  	  
This	  induction	  of	  apoptosis	  has	  been	  suggested	  to	  be	  an	  event	  that	  can	  be	  both	  MAPK	  
dependent	  and	  MAPK	  independent,	  where	  the	  MAPK	  dependent	  induction	  is	  regulated	  by	  ASK1	  
(Ichijo,	  Nishida	  et	  al.	  1997;	  Tibbles	  and	  Woodgett	  1999;	  Saeki,	  Kobayashi	  et	  al.	  2002;	  Takeda,	  
Matsuzawa	  et	  al.	  2003;	  Sumbayev	  and	  Yasinska	  2006).	  ASK1	  is	  a	  MAP3K	  that	  is	  ubiquitously	  ex-­‐
pressed	  and	  can	  activate	  both	  the	  JNK	  and	  p38	  pathways	  by	  phosphorylating	  (serine,	  threonine)	  
their	   upstream	   MAP2Ks,	   MKK4/7	   and	   MKK3/6,	   respectively	   (Sumbayev	   and	   Yasinska	   2006).	  
ASK1	  has	  been	   found	   to	  play	   an	   important	   role	   in	   linking	  upstream	  TLR	   signals	   to	   the	  MAPK	  
pathway,	  in	  skin	  innate	  immunity	  by	  its	  regulation	  of	  antimicrobial	  peptides,	  and	  in	  its	  interac-­‐
tion	  with	  PKR	  to	  promote	  apoptosis	  (Takizawa,	  Tatematsu	  et	  al.	  2002;	  Sayama,	  Komatsuzawa	  et	  
al.	  2005;	   Li,	  Min	  et	  al.	  2006;	  Sumbayev	  and	  Yasinska	  2006).	  The	  MAP2K	   then	  phosphorylates	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(threonine,	  tyrosine)	  JNK	  and	  p38,	  which	  in	  turn	  phosphorylate	  (serine,	  threonine)	  transcription	  
factors	   cJun,	   cFos	   and	  ATF2,	   respectively	   (Sumbayev	   and	   Yasinska	   2006).	   These	   transcription	  
factors	  may	  form	  homodimers	  (cJun-­‐cJun)	  or	  heterodimers	  (cJun-­‐cFos,	  cJun-­‐ATF2)	  and	  bind	  to	  
the	  AP1	  site	  (Halazonetis,	  Georgopoulos	  et	  al.	  1988).	  	  
AP1	  complexes	  are	  heterodimeric	  transcription	  factors	  that	  are	  ubiquitously	  expressed	  
and	  bind	  a	  12-­‐O-­‐tetradecanoylphorbol	  13-­‐acetate	  (TPA)	  response	  element	  (TRE)	  or	  a	  cyclic	  AMP	  
response	   element	   (Karin,	   Liu	   et	   al.	   1997;	   Xie,	   Pan	   et	   al.	   2005).	   As	  with	  NFkB,	   consensus	  AP1	  
binding	  elements	  have	  been	  found	  in	  the	  promoter	  region	  of	  many	  herpesvirus	  genes	  (Xie,	  Pan	  
et	  al.	  2005).	  These	  complexes	  are	  made	  up	  of	  activating	  transcription	  factor	  2	  (ATF2),	  Jun	  (cJun,	  
JunB	  and	  JunD)	  and	  Fos	  (cFos,	  FosB,	  Fra1	  and	  Fra2)	  subfamilies	  all	  of	  which	  are	  modulated	  via	  
phosphorylation	  (Karin	  1995;	  Karin,	  Liu	  et	  al.	  1997;	  Xie,	  Pan	  et	  al.	  2005).	  These	  transcription	  fac-­‐
tors	   are	   inducible	   within	   cells,	   and	   though	   low	   levels	   of	   cJun	   have	   been	   reported	   to	   be	   ex-­‐
pressed	  in	  some	  cell	  lines,	  ATF2	  is	  the	  only	  transcription	  factor	  (from	  the	  members	  listed	  above)	  
that	   is	  known	  to	  be	  constitutively	  expressed	  (Karin	  1995).	   	   Jun	  proteins	  can	  homodimerize	  or	  
heterodimerize	   with	   the	   other	   factors	   to	   form	   stable	   AP1	   binding	   factors,	   and	   it	   has	   been	  
shown	  that	  Jun-­‐Jun	  and	  Jun-­‐Fos	  dimmers	  bind	  the	  TRE-­‐responsive	  element	  and	  Jun-­‐ATF2	  bind	  
cAMP-­‐responsive	  elements	  preferentially	  (Karin,	  Liu	  et	  al.	  1997).	  
Inactive	   JNK	   (nonphosphorylated)	   has	   been	   found	   to	   be	   associated	  with	   transcription	  
factor	  p53	  in	  non-­‐stressed	  cells	  (Fuchs,	  Adler	  et	  al.	  1998;	  Fuchs,	  Adler	  et	  al.	  1998).	  The	  binding	  
of	  JNK	  to	  p53	  targets	  p53	  for	  ubiquitination	  and	  subsequent	  degradation,	  whereas	  the	  activa-­‐
tion	  of	   JNK	   (phosphoryaltion)	   releases	  p53	  and	  allows	   for	   its	   stabilization	  within	   cells	   (Fuchs,	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Adler	  et	  al.	  1998;	  Fuchs,	  Adler	  et	  al.	  1998).	  The	  disassociation	  of	  p53	  from	  JNK	  and	  the	  subse-­‐
quent	  transcription	  of	  AP1	  dimers	  (cJun-­‐cJun	  or	  cJun-­‐ATF2)	  allows	  for	  sequential	  events	  of	  Bid	  
cleavage,	  Bax	  translocation	  and	  cytochrome	  c	  release	  for	  the	  activation	  of	  caspase	  3	  and	  apop-­‐




Figure	  20.	  	  ASK-­‐1-­‐dependent	  apoptosis	  
	  
The	  activation	  of	  executioner	  caspases	  3,	  6	  and	  7	  has	  primarily	  been	  thought	  to	  be	  in-­‐
volved	   in	  apoptosis	  but	  they	  have	  also	  been	  shown	  to	  play	  a	  non-­‐apoptotic	  role	   in	   inflamma-­‐
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tion,	  cell	  cycle	  control	  and	  cell	  differentiation	  and	  hematopoiesis	   (Creagh,	  Conroy	  et	  al.	  2003;	  
Best	  and	  Bloom	  2004;	  Kuranaga	  and	  Miura	  2007).	  
Regarding	  JNK	  it	  should	  be	  noted	  that	  all	  three	  isoforms	  of	  JNK	  have	  been	  shown	  to	  in-­‐
teract	  with	  p53	  and	  contribute	  to	  p53	  activation	  and	  stabilization	  (Buschmann,	  Potapova	  et	  al.	  
2001;	  Fogarty,	  Downer	  et	  al.	  2003).	  It	  has	  also	  been	  shown	  that	  JNK1	  and	  JNK2	  can	  differentially	  
regulate	  p53.	  In	  these	  studies,	  JNK1	  expression	  led	  to	  decreased	  p53	  levels,	  whereas	  JNK2	  ex-­‐
pression	  led	  to	  increased	  p53	  levels,	  suggesting	  that	  pJNK1	  was	  a	  negative	  regulator	  and	  pJNK2	  
was	  a	  positive	  regulator	  of	  p53	  (Tafolla,	  Wang	  et	  al.	  2005).	  Other	  studies	  have	  shown	  that	  dual	  
inhibition	  of	  p38	  and	  JNK	  also	   leads	  to	   increased	   levels	  of	  p53	  dependent	  apoptosis,	  whereas	  
studies	  also	  show	  that	  prolonged,	  rather	  than	  transient	  activation	  of	  JNK	  can	  lead	  to	  apoptosis	  
possibly	  by	  inactivating	  suppressors	  of	  the	  mitochondrial	  death	  pathway	  (Lin	  and	  Dibling	  2002;	  
Lin	  2003;	  Brown	  and	  Benchimol	  2006).	  	  
Overall,	   it	   can	  be	   said	   that	   JNK	   seems	   to	   function	  pro-­‐apoptotic	   under	   stress-­‐induced	  
conditions	   and	   anti-­‐apoptotic	   under	   non-­‐stressed	   conditions,	   suggesting	   that	   JNK’s	   activity	   is	  
both	  stimulus	  and	  cell	  type	  dependent.	  
Other	   important	  proteins	  for	  the	  regulation	  of	  p53	  for	  MAPK-­‐dependent	  apoptosis	  are	  
the	  14-­‐3-­‐3	  proteins	  (Xing,	  Zhang	  et	  al.	  2000).	  They	  are	  ubiquitously	  expressed	  in	  the	  cytoplasm	  
of	  all	  mammalian	  cells	  and	  there	  are	  seven	  isoforms	  encoded:	  β,	  γ,	  ε,	  η,	  δ,	  θ	  and	  ζ	  (Shaw	  2000;	  
Xing,	  Zhang	  et	  al.	  2000).	  They	  are	  known	  to	  bind	  phosphorylated	  Bad,	  a	  pro-­‐apoptotic	  protein	  
and	  sequester	  it	  in	  the	  cytoplasm,	  and	  that	  14-­‐3-­‐3	  phosphorylation	  by	  JNK	  allows	  for	  Bad-­‐14-­‐3-­‐
69	  
	  
3	  dissociation	  followed	  by	  Bad	  translocation	  to	  the	  mitochondria	  for	  the	  induction	  of	  apoptosis	  
(Sunayama,	  Tsuruta	  et	  al.	  2005;	  Brown	  and	  Benchimol	  2006).	  	  
Of	  the	  seven	  isoforms	  of	  14-­‐3-­‐3,	  β	  and	  ζ	  are	  abundantly	  expressed	  in	  brain	  tissue;	  ζ	  and	  
δ	  isoforms	  are	  phosphorylated	  by	  JNK;	  η	  and	  ζ	  have	  been	  shown	  to	  play	  a	  role	  in	  increasing	  the	  
basal	   activity;	   δ	  has	  been	   implicated	   in	   the	   regulation	  of	  p53	   transcription;	   and	  14-­‐3-­‐3	   levels	  
have	  been	  correlated	  as	  an	  early	  predictor	  of	  CNS	  disease	  after	  SIV	  infection	  (Xing,	  Zhang	  et	  al.	  
2000;	  Helke,	  Queen	  et	  al.	  2005;	  Hermeking	  2005;	  Sunayama,	  Tsuruta	  et	  al.	  2005;	  Tafolla,	  Wang	  
et	  al.	  2005).	  
3.10 Herpesvirus	  detection	  by	  PRRs	  and	  subversion	  of	  the	  downstream	  MAPK	  response	  
Herpesviruses	  are	  large	  enveloped	  DNA	  viruses	  whose	  replication	  cycle	  occurs	  in	  three	  
waves	   for	   the	  expression	  of	   immediate	  early	   (IE	  or	  α),	   early	   (E	  or	  β)	   and	   late	   (L	   or	   γ)	   genes.	  
There	   are	   130	   identified	   herpesviruses,	   eight	   of	   which	   are	   human	   pathogens	   (HSV-­‐1,	   HSV-­‐2,	  
Human	  Cytomegalovirus	   (HCMV),	  varicella	  zoster	  virus	   (VZV),	  Epstein-­‐Barr	  virus	   (EBV),	  human	  
herpesvirus	  6	  HHV,	  human	  herpesvirus	  (HHV-­‐7)	  and	  human	  herpesvirus	  (HHV-­‐8)	  (Vandevenne,	  
Sadzot-­‐Delvaux	   et	   al.	   2010).	   Herpesviruses	   are	   known	   to	  modulate	   interferon	   effector	   func-­‐
tions,	  cytokine	  expression	  and	  activation,	  cytokine	  effector	  networks,	  chemokine	  effector	  net-­‐
works,	  apoptosis	  and	  downstream	  adaptive	  immune	  responses.	  	  
Studies	   have	   shown	   that	   herpesviruses	   can	   be	   recognized	   by	   TLR-­‐dependent	   mecha-­‐
nisms	   (TLR2,	   TLR3,	   TLR9)	   and	   by	   TLR-­‐independent	   mechanisms	   (RIG-­‐I,	   AIM2,	   DAI,	   PKR)	   (Zhu	  
2007;	  Daubeuf,	  Singh	  et	  al.	  2009;	  Vandevenne,	  Sadzot-­‐Delvaux	  et	  al.	  2010).	  	  
70	  
	  
Research	  has	  also	  shown	  that	  the	  activation	  of	  TLR2	  via	  recognition	  of	  herpesvirus	  gly-­‐
coproteins	  can	  be	  detrimental	  to	  the	  host,	  as	  TLR2	  activation	  induces	  the	  expression	  of	  proin-­‐
flammatory	   cytokines	   that	   can	   facilitate	   the	   development	   of	   lethal	   encephalitis	   (Kurt-­‐Jones,	  
Chan	  et	  al.	  2004;	  Daubeuf,	  Singh	  et	  al.	  2009;	  Vandevenne,	  Sadzot-­‐Delvaux	  et	  al.	  2010).	  	  
TLR3	  has	  been	  shown	  to	  recognize	  the	  viral	  dsRNA	  generated	  through	  self-­‐hybridization	  
of	  viral	  genes	  transcribed	  from	  complementary	  DNA	  strands	  (Daubeuf,	  Singh	  et	  al.	  2009).	  TLR3	  
has	  been	  shown	  to	  play	  a	  role	  in	  preventing	  herpesvirus	  spread	  to	  the	  central	  nervous	  system	  
and	  its	  lack	  of	  activation	  has	  been	  shown	  to	  contribute	  to	  encephalitis	  (Zhang,	  Jouanguy	  et	  al.	  
2007;	  Daubeuf,	  Singh	  et	  al.	  2009).	  	  
TLR9	  has	  been	  shown	  to	  recognize	  the	  unmethylated	  CpG	  motifs	  in	  the	  DNA	  of	  herpesvi-­‐
ruses	  (Kurt-­‐Jones,	  Chan	  et	  al.	  2004;	  Daubeuf,	  Singh	  et	  al.	  2009;	  Vandevenne,	  Sadzot-­‐Delvaux	  et	  
al.	  2010).	  	  
Herpesvirus	  DNA	  has	  been	  shown	  to	  serve	  as	  a	  template	  for	  cellular	  RNA	  Pol	  III,	  which	  
functions	  to	  transcribe	  the	  dsDNA	  into	  RNA	  bearing	  5’triphosphate	  moieties	  that	  is	  recognized	  
by	  RIG-­‐I	  (Chiu,	  Macmillan	  et	  al.	  2009).	  Cytosolic	  dsDNA	  sensor	  AIM2	  and	  DAI	  have	  been	  shown	  
to	  recognize	  some	  herpesviruses	  to	  form	  the	  inflammasome	  complex	  for	  caspase-­‐1	  activation,	  
and	  IRF	  expression	  for	  downstream	  IFN	  production	  and	  interferon	  stimulate	  gene	  (ISG)	  expres-­‐
sion	  (Takaoka,	  Wang	  et	  al.	  2007;	  Rathinam,	  Jiang	  et	  al.	  2010).	  An	  overview	  of	  herpesvirus	  inter-­‐











Figure	   21.	   	   Diagram	  of	   known	  herpesvirus	  mechanisms	  of	   interference	  with	   the	   innate	   im-­‐
mune	  response	  at	  the	  cellular	  level.	  
	  
In	  summary,	  we	  know	  that	  viral	  infection	  of	  host	  cells	  triggers	  not	  only	  early	  recognition	  
sensors,	  but	  also	  an	  early	  stress	  response	  within	  cells.	  The	  endoplasmic	  reticulum	  is	  the	  site	  of	  
folding	  and	  other	  post	  translation	  modifications	  for	  proteins,	  and	  it	  is	  also	  an	  essential	  organelle	  
for	  viral	  replication	  and	  maturation	  (He	  2006).	  Thus,	  viral	   infection	  can	  be	  considered	  a	  major	  
cause	  of	  ER	  stress	  due	  to	  the	  many	  viral	  glycoproteins	  that	  are	  excessively	  produced	  (He	  2006).	  
It	   is	   therefore	   reasonable	   to	   hypothesize	   that	   after	   B	   virus	   infection	   the	  MAPK	  pathway	   and	  
73	  
	  
downstream	  events	  associated	  with	  the	  MAPK	  pathway	  may	  differ	   in	  a	  host-­‐dependent	  man-­‐
ner.	  
4 Specific	  Aim	  3:	  Measure	  MAPK-­‐induced	  gene	  products	   and	  proinflammatory	  mediators	  
that	   are	   upregulated	   in	   response	   to	   MAPK-­‐adaptor	   molecule	   activation	   to	   establish	  
whether	  these	  events	  correlate	  with	  observed	  adaptive	  responses	  characterristic	  of	  each	  
host	  species	  defenses	  against	  B	  virus	  infection.	  
4.1 Transcriptional	  and	  translational	  events	  regulated	  by	  the	  innate	  signaling	  pathways	  
The	   innate	   immune	   response	   involves	   the	  upregulation	  of	   genes	   (cytokine/chemokine	  
and	  non-­‐cytokine/chemokine)	  that	  lead	  to	  the	  downstream	  synthesis	  of	  proteins	  that	  influence	  
the	  host	  response	  to	  infection	  and	  help	  shape	  the	  subsequent	  adaptive	  response.	  Initiation	  and	  
propagation	  of	  the	  inflammatory	  response	  by	  cytokines	  must	  occur	  via	  one	  or	  more	  pathways	  
that	  are	  activated	  after	  infection.	  The	  early	  upregulation	  of	  genes	  for	  the	  transcription	  of	  proin-­‐
flammatory	   and	   immunosuppressive	   cytokines	   in	   response	   to	   viral	   infection	   can	   be	   done	  
through	   four	  main	  pathways:	   the	  MAPK	  pathway,	   the	   IRF3/IRF7	  pathway,	   the	  NFAT	  pathway	  
and	   the	   NFkB	   pathway,	   each	   of	   which	   can	   occur	   concurrently	   or	   separately	   (Mogensen	   and	  
Paludan	  2001).	  The	  MAPK	  pathway	  has	  been	  shown	  to	  not	  only	  act	  at	  the	  transcriptional	  level	  
for	  cytokine	   induction,	  but	  also	  to	  act	  at	  the	  posttranscriptional	   level	  where	  they	  functions	   in	  
signal-­‐induced	  stabilization	  of	  cytokines	  and	  chemokine	  mRNAs	  that	  contain	  A/U	  rich	  elements	  
(Andrews	  and	  Matthews	  2004).	  
Cytokines	  are	  proteins	  with	  potent	  activity	  that	  are	  bio-­‐reactive	  at	  very	  low	  concentra-­‐
tions	   ranging	   from	  10-­‐10	   to	   10-­‐13ml/L	   (1ng	   to	   1pg/ml)	   (Joost	   2001).	   There	   are	  more	   than	   100	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identified	  cytokines,	  each	  of	  which	  exhibits	  unique	  structural,	  and	  some	  redundant,	  activities	  by	  
its	  sharing	  of	  cellular	  receptors	  or	  receptor	  chains	  (Joost	  1993).	  Cytokines	  can	  be	  divided	   into	  
two	  main	  groups,	  although	  basic	  responses	  can	  be	  further	  broken	  down:	  T	  helper	  1	  cytokines	  
(Th1)	  and	  T	  helper	  2	  cytokines	  (Th2).	  	  
Th1	  response	  involves	  the	  secretion	  of	  cytokines	  that	  help	  shape	  the	  celluar	  immune	  re-­‐
sponse	  and	  activate	  cells	  associated	  with	  these	  defenses;	  Th2	  response	  is	  involved	  in	  B	  cell	  acti-­‐
vation	  and	  antibody	  development,	  both	  of	  which	  are	  part	  of	   the	  adaptive	   immune	   response.	  	  
There	  is	  of	  course	  cross-­‐talk	  between	  these	  two	  systems	  in	  that	  Th1	  responses	  also	  induce	  anti-­‐
bodies	  and	  Th2	  responses	  have	  cellular	  regulators.	  	   	  As	  such	  it	  has	  been	  shown	  that	  cytokines	  
associated	  with	  the	  Th1	  and	  Th2	  responses	  can	  regulate	  each	  other	  such	  that	  IL2	  a	  Th1	  cytokine	  
suppresses	  Th2	  cytokine	  responses,	  and	  IL10	  a	  Th2	  cytokine	  suppresses	  Th1	  cytokine	  responses	  
(Mogensen	  and	  Paludan	  2001;	  Sloan	  and	  Jerome	  2007).	  	  
Regarding	   non-­‐human	   primates	   such	   as	   macaques,	   comparative	   analysis	   of	   responses	  
such	  as	  cytokine	  gene	  expression	  and	  secretion	  has	  been	  limited	  to	  human	  assays	  and	  reagents,	  
especially	   as	   they	   have	   been	   shown	   to	   induce	   similar	   responses	   (Villinger,	   Brar	   et	   al.	   1995).	  
However,	  with	   the	   advent	   of	   software	   and	  molecular	   assays	   (arrays)	   specifically	   designed	   to	  
look	  at	  genes	  and	  proteins	  such	  as	  cytokines	   involved	  in	  the	  innate	  immune	  response	  of	  non-­‐
human	  primates,	  a	  more	  thorough	  host-­‐specific	  analysis	  of	  the	  roles	  played	  by	  specified	  tran-­‐
scription	  factors	  and	  cytokines	  in	  disease	  models	  can	  be	  made	  (Villinger,	  Brar	  et	  al.	  1995).	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4.2 Cytokines	  and	  chemokines	  involved	  in	  the	  modulation	  of	  innate	  components	  of	  the	  host	  
response	  to	  infection	  
The	  induction	  of	  defined	  factors	  involved	  in	  immune	  responses	  leads	  to	  a	  coordinated	  re-­‐
sponse	  involving	  a	  plethora	  of	  cytokines	  and	  chemokines	  for	  downstream	  effector	  cells	  involved	  
in	  the	  innate	  and	  adaptive	  immune	  response	  to	  be	  recruited	  and	  activated.	  The	  induction	  and	  
secretion	  occurs	  in	  all	  cell	  types	  after	  stimulation	  but	  to	  differing	  levels	  or	  amounts.	  Though	  all	  
cells	   are	   known	   to	   produce	   cytokines	   in	   response	   to	   stimuli,	   the	   repertoire	   of	   cytokines	   se-­‐
creted	  by	  a	  cell	  depends	  on	  the	  type	  of	  stimulus,	  the	  duration,	  the	  intensity	  and	  the	  presence	  of	  
other	  factors	  (Joost	  2001).	  Cells	  which	  play	  primary	  roles	  in	  the	  innate	  response	  to	  infection	  and	  
help	  shape	  the	  adaptive	  response,	  such	  as	  NK	  cells,	  dendritic	  cells	  and	  B	  cells,	  are	  expected	  to	  
produce	   larger	   amounts	   (nanograms)	   of	   cytokines	   and	   chemokines	   than	   do	   cells	   of	   non-­‐
hematopoietic	  origin,	  such	  as	  fibroblasts	  and	  epithelial	  cells,	  which	  produce	  amounts	  that	  can	  
be	  measured	  in	  picograms	  (Joost	  2001).	  	  
Traditionally,	  when	   investigating	   cytokines	   involved	   in	   the	   innate	   immune	   response,	   one	  
speaks	   of	   the	   proinflammatory	   cytokines.	   Some	   of	   the	  major	   proinflammatory	   cytokines	   are	  
IL1,	  TNFα,	  IL6,	  IL12,	  GM-­‐CSF	  and	  IFNγ	  (Joost	  2001).	  However,	  IL2,	  LT,	  IL4	  and	  IL10	  are	  also	  con-­‐
sidered	  proinflammatory	  (Joost	  2001).	  Generally	  when	  one	  speaks	  of	  cytokines	  they	  are	  refer-­‐
ring	   to	   the	  proinflammatory	  cytokines,	  but	   it	  must	  be	  noted	   that	   there	  are	  also	  cytokines	   re-­‐
ferred	  to	  as	  anti-­‐inflammatory	  cytokines,	  which	  act	  as	  immunomodulatory	  mediators	  of	  the	  in-­‐
flammatory	   response	   and	   function	   to	   regulate	   proinflammatory	   activities.	   	   Some	   commonly	  
known	  anti-­‐inflammatory	  cytokines	  known	  to	  limit	  the	  magnitude	  and	  extent	  of	   inflammation	  
are	  IL1Ra,	  IL4,	  IL6	  IL10,	  IL11,	  IL13	  and	  TGFβ	  (Opal	  and	  DePalo	  2000;	  Joost	  2001).	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In	  general,	  it	  can	  be	  said	  during	  the	  regulation	  and	  modulation	  of	  host	  innate	  immune	  re-­‐
sponses,	  there	  is	  a	  constant	  shift	  in	  the	  balance	  and	  regulation	  of	  cytokines	  such	  that	  their	  net	  
effect	  is	  dependent	  on	  the	  time	  of	  release/secretion,	  the	  location	  of	  the	  effect,	  the	  responsive-­‐
ness	  of	  cells	  within	  the	  area	  of	  release,	  the	  density	  of	  receptors	  for	  the	  region	  of	  its	  effect	  and	  
the	   overall	   composition	   of	   other	   competing	   or	   synergistic	   cytokines	   within	   the	   defined	   area	  
(Opal	  and	  DePalo	  2000).	  Thus,	   it	   is	   important	  to	  consider	  all	  of	   these	  factors	  when	   looking	  at	  
models	  of	  infection	  and	  disease	  and	  to	  be	  aware	  of	  the	  limitations	  of	  in	  vitro	  work	  as	  well	  as	  to	  
be	  cautious	  in	  making	  generalized	  assumptions	  about	  in	  vivo	  studies.	  
4.3 Cytokine	  and	  chemokine	  response	  to	  herpesvirus	  infections	  
After	  infection,	  most	  herpesviruses	  have	  been	  shown	  to	  induce	  a	  plethora	  of	  biphasic	  cy-­‐
tokines	   responses:	   the	   first	   phase	   including	   IL1β,	   IL2,	   IL6,	   IL10,	   IL12,	   Il13,	   TNFα,	   IFNα/β,	   IFNγ	  
and	  GM-­‐CSF;	  and	  the	  second	  phase	  including	  cytokines	  IL8,	  MIP1α,	  MIP1β,	  MCP1	  and	  RANTES	  
(Mogensen	  and	  Paludan	  2001).	  These	  responses	  are	  thought	  to	  be	  initially	  dependent	  on	  viral	  
surface	  and	  tegument	  proteins,	  to	  be	  followed	  by	  a	  later	  response	  induced	  by	  factors	  involved	  
in	  the	  replication	  of	  the	  virus	  (Sloan	  and	  Jerome	  2007).	  The	  Th1	  response	  to	  infection	  allows	  for	  
early	  recognition,	  containment	  and	  removal	  of	  virus	  infection	  and	  it	  is	  for	  this	  reason	  that	  HSV-­‐
1	  has	  found	  mechanisms	  to	  inhibit	  Th1	  cytokine	  synthesis	  and	  upregulate	  the	  anti-­‐inflammatory	  
cytokine	  IL10	  to	  inhibit	  the	  proinflammatory	  response	  (Sloan	  and	  Jerome	  2007).	  	  	  
Because	  many	  early	   innate	   immune	  events	  that	  occur	  after	  B	  virus	   infection	  can	  be	  influ-­‐
enced	  by	  the	  MAPK	  pathway,	  it	  is	  important	  to	  investigate	  the	  transcriptional	  profile	  of	  factors	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regulated	  selectively	  by	  each	  arm	  (p38	  and	  JNK)	  of	  the	  MAPK	  pathway,	  and	  to	  investigate	  the	  
induced	  cytokine	  profile	  in	  cells	  derived	  from	  both	  hosts.	  
In	   summary,	   the	   innate	   responses	   engaged	   in	  macaque	   and	  humans	   cells	  would	  be	  pre-­‐
dicted	   to	   differ	   based	   on	   the	   observed	   differences	   in	   adaptive	   immune	   defenses	   induced	   in	  
each	  species.	   	  Correlating	   these	   innate	   responses	  with	  adaptive	  defense	  outcomes	  of	   species	  
specific	  B	  virus	  infections	  has	  not	  previously	  been	  possible.	  	  With	  the	  novel	  cell-­‐based	  model	  of	  
infection	   developed	   as	   part	   of	   this	   dissertation	   research,	   we	   can	   evaluate	   for	   the	   first	   time	  
whether	  macaque	  and	  human	  cells	  do	  indeed	  differ	  in	  their	  innate	  defense	  strategies	  when	  in-­‐
fected	  with	   B	   virus	   and	  whether	   the	   observed	   responses	   correlate	  with	   the	   reported	   differ-­‐
ences	  in	  adaptive	  immune	  responses	  observed	  in	  macaques	  and	  humans.	  
5 Materials	  and	  Methods	  
5.1 Cell	  lines	  
Macaque	   biopsies	   from	   male	   and	   female	   genital,	   skin	   and	   ganglion	   were	   obtained	  
through	  a	  tissue-­‐sharing	  program	  with	  Yerkes	  Primate	  Center,	  Emory	  University,	  Atlanta,	  GA	  in	  
April,	   July	   and	  August	   2007.	   The	  primary	   isolation	   and	   subculture	  of	   keratinocytes	   and	   fibro-­‐
blasts	  and	  glial	  cells	  were	  then	  done	  using	  the	  different	  sections	  from	  the	  macaque	  tissue	  sec-­‐
tions	  (skin,	  foreskin,	  clitoral	  hood	  and	  ganglion)	  received.	  	  
Briefly,	   tissue	  was	  removed	  from	  collection	  vessels	  and	  any	  accompanying	  media	  ster-­‐
ilely	  aspirated	  and	  blotted.	  	  If	  hair	  was	  present,	  it	  was	  removed	  with	  Scotch	  tape	  ©	  and	  a	  razor.	  
Scotch	  tape	  ©	  was	  also	  used	  to	  remove	  the	  upper-­‐most	  cornified	  epithelial	  layer	  (i.e.,	  the	  top	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layer	  of	  the	  skin).	  Tissues	  were	  then	  disinfected	  with	  an	  antiseptic	  or	  antimicrobial	  cleanser	  and	  
rinsed	   in	  30	  mM	  HEPES	  buffer	  or	  phosphate	  buffered	  solution	   (PBS)	   (without	  Ca2+	  and	  Mg2+).	  
The	  epidermal	  side	  was	  placed	  facing	  downward,	  rinsed	  and	  the	  buffer	  was	  replace	  with	  serum-­‐
free	  basal	  media.	  All	  fat	  and	  excess	  subcutaneous	  connective	  tissue	  were	  removed	  prior	  to	  cut-­‐
ting	  tissue	  into	  2	  mm3-­‐5	  mm3	  pieces	  and	  placing	  these	  pieces	  into	  collagenase-­‐dispase	  or	  tryp-­‐
sin-­‐EDTA	  solutions	  overnight	  at	  4°C	  for	  dissociation	  and	  digestion	  of	  layers.	  
Following	  overnight	   incubation	   for	  digestion,	   dermal	   and	  epidermal	   layers	  were	   sepa-­‐
rated	  and	  placed	  into	  a	  trypsin-­‐EDTA	  solution	  at	  37°C	  with	  gentle	  agitation	  for	  further	  digestion	  
of	  the	  separated	  layers.	  Neutralization	  of	  digestion	  with	  serum	  was	  followed	  by	  dissociation	  of	  
cells	   into	   suspension	  and	  by	   straining	   to	   remove	  all	   unwanted	   components	  of	   the	   respective	  
layer.	  Collected	  cell	  suspensions	  were	  centrifuged	  at	  180g	  and	  the	  supernatant	  was	  discarded.	  
The	  pellet	  was	  resuspended	  in	  differing	  groups	  of	  defined	  media	  for	  each	  stated	  cell	  type	  (glial,	  
keratinocyte	  or	  fibroblast)	  supplemented	  with	  Penicillin/Streptomycin/Amphotericin	  B	  solution	  
or	  a	  Gentamicin/Amphotericin	  B	  solution.	  Note	  that	  for	  each	  cell	  type,	  several	  different	  media	  
cocktails	  were	  used	  with	  varying	  concentrations	  of	  fetal	  bovine	  serum	  (FBS),	  human	  keratino-­‐
cyte	  growth	  serum	  (HKGS)	  and	  antibiotic/antimycotic	  because	  it	  was	  not	  known	  which	  cocktail	  
could	   support	  macaque	   primary	   cell	   line	   growth	  more	   efficiently.	   For	   each	   group,	   viable	   cell	  
counts	  were	   then	   done	   using	   trypan	   blue	   (classical	  method	   for	   determining	   cell	   count),	   and	  
cells	  were	  plated	  onto	  collagen	  coated	  T25	  flasks	  and	  6-­‐well	  plates	  to	  establish	  a	  viable	  cell	  cul-­‐
ture.	  Cells	  were	  observed	  every	  24	  hrs	  and	  media	  was	  replaced	  every	  48	  hrs.	  When	  cells	  were	  
at	  an	  80%	  density	  in	  their	  respective	  container	  they	  were	  subcultured.	  Primary	  cells	  were	  never	  
allowed	   to	   become	   completely	   confluent	   and	   harvesting	   and	   cryopreservation	   of	   cells	   were	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done	  as	  described	  for	  human	  keratinocytes	  and	  human	  fibroblasts	  (Current	  Protocols	  Unit	  2.1).	  
Glial	  cells	  were	  not	  passaged.	  They	  were	  removed	  and	  stored	  in	  liquid	  nitrogen	  for	  future	  use.	  
Human	  foreskin	  fibroblast	  (HFF)	  (ATCC,	  CRL-­‐2097)	  cells	  were	  purchased	  from	  ATCC	  and	  
grown	  in	  minimum	  essential	  medium	  (MEM)	  (Mediatech,	  Herndon,	  VA)	  supplemented	  with	  0.1	  
mM	  non-­‐essential	  amino	  acids,	  1.0	  mM	  sodium	  pyruvate,	  and	  18%	  FBS.	  These	   fibroblasts	  are	  
primary	  human	  foreskin	  fibroblasts	  (HFF)	  and	  are	  the	  fibroblast	  cell	  type	  used	  for	  current	  and	  
past	  investigations	  in	  this	  lab	  to	  study	  B	  virus	  infection.	  	  
Human	  Epidermal	  Keratinocyte	  (HEK)	  cells	  were	  grown	  in	  EpiLife	  cell	  culture	  media	  (Invi-­‐
trogen)	  supplemented	  with	  human	  keratinocyte	  growth	  supplement	  media	  (Invitrogen).	  
Vero	  African	  Green	  monkey	  kidney)	  cells	  (ATCC,	  CL81)	  were	  grown	  in	  Dulbecco’s	  Modi-­‐
fied	  Eagles	  Essential	  Medium	  (Cellgro)	  supplemented	  with	  10%	  FBS	  
5.2 Viruses	  
The	  viruses	  used	  in	  this	  study:	  B	  virus	  laboratory	  strain	  E2490	  propagated	  in	  Vero	  cells,	  
HSV-­‐1	  MacIntyre	  (ATCC,	  VR-­‐539)	  propagated	  in	  Vero	  cells	  and	  HSV-­‐1	  F	  strain	  (initially	  received	  
from	  B.	  Roizman,	  The	  University	  of	  Chicago,	  Chicago	  IL)	  propagated	  in	  Vero	  cells.	  	  
All	   infections	  with	  virus	  were	  performed	  under	  BSL-­‐4	  conditions	   in	  a	  registered	  facility	  
under	  Select	  Agent	  status	   in	  accordance	  with	   the	  Biosafety	   in	  Microbiological	  and	  Biomedical	  
Laboratories	   (BMBL)	  manual	   (CDC/Office	  of	   Safety	   2009).	   Though	  HSV-­‐1	   is	   not	   classified	   as	   a	  
select	  agent,	  all	  infections	  were	  also	  performed	  under	  BSL-­‐4	  conditions	  unless	  noted	  differently	  
in	  order	  to	  maximize	  the	  comparative	  analyses.	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5.3 Subculture	  of	  cells	  (passaging),	  seeding	  of	  cells	  for	  experiments	  and	  cryopreservation	  
Briefly,	   for	  stated	  cell	   types,	   flasks	  and	  wells	  were	  washed	  twice	  with	  phosphate	  buff-­‐
ered	  saline	  (PBS),	  followed	  by	  the	  addition	  of	  Trypsin-­‐EDTA.	  Vessels	  were	  then	  placed	  in	  an	  in-­‐
cubator	  at	  37°C	  for	  a	  few	  minutes	  for	  cells	  to	  round	  up	  and	  detach.	  After	  detachment,	  the	  tryp-­‐
sin	  was	  neutralized	  by	  the	  addition	  of	  serum-­‐containing	  media	  and	  cells	  were	  resuspended	   in	  
defined	  media	  with	  or	  without	  antibiotic/antimycotic	   for	   the	   stated	  cell	   type	  and	  placed	   into	  
new	   flasks	  or	   seeded	   into	  well	  of	  plates.	   For	  all	   experiments	  aliquots	  of	  each	  cell	   suspension	  
was	  counted	  via	  the	  classical	  method	  involving	  trypan	  blue	  staining	  and	  counting	  with	  hemocy-­‐
tometers.	   They	   plates,	   flasks	   or	   LabTek™	   chamber	   slides	  were	   seeded	   equally	  with	   each	   cell	  
type.	  If	  cells	  were	  to	  be	  stored,	  then	  suspensions	  were	  transferred	  to	  sterile	  conicals	  and	  spun	  
at	  1200	  RPM	  for	  3-­‐5	  mins.	  Supernatants	  were	  discarded	  and	  pellets	  were	  resuspended	   in	  de-­‐
fined	  freezing	  media	  (10%DMSO	  with	  20%FBS	  in	  DMEM).	  Cell	  counts	  were	  done	  manually	  using	  
a	  hemacytometer	  and	  tubes/aliquots	  stored	  with	  a	  defined	  amount	  of	  cells.	  Aliquots	  were	  ini-­‐
tially	  cooled	  and	  frozen	  at	  -­‐80°C	  in	  a	  designated	  cell-­‐freezing	  container	  followed	  by	  long-­‐term	  
storage	  in	  liquid	  nitrogen.	  
5.4 Detection	  of	  potential	  contaminants	  
Cell	   cultures	  maintained	   for	   a	  minimum	   of	   two	   days.	  Media	   and	   cells	   were	   collected	  
separately	  and	  mycoplasm	  detection	  done	  according	  to	  protocol	  outlined	  by	  mycoplasma	  PCR	  
detection	  kit	  (Sigma	  MP0035).	  Briefly,	  the	  kits	  contains	  a	  primer	  set	  specific	  to	  the	  highly	  con-­‐
served	  16SrRNA	  coding	  region	  in	  the	  mycoplsma	  genome,	  pre-­‐coated	  with	  appropriate	  dNTPs	  
and	  primers	  in	  reaction	  tubes	  and	  internal	  DNA	  control	  (481bp).	  After	  PCR	  is	  performed,	  sam-­‐
ples	   are	   run	   in	   1.2	   percent	   agarose	   gels.	   Cells	  were	   also	   grown	   and	   immunofluorescencence	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staining	  was	  done	  using	  Hoechst	  to	  confirm	  the	  absence	  of	  mycoplasma	  (Battaglia,	  Pozzi	  et	  al.	  
1994;	  Valladeau	  and	  Saeland	  2005).	  	  
For	  other	  potential	  contaminants,	  subculturing	  procedures	  were	  done	  and	  cells	  left	  for	  a	  
minimum	  of	  two	  days	  in	  the	  absence	  of	  antibiotic	  or	  antimycotic	  in	  their	  respective	  media	  mix-­‐
tures	  and	  visualized.	  
5.5 Determination	  of	  efficiency	  of	  plating	  	  
HFF,	  RMF,	  HEK	  and	  Vero	  cells	  were	  counted	  and	  seeded	  at	  a	  desired	  density	  equally	  for	  
each	   cell	   line	   to	   be	   ready	   (85-­‐90	   percent	   confluent)	   in	   2-­‐3	   days	   for	   infection	   in	   12-­‐well	   flat-­‐
bottom	  plates.	  Viruses	  used	  were	  HSV-­‐1	  (HSV-­‐1	  McIntyre	  and	  F	  strains)	  and	  B	  virus	  (E2490).	  Se-­‐
rial	  dilutions	  (10-­‐1	  –	  10-­‐6)	  for	  each	  defined	  plaque	  forming	  unit	  (p.f.u.)	  stock	  virus	  was	  prepared	  
in	  Hanks	  Balanced	  Salt	  solution	  (HBSS).	  Media	  was	  removed,	  cells	  washed	  with	  Phosphate	  Buff-­‐
ered	  Solution	  (PBS)	  twice.	  This	  was	  followed	  by	  the	  addition	  of	  300ul	  of	  the	  respective	  dilution	  
into	  each	  well,	  which	  was	  left	  for	  1hour	  absorption	  at	  37C.	  After	  1	  hour	  unadsorbed	  virus	  was	  
removed	  and	  addition/replacement	  with	  a	  1	  percent	  methyl	   cellulose,	  2	  percent	   fetal	  bovine	  
serum	  (FBS)	  mix	  and	  left	  for	  48	  hours	  (2dys).	  After	  2	  dys,	  infection	  was	  stopped	  by	  fixation	  with	  
100	  percent	  methanol	  and	  monolayers	  stained	  with	  crystal	  violet	  or	  by	  immunofluroescense	  for	  
the	  detection	  and	  the	  observation	  of	  plaques.	  The	  differing	  titers	  (pfu)	  calculated	  for	  each	  virus	  
in	  the	  defined	  cell	  line	  were	  then	  used	  to	  calculate	  fold	  difference	  when	  compared	  to	  Vero	  cells	  




Cells	  were	  counted	  and	  seeded	  at	  a	  desired	  density	  equally	  for	  each	  cell	  line	  to	  be	  ready	  
(85-­‐90	  percent	   confluent)	   in	  2-­‐3	  days	   for	   infection.	   The	   following	   virus	  used	   for	   infections	   as	  
outline	  by	  the	  experiments	  was	  B	  virus	  (E2490).	  The	  multiplicity	  of	  infection	  for	  all	  experiments	  
was	  MOI	  of	  5.	  The	  control	  was	  mock	  cell	   lysate	   (MCL)	   for	   infections	  unless	  otherwise	   stated.	  
Mock	  cell	   lysate	   represents	   the	  Vero	  cell	   lysate	   from	  mock	   infected	  cells	  prepared,	  collected,	  
and	  treated	  at	  the	  same	  time	  and	  same	  manner	  as	  the	  B	  virus	  stock	  that	  was	  being	  prepared.	  
Mock	  cell	  lysate	  was	  used	  as	  the	  control	  for	  theses	  signaling	  studies	  as	  virus	  stock	  preparation	  is	  
done	  using	   infected	  Vero	  cells	  and	  as	  such	  with	  the	  prepared	  virus	  stock,	   it	  will	  have	  compo-­‐
nents	  that	  are	  part	  of	  the	  lysed	  Vero	  cells	  and	  components	  that	  were	  secreted	  in	  response	  to	  B	  
virus	  infection.	  Thus,	  MCL	  when	  compared	  to	  B	  virus	  stock	  should	  comprise	  of	  the	  same	  com-­‐
ponents	  minus	  virus,	  virus	  related	  or	  induced	  components.	  	  
Note:	  Calculated	  volumes	  of	  virus	  for	  an	  MOI	  5	  infection	  in	  the	  respective	  cell	  line	  (de-­‐
termined	   from	  the	  plating	  efficiency	   results)	  were	  placed	   into	  HBSS	   to	  give	   the	  working	  virus	  
mixture.	  	  
For	  all	  time	  point	  experiments	  except	  those	  involving	  collection	  of	  supernatants	  for	  cy-­‐
tokine	  and	  chemokine	  analysis,	  media	  was	  removed	  and	  kept	   in	  50ml	  conicals	  for	  the	  respec-­‐
tive	  cell	   line.	  This	  media	   is	  referred	  to	  as	  spent	  media.	  Prior	  to	   infection	  media	  was	  removed,	  
cells	  washed	  with	  Phosphate	  Buffered	  Solution	  (PBS)	  twice	  and	  experiments	  done	  in	  T25	  flasks	  
received	  1ml	  virus	  mixture,	  12	  well	  plates	  received	  300ul	  virus	  mixture	  per	  well,	  those	  done	  in	  6	  
well	  plated	  received	  500	  ul	  per	  well	  and	  those	  done	  in	  LabTek™	  chamber	  slides	  received	  100-­‐
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300ul	  per.	  After	  virus	  input	  the	  flask/plate	  or	  chamber	  slides	  were	  placed	  at	  37°C	  for	  1hr	  for	  vi-­‐
rus	   to	  absorb.	  After	  1	  hour	  absorption	   the	  unadsorbed	  virus	  was	   removed	  and	  well	   replaced	  
with	   spent	  media	   (3ml	  per/T25	   flask;	   2ml/well	   of	   6-­‐well	   plate;	   1ml/well	   of	   12-­‐well	   plate	   and	  
0.5-­‐1ml	  per	  well	  for	  LabTek™	  chambers).	  	  
Only	  in	  the	  cases	  where	  supernatants	  were	  being	  collected	  for	  cytokine	  analysis	  the	  re-­‐
placement	  media	  after	  virus	  absorption	  was	  2%FBS	  media	  and	  the	  input	  volumes	  were	  as	  fol-­‐
lows:	  500ul/well	  of	  6-­‐well	  plate	  and	  300ul/well	  of	  12-­‐well	  plate.	  Note	  for	  all	  experiments	  that	  1	  
hr	  post	  infection	  (pi)	  refers	  to	  the	  amount	  of	  time	  after	  virus	  had	  been	  placed	  onto	  cells	  (the	  1	  
hr	  absorption	  period),	  whereas	  1	  hr	  post	  absorption	  (pa)	  refers	  to	  the	  amount	  of	  time	  after	  the	  
unadsorbed	  virus	  was	  removed	  and	  the	  replacement	  media	  was	  added.	  All	  time	  points	  repre-­‐
sented	  in	  the	  cytokine	  and	  chemokine	  analysis	  are	  representative	  of	  times	  post	  adsorption.	  	  
5.7 Immunofluoresence	  
Rhesus	  macaque	  fibroblasts	  (RMF),	  human	  foreskin	  fibroblasts	  (HFF),	  human	  epidermal	  
keratinocytes	  (HEK)	  and	  African	  Green	  monkey	  kidney	  cells	  (Veros)	  were	  seeded	  onto	  LabTek™	  
chamber	  slides	  and/or	   into	  6-­‐well	  and	  12-­‐well	  plates.	  After	  no	  treatment	  or	  stated	  treatment	  
(infection	  or	  mock	   infection),	   cells	  were	   fixed	  and	  permeabilized	  using	  4%	  paraformaldehyde	  
with	  Triton	  X	  or	  100%	  methanol	  (MeOH).	  The	  addition	  of	  triton	  X	  or	  the	  use	  of	  MeOH	  	  disrupted	  
cellular	  membranes	  such	  that	  staining	  on	  cytoskeletal	  components	  could	  be	  done.	  Cells	  were	  
washed	  with	  PBS	  and	  incubated	  in	  20%	  normal	  goat	  serum	  (NGS).	  This	  process	  was	  followed	  by	  
PBS	  washes	  and	  subsequent	  incubation	  of	  the	  respective	  primary	  antibody	  (1°Ab)	  at	  a	  defined	  
dilution	  in	  10%	  NGS.	  	  Primary	  antibody	  incubation	  was	  followed	  by	  subsequent	  washes,	  incuba-­‐
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tion	  in	  appropriate	  fluorescent	  conjugated	  secondary	  antibody	  (2°Ab)	  at	  stated	  dilution	  in	  10%	  
NGS	   and	   additional	  washes	  with	   PBS.	  After	   the	   2°Ab	   incubation	   and	  washes,	   other	   commer-­‐
cially	   available	   stains	   for	  DNA	   (Hoechst/DAPI),	   lectin	  membranes	   (Alexa	   Fluor	   529),	   Vimentin	  
(R28)	  and	  F-­‐actin	  (Alexa	  Fluor	  568	  phalloidin)	  were	  added	  together,	  where	  applicable,	  and	  fol-­‐
lowed	  by	  PBS	  washes.	  Slides	  were	  then	  mounted,	  sealed	  and	  stored	  in	  a	  dark	  container	  at	  4°C	  
before	  and	  after	  viewing	  under	  Zeiss	  LSM	  700	  immunfluroescence	  scope.	  Plates	  were	  covered	  
with	  foil	  and	  stored	  at	  4°C	  before	  and	  after	  viewing	  under	  Zeiss	  LSM	  700	   immunfluroescence	  
scope.	  
5.8 Polymerase	  chain	  reaction	  (PCR)	  
At	  stated	  times,	  post	  infection	  samples	  were	  collected	  with	  RTL	  buffer	  and	  purified	  ac-­‐
cording	   to	  manufacturer’s	   instructions	   (RNeasy	  Mini	   kit	   -­‐	   Qiagen).	   Concentration	   of	   purified	  
RNA	  was	   determined	   using	   the	  Nanovue	  machine	   (GE).	   Purified	   RNA	  was	   then	   converted	   to	  
cDNA	  using	  RT2	  First	  strand	  kit	  (SA	  Biosciences)	  and	  PCR	  performed	  using	  RT2	  SybrGreen/ROX	  
qPCR	  mix	  kit	  in	  conjunction	  with	  one	  of	  the	  following:	  RT2	  Profiler	  PCR	  Array	  Human	  Inflamma-­‐
tory	  Cytokines	  and	  Receptors	  array,	  RT2	  Profiler	  PCR	  Array	  Human	  MAP	  Kinase	  Signaling	  Path-­‐
way	  array’s	  (SA	  Biosciences)	  or	  self-­‐designed	  primers	  that	  were	  ordered	  from	  Integrated	  DNA	  
Technologies	  (IDT)	  to	  conserved	  regions	  in	  both	  human	  and	  macaque	  cells.	  Samples	  were	  run	  
using	  the	  ABI	  7900HT	  Real	  time	  PCR	  machine	  (SA	  Biosciences).	  
5.9 SDS	  Page	  and	  Western	  Blotting	  
After	   infection	  or	  mock-­‐infection	  total	  cell	   lysates	  were	  collected	  using	  Laemmli	  buffer	  
and	  aliquoted	  prior	  to	  storage	  at	  -­‐20°C.	  Then	  10%	  SDS	  gels	  were	  prepared	  and	  used	  for	  all	  pro-­‐
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teins	  analyzed.	  Gels	  were	  transferred	  overnight	  and	  proteins	  detected	  with	  primary	  antibodies	  
from	   Santa	   Cruz	   Technologies,	   ABCam,	  Millipore	   and	   Cell	   Signaling	   Technologies	   followed	   by	  
appropriate	  HRP-­‐conjugated	  secondary	  antibodies	  and	  ECL	  detection	  reagents.	  All	  represented	  
westerns	  have	  been	  reproduced	  at	  least	  3	  times	  from	  different	  experiments.	  	  
5.10 Inhibitors	  and	  stimulators	  
Stock	  of	  each	   inhibitor	   in	  DMSO	  or	  water	  was	  prepared	  as	  directed	  by	  Calibiochem	  or	  
Sigma	  and	  stored	  in	  aliquots	  at	  -­‐20°C.	  The	  following	  inhibitions	  were	  used:	  
a. p38	   inhibitor:	  SB202190-­‐Competitive	   inhibitor	  of	  p38b	  activity	  and	  ATF2	  
activation,	  reversible	  (20μM).	  
b. p38	  inhibitor:	  SB239063-­‐ATP	  competitive	  inhibitor	  of	  p38a	  and	  p38b,	  re-­‐
versible	  (10μM).	  
c. p38	  inhibitor:	  SB203580-­‐ATP	  competitive	  inhibitor,	  reversible	  (20μM).	  
d. JNK	   inhibitor:	   (L-­‐form)-­‐Blocks	   the	   phosphorylation	   of	   the	   activation	   do-­‐
mains	  of	  JNK	  (20μM).	  
e. JNK	   inhibitor:	  SP600125-­‐	  Complexes	  with	  ATP,	  blocks	  cJun	  transcription,	  
reversible	  (10μM)	  
f. Stimulator	   JNK:	   Anisomycin	   from	   Streptomyces	   griseolus.	   Affects	   DNA	  
and	  protein	  synthesis	  (0.005M).	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g. Stimulator	   p38:	   Sorbitol.	   Sugar	   that	   influences	   the	   overall	   osmotic	   con-­‐
centration	  in	  cells	  (0.2M).	  
DMSO	   working	   and	   control	   concentration	   was	   0.5μl/ml	   in	   HBSS/spent	   media.	   DMSO	  
concentration	  was	  maintained	  at	   0.5%	   (vol/vol)	   in	   all	  media	   containing	  DMSO	   irrespective	  of	  
the	  inhibitor	  concentration.	  
The	   inhibitor	   concentrations	   used	  were	   non-­‐toxic	   to	   cells	   as	   cell	  morphology	   and	   cell	  
counts	   to	  calculate	  percent	  viability	   (trypan	  blue)	  are	  similar	   in	  each	  cell	   culture	   treated	  with	  
inhibitors	  or	  DMSO.	  
Cells	  were	  pretreated	  with	  their	  respective	  inhibitors	  for	  thirty	  minutes	  prior	  to	  infection	  
and	   inhibitor	  was	   present	   during	   adsorption,	   during	   infection	   and	  during	   the	   replacement	   of	  
media	  after	   infection	  (24hrs).	  The	  media	   left	  after	  the	  one	  hour	  adsorption	  period	  consists	  of	  
presence	  or	  absence	  of	  the	  inhibitor	  and	  2	  percent	  FBS.	  
5.11 Plaque	  Assays	  
Vero	  cells	  were	  seeded	  in	  12-­‐well	  flat	  bottom	  plates	  and	  serial	  dilutions	  (10-­‐1	  to	  10-­‐6)	  for	  
collected	  lysates	  were	  run	  in	  duplicate.	  After	  1	  hour	  adsorption,	  unadsorbed	  virus	  was	  removed	  
and	  media	  replaced	  with	  replacement	  media	  that	  comprised	  of	  a	  1	  percent	  methyl	  cellulose,	  2	  
percent	  fetal	  bovine	  serum	  (FBS)	  mix.	  This	  was	  left	  for	  48	  hours,	  then	  the	  infection	  was	  stopped	  
by	   fixation	  with	   100	   percent	  methanol,	   and	  monolayers	   stained	  with	   crystal	   violet	   or	   by	   im-­‐
munofluroescense	  for	  the	  detection	  and	  the	  observation	  of	  plaques.	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5.12 Viral	  kinetics	  
Cells	  were	  infected	  at	  MOI	  5	  as	  described	  in	  infections	  for	  efficiency	  of	  plating	  and	  infec-­‐
tions.	   After	   the	   one	   hour	   adsorption	   period,	  media	  was	   replaced	  with	   2%	   FBS	  media	   and	   at	  
stated	   time	   points	   samples	   collected	   for	   DNA-­‐analysis,	   RNA-­‐analysis	   or	   total	   cell	   lysates	   col-­‐
lected	   separately	   for	   SDS-­‐PAGE	  analysis	   and	   for	  plaque	  assay	   (titration	  of	  pfu/ml	   at	   the	   time	  
point).	  B	  virus	  glycoproteins	  gC	  and	  gD	  as	  well	  as	  B	  virus	  protein	  US11	  were	  probed	  for	  in	  total	  
cell	  lysate	  collected	  for	  SDS-­‐PAGE	  analysis.	  	  
5.13 FACS	  (flow	  cytometry)	  analysis	  
Cells	  were	  untreated	  or	  mock-­‐infected	  or	  infected	  with	  B	  virus	  at	  MOI	  5,	  and	  at	  defined	  
time	  points,	  media	  was	  removed	  and	  enzymatic	  digestion	  at	  37°C	  was	  used	  to	  lift	  the	  adhered	  
cells.	  This	  process	  was	  followed	  by	  a	  cold	  PBS	  wash	  and	  fixation	  in	  paraformaldehyde	  (PFA)	  4%	  
to	   8%.	   The	   fixation	   solution	  was	   removed,	   and	   cells	  were	   centrifuged.	   These	   steps	  were	   fol-­‐
lowed	  by	  permeabilization	  and	  resuspension	  by	  the	  slow	  addition	  of	  90%	  methanol.	  Cells	  were	  
equally	   aliquoted	   and	   incubated	   in	   blocking	   buffer	   at	   room	   temperature	   for	   10	  minutes	   and	  
then	  rinsed	  by	  centrifugation	  in	  incubation	  buffer.	  This	  was	  followed	  by	  primary	  antibody	  incu-­‐
bation,	   washes	   and	   fluorochrome-­‐conjugated,	   secondary	   antibody	   incubation.	   Washes	   were	  
then	  done	  and	  cells	   resuspended	   in	  0.5	  ml	  PBS	   for	  detection/reading	   in	   the	  cytometer.	   FACS	  
limits	  were	  for	  10000	  events	  and	  data	  is	  representative	  of	  duplicate	  experiments.	  For	  each	  ex-­‐
periment	   the	   histograms	   show	   the	   untreated	   unstained	   for	   that	   time	   point	  with	   the	   stained	  




Cells	  were	   prepared	   to	   be	   ready	   in	   2	   to	   3	   days	   for	   infection.	   Cells	  were	   either	  mock-­‐
infected	   (MCL)	  or	   infected	  with	  B	  virus	   (BV)	  at	  MOI	  5.	  After	  1	  hour	  unadsorbed	  virus	  was	   re-­‐
moved	   and	  media	   replaced	  with	  minimal	   volume	  1%	   FBS	  media.	   At	   the	   defined	   time	  points,	  
post	  absorption	  supernatant	  was	  removed,	  spun	  for	  5	  minutes	  at	  1000	  rpm	  to	  pellet	  any	  cell	  
debris	  and	  the	  addition	  of	  Tween/DOC	  done	  (i.e.,	  add	  10%	  Tween	  and	  vortex,	  followed	  by	  10%	  
Doc	  to	  make	  Tween	  and	  Doc	  1%	  of	   the	   final	  concentration).	  After	   removal	   from	  BSL4,	  100	  ul	  
aliquots	  were	  prepared	  and	  stored	  at	   -­‐20°C.	  Prior	   to	  usage	  for	  readings,	   the	  supernatant	  was	  
vortexed	  and	  cytokines	  read	  using	  the	  Luminex	  100™	  IS,	  200™/HTS	  by	  Luminex	  Corporation	  for	  
LiquiChip	  analysis	  or	  using	  the	  ELISA	  plate	  reader	  as	  specified	  by	  manufacturer	  for	  desired	  OD	  
readings.	  Note	  that	  for	  each	  technique	  used,	  Luminex	  or	  ELISA	  a	  supplied	  negative	  for	  each	  cy-­‐
tokine	  was	  supplied	  and	  the	  values	  for	  each	  supplied	  negative	  was	  represented	  what	   is	  tradi-­‐
tionally	  called	  the	  blank	  in	  ELISA.	  This	  reading	  received	  for	  each	  supplied	  negative	  (N	  value)	  was	  
used	   to	  calculate	  P/N	  values	   for	  each	   treatment	   (mock	  cell	   lysate	  or	  B	  virus)	   ie	  P	  value,	   such	  
that	  the	  charts	  represent	  the	  P/N	  values	  for	  both	  treatments	  through	  time.	  This	  method	  did	  not	  




6.1 Specific	  Aim	  1:	   	  Establish	   in	  vitro	  target	  cell	  models	  representing	  the	  cells	  that	  are	   ini-­‐
tially	  Infected	  during	  acute	  infection	  in	  order	  to	  study	  early	  virus:host	  interactions.	  	  
6.1.1 Isolation	  of	  cells	  
Each	   of	   the	   three	   batches	   of	   tissue	   received	   throughout	   the	   year	   (April,	   July,	   and	  
August)	  via	  a	  tissue	  sharing	  program	  with	  Yerkes	  Primate	  Center,	  Emory	  University,	  Atlanta	  GA,	  
led	  to	  differing	  cell	   retrieval	  successes	  via	  the	  classically	  established	  method	  presented	   in	  the	  
Materials	  and	  Methods	  section.	  The	  differences	  in	  success	  were	  due	  to	  problems	  encountered	  
with	  contamination,	  isolation	  of	  cell	  type,	  propagation	  of	  cells	  for	  passage	  and	  storage,	  as	  well	  
as	  determination	  of	  appropriate	  media	  cocktail	  and	  additives	  necessary	   for	   long-­‐term	  growth	  
and	  storage.	  
In	  brief,	  with	  the	  first	  (April)	  batch	  of	  tissues,	  I	  had	  success	  only	  in	  isolating	  and	  seeding	  
keratinocytes	  and	  fibroblasts.	  However,	  with	  time,	  fungal	  contamination	  became	  a	  major	  issue	  
with	  the	  fibroblasts	  and	  no	  cells	  were	  salvaged.	  The	  contamination	  also	  made	  it	  difficult	  to	  de-­‐
termine	  which	  media	  cocktail	  was	  appropriate	   for	   long-­‐term	  use	  and	  storage	  of	   the	  macaque	  
fibroblasts.	  	  
With	  the	  second	  (July)	  batch	  of	  tissues,	  I	  once	  again	  had	  limited	  success	  in	  the	  isolation	  
of	   keratinocytes	  and	   the	  keratinocytes	   survived	  only	  45	  days.	   I	   also	  had	  problems	  again	  with	  
contamination	  of	  the	  fibroblasts	  which	  were	  the	  intended	  cells	  for	  isolation	  in	  this	  aim..	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On	  receipt	  of	  the	  third	  (August)	  batch	  of	  tissues,	  I	  specifically	  worked	  with	  the	  skin	  and	  
foreskin	  tissue	  sections	  only	  because	  I	  had	  isolated	  glial	  or	  satellite	  cells	  which	  were	  now	  stored	  
in	  the	  liquid	  nitrogen.	  With	  the	  third	  (August)	  batch,	  I	  was	  able	  to	  successfully	  isolate	  keratino-­‐
cytes	   and	   fibroblasts	   (foreskin)	   without	   any	   contamination.	   It	   should	   be	   noted	   after	   attach-­‐
ment,	  cells	  initially	  grew	  slowly	  as	  they	  established	  a	  population	  within	  the	  flasks	  or	  wells.	  The	  
fibroblasts	  stored	  and	  used	  for	  this	  dissertation	  work	  were	  derived	  from	  foreskin	  because	  con-­‐
tamination	  was	  a	  constant	  problem	  with	  skin-­‐derived	  fibroblasts.	  Twenty-­‐two	  tubes	  of	  passage	  
2	  rhesus	  macaque	  foreskin	  fibroblasts	  were	  obtained.	  Regarding	  cells	  seeded	  in	  the	  T-­‐25	  flasks,	  
the	  small	  populations	  were	  transferred	  into	  6-­‐well	  plates,	  as	  the	  surface	  on	  the	  T-­‐25	  may	  have	  
been	  too	  large	  for	  them	  to	  maintain	  the	  contact	  necessary	  for	  growing.	  The	  cells	  maintained	  a	  
healthy	  appearance	  as	  they	  began	  grow	  and	  multiply.	  	  
Primary	  macaque	  fibroblasts	  were	  successfully	  isolated	  and	  passaged	  for	  use	  in	  	  all	  future	  ex-­‐
periments	  described.	  
6.1.2 Verification	  of	  no	  bacteria,	  fungal	  or	  mycoplasma	  contamination	  
Subcultured	  cells	  and	  their	  media	  were	  observed	  over	  several	  weeks	  and	  proved	  to	  be	  
consistently	  healthy	  and	  free	  of	  contaminants.	  PCR	  analysis	  for	  mycoplasma	  also	  showed	  that	  




6.1.3 Visualization	  of	  morphological	  characteristics	  and	  passage	  stability	  
Morphologically	  the	  fibroblasts	  maintained	  their	  characteristic	  structure	  with	  each	  sub-­‐
sequent	  passage:	  branched	  cytoplasm,	  elliptical	   speckled	  nucleus	  with	  one	  or	   two	  nuclei	   and	  
abundant	  rough	  endoplasmic	  reticulum	  (RER)	  (Figure	  22).	  	  
	  
	  
Figure	  22.	  	  Rhesus	  macaque	  fibroblasts	  (RMF)	  isolated	  and	  established	  successfully	  in	  Specific	  	  
Aim	  1.	  
	  
They	  also	  had	   the	   characteristic	   disorganized	  and	  dispersed	  pattern	   that	   is	   associated	  
with	   fibroblasts	   in	  a	   large	  area	  of	   space,	  and	  gradually	  became	  more	  parallel	   in	  alignment	  as	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they	  neared	  each	  other	  and/or	  approached	  confluency	  (Figure	  22	  and	  Figure	  23).	  Staining	  for	  
fibroblast	   cell	   markers	   vimentin	   and	   fibronectin	   and	   staining	   for	   actin	   to	   view	   cell	  
shape/morphology	  also	  verified	  that	  these	  cells	  were	  fibroblasts.	  	  
	  
	  
Figure	  23.	  RMFs	  showing	  typical	  fibroblast	  characteristics	  
	  
Branched	  cytoplasm,	  elliptical	  speckled	  nucleus	  with	  one	  or	  two	  nuclei,	  abundant	  rough	  endo-­‐
plasmic	  reticulum,	  and	  parallel	  alignment	  as	  confluency	  is	  approached.	  
	  
As	  with	  any	  primary	  cell	  line,	  the	  division	  of	  cells	  slowed	  with	  increased	  passaging	  (p12	  
and	   higher),	   and	   as	   confluency	   approached	   100%	   senescence	   occurred,	   resulting	   in	   a	   slower	  
growth	   rate	   in	   any	   subsequent	   passage.	  Morphological	   characteristics	   also	   changed	   with	   in-­‐
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Figure	  24.	  RMFs	  showing	  parallel	  alignment	  as	  confluency	  is	  approached	  
	  
6.1.4 Plating	  efficiency	  
The	  overall	  purpose	  in	  determining	  the	  efficiency	  of	  plating	  is	  to	  equalize	  the	  multiplicity	  
of	   infection	   (MOI)	   for	   future	   infections	  with	   the	  stated	  virus	   in	   the	  different	  cell	   types.	   	  Vero	  
cells	  were	  used	  as	  they	  are	  a	  susceptible	  cell	  line	  that	  is	  classically	  used	  for	  the	  titration	  of	  HSV-­‐
1,	  HSV-­‐2	  and	  B	  virus	  stock	  as	  well	  as	  many	  other	  viruses.	  All	  B	  virus	  stock	  preparation	  and	  de-­‐
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termination	  of	  their	  pfu/ml	  for	  the	  stated	  stick	  is	  done	  in	  Vero	  cells.	  Therefore	  by	  comparison	  of	  
the	  calculated	  pfu	  for	  B	  virus	  in	  the	  human	  fibroblasts	  and	  the	  monkey	  fibroblasts	  compared	  to	  
Vero	  cells	  allows	  for	  one	  to	  calculate	  the	  fold	  difference	  in	  pfu/ml	  for	  each	  cell	  line	  compared	  to	  
the	  pfu/ml	  for	  the	  Vero.	  With	  this	  calculation	  one	  is	  able	  to	  determine	  the	  fold	  increase	  or	  de-­‐
crease	   in	   pfu/ml	   compared	   to	  Vero	   needed	   to	   equally	   infect	   the	   human	   and	  macaque	   fibro-­‐
blasts	  at	  defined	  multiplicity	  of	  infections	  (MOIs).	  
The	  general	   fold	  difference	  compared	  to	  Vero	  cells	   is	  outlined	  below	  (Table	  4)	   for	   the	  
stated	  cell	  line,	  with	  the	  stated	  virus,	  as	  determined	  by	  parallel	  plaque	  assays	  performed.	  Vero	  
cells	  were	  used,	  as	   they	  are	   the	  classical	   susceptible	  cell	   line	  used	   for	   titrations	  done	   (plaque	  
assays)	  to	  determine	  the	  virus	  concentration	  in	  prepared	  B	  virus	  stock.	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Table	  4	  Efficiency	  of	  plating	  fold	  comparisons	  for	  the	  stock	  of	  B	  virus	  used	  
	   B	  Virus	  (E2490)	  
HFF	  (Human	  foreskin	  fibroblasts)	   6	  fold	  less	  
(B	  Virus	  pfu	  in	  HFF)/(B	  Virus	  pfu	  in	  Vero)	  
RMF	  (Rhesus	  macaque	  fibroblasts)	   0.5	  fold	  less	  
(B	  Virus	  pfu	  in	  RMF)/(B	  Virus	  pfu	  in	  Vero)	  
	  
For	  each	  new	  stock	  of	  virus	  that	  was	  prepared	  or	  used,	  the	  necessary	  titrations	  followed	  
by	  plaque	  assay	  on	  Vero	  cells	  were	  done	  to	  determine	  the	  efficiency	  of	  plating	  for	  that	  stock	  of	  
virus	   (as	   shown	   in	   table	   above).	   In	   order	   to	   determine	   the	   amount	   of	   virus	   needed	   (plaque	  
forming	  unit	  (pfu))	  to	  equally	  infect	  each	  cell	  line	  at	  a	  defined	  multiplicity	  of	  infection	  (MOI)	  the	  
difference	  in	  pfu	  for	  each	  cell	  line	  was	  compared	  to	  the	  calculated	  pfu	  for	  the	  Vero	  cell	  titration	  
(plaque	  assay)	  with	  B	  virus.	  Figure	  25	  and	  Figure	  26	  show	  the	  general	  plaque	  formation	  after	  












Figure	  26.	  	  Plaque	  morphology	  observed	  after	  infection	  of	  established	  rhesus	  macaque	  fibro-­‐
blasts	  with	  B	  virus.	  
	  
6.1.5 Kinetics	  of	  B	  virus	  replication	  in	  HFF,	  RMF	  and	  Vero	  cells	  
The	  kinetic	  analysis	  of	  B	  virus	  in	  each	  of	  the	  three	  cell	  lines	  is	  shown	  in	  Figures	  27	  and	  28	  
depicting	  virus	  quantification	  and	  viral	  protein	  production,	  respectively.	  	  	  The	  goal	  of	  this	  analy-­‐
sis	  was	  to	  establish	  the	  ability	  of	  B	  virus	  to	  replicate	   in	  the	  three	  cell	   lines	  and	  assess	  the	  ex-­‐
pression	  of	  viral	  glycoproteins	  during	  replication.	  Over	  a	  twenty-­‐four	  hour	  period	  we	  observed	  
that	  the	  amounts	  of	  viral	  DNA	  and	  the	  pfu/ml	  increased	  through	  time.	  We	  also	  observed	  that	  
there	  was	  expression	  of	  viral	  glycoproteins	  (gC	  and	  gD)	  and	  that	  the	  expression	  of	  viral	  protein	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US11	  increased	  through	  time	  in	  all	  three	  cell	   lines	  establishing	  the	  competency	  of	  the	  cells	  to	  
replicate	  B	  virus.	  
	  
	  
Figure	  27	  Kinetics	  of	  B	  virus	  infection	  in	  three	  different	  cell	  lines	  
The	  kinetics	  of	  B	  virus	  infection	  is	  shown	  for	  human	  foreskin	  fibroblasts	  (HFF),	  Rhesus	  macaque	  
fibroblasts	  (RMF)	  and	  African	  green	  monkey	  kidney	  cells	  (Veros)	  over	  a	  24	  hour	  period.	  The	  top	  
chart	   represents	   DNA	   copy	   number	   and	   the	   bottom	   represents	   plaque-­‐forming	   units/ml	  
(pfu/ml).	  Human	  (HFF)	  and	  monkey	   (RMF)	  cells	  were	   infected	  with	  B	  virus	   (BV)	  MOI	  5	  and	  at	  
defined	  time	  points	  samples	  were	  collected	  for	  DNA	  analysis	  by	  PCR	  or	  total	  lysate	  collected	  for	  
plaque	   assay.	   Data	   over	   this	   24hour	   period	  were	   collected	   only	   once	   for	   kinetic	   analysis	   but	  
each	  point	  was	  evaluated	  from	  replicate	  wells	  that	  were	  averaged	  for	  this	  figure.	  	  PCR	  analysis	  
reflects	  total	  particle	  number,	  whereas	  PFU/ml	  reflects	  replication	  competent	  virus.	  	  A	  1:10,000	  






Figure	  28.	  	  	  Viral	  protein	  production	  at	  different	  time	  points	  post	  B	  virus	  infection	  in	  each	  of	  
three	  cell	  lines.	  
Representative	  western	   blot	   analyses	   for	   late	   protein	   synthesis,	   glycoproteins	   gD	   and	   gC,	   as	  
well	  as	  viral	  protein	  US11	  levels	  during	  24	  hours	  of	  infection	  with	  B	  virus	  in	  HFF,	  RMF	  and	  Vero	  
cells	  are	  shown	  in	  each	  panel.	  Human	  (HFF)	  and	  monkey	  (RMF)	  cells,	  as	  well	  as	  Vero	  cells	  were	  
infected	  with	  B	  virus	  at	  MOI	  5.	  At	  defined	  time	  points	  total	  cell	  lysate	  were	  collected	  from	  each	  
cell	  line	  using	  SDS	  lysis	  buffer	  with	  added	  HALT	  phosphatase	  inhibitors.	  SDS-­‐	  PAGE	  and	  Western	  




6.2 Specific	  Aim	  2:	   Identify	   the	   specific	  MAPK	   responses	   induced	  by	  B	  virus	   in	  acutely	   in-­‐
fected	  cells.	  
6.2.1 Adaptor	  proteins	  recruited	  after	  B	  virus	  infection	  
To	  determine	  which	  signaling	  pathways	  are	  induced	  by	  B	  virus	  infection	  of	  macaque	  and	  
human	  fibroblasts	  we	  initially	  investigated	  the	  contribution	  of	  three	  adaptor	  proteins	  (six	  adap-­‐
tor	  proteins	  total)	  known	  to	  play	  a	  role	  in	  relaying	  pathogen	  associated	  molecular	  patterns	  re-­‐
ceived	  by	  pattern	  recognition	  receptors	  to	  associated	  signaling	  pathways,	  because	  these	  (adap-­‐
tor	  proteins)	  serve	  as	  points	  for	  signals	  to	  be	  integrated	  and	  relayed	  such	  that	  cellular	  signaling	  
pathways,	  such	  as	  the	  MAPK	  pathway,	  is	  activated.	  The	  results	  of	  these	  experiments	  are	  seen	  in	  
Figure	  29.	  	  	  
	  We	  measured	  	  the	  levels	  of	  phosphorylated	  TRAF2,	  TRAF6	  and	  TRIF	  proteins	  after	  B	  vi-­‐
rus	  infection	  and	  found	  comparable	  to	  to	  cells	  exposed	  to	  uninfected	  cell	  lysate	  controls.	  Levels	  
of	  TRAF2at	  30	  minutes	  post	   infection	   in	   the	  macaque	  cells	   are	   relatively	   larger	   than	   that	  ob-­‐
served	   for	   the	  human	  cells.	   The	   larger	  band	  observed	   is	   likely	  due	   to	  activation	  of	  TRAF2	   re-­‐
cruited	  to	  adaptor	  complex	  formation	  following	  exposure	  of	  macaque	  fibroblasts	  to	  both	  unin-­‐
fected	  and	  infected	  cell	  lysates.	  	  	  Curiously,	  no	  indication	  of	  virus	  specific	  TRAF2	  or	  TRAF6	  acti-­‐
vation	  was	  noted	  in	  spite	  of	  the	  observation	  that	  MAPK	  pathways	  were	  engaged	  following	  ex-­‐
posure	   of	   both	  macaque	   and	   human	   cells	   to	   B	   virus.	   	   Each	   of	   these	   adaptor	  molecules	   are	  





Figure	  29.	  	  Adaptor	  proteins	  recruited	  after	  B	  virus	  infection	  
Human	  (HFF)	  and	  monkey	  (RMF)	  cells	  were	  either	  infected	  with	  B	  virus	  (BV)	  or	  exposed	  to	  mock	  
infected	   (MCL)	   cell	   lysates	  at	  MOI	  5.	  At	  defined	   time	  points	   cells	  were	  harvested	   in	  SDS	   lysis	  
buffer	  with	  added	  HALT	  phosphatase	  inhibitors.	  SDS-­‐	  PAGE	  and	  Western	  blotting	  detection	  pro-­‐
cedures	  were	  carried	  followed	  by	  ECL	  immunodetection.	  
	  
6.2.2 Verification	  of	  JNK	  and	  p38	  activation	  after	  B	  virus	  infection	  
The	  points	  of	  convergence	   from	  the	  adaptor	  proteins	  allow	   for	   initial	   signals	   from	  the	  
PRRs	  to	  be	  relayed	  to	  the	  MAPK	  pathway.	  I	  therefore	  sought	  to	  verify	  that	  the	  MAPK	  pathway	  
was	  activated	  after	  B	  virus	  infection.	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Analysis	  of	  western	  blots	  revealed	  that	  JNK1	  and	  JNK2	  were	  activated	  by	  1-­‐5	  hours	  post	  
infection	  in	  both	  cell	  lines	  in	  a	  non	  specific	  manner,	  .i.e.,	  exposure	  of	  cells	  from	  both	  species	  to	  
either	  infected	  or	  uninfected	  cells	  resulted	  in	  activation	  (Figure	  30).	  	  JNK2	  activation	  lagged	  un-­‐
til	  3	  hours	  post	  infection	  in	  macaque	  cells,	  but	  not	  in	  human	  cells,	  which	  would	  potentially	  re-­‐
sult	  in	  delays	  in	  the	  downstream	  events	  of	  this	  activation	  process.	  	  By	  five	  hours	  post	  infection	  
JNK2	  activation	  was	  almost	  complete	  inapparent	  and	  data	  suggested	  a	  monophasic	  increase	  at	  
three	   hours	   	   unlike	   the	   pattern	   of	   activation	   in	   humans	   cells.	   	   JNK	   3	   isoform	  was	   activated	  
slightly	   in	  a	   virus	   specific	  manner	  across	  all	   time	  periods	   in	  human	  cells,	  but	  again	   showed	  a	  
monophasic	  pattern	  of	  activation	  at	  three	  hours	  post	  infection	  in	  macaque	  cells,	  followed	  by	  a	  
nearly	  completely	   loss	  activation	  at	   five	  hours.	   	  This	   raises	   the	  question	  of	   the	   importance	  of	  
each	  of	  the	  isomeric	  forms	  of	  JNK,	  an	  area	  which	  is	  largely	  unexplored.	  Though	  JNK3	  is	  thought	  
to	  be	  expressed	  mainly	   in	  heart,	  brain	  and	   testis	   tissues	  and	  play	  a	   role	   in	   the	  stimulation	  of	  
apoptosis,	   our	   data	   show	   that	   fibroblast	   cells	   do	   express	   JNK3	   and	   B	   virus	   effectively	   shuts	  
down	  JNK3	  activation	  in	  a	  biphasic	  manner	  at	  one	  hour	  and	  five	  hours	  post	  infection	  specifically	  
in	  human	  cells	   (Figure	  30)	  and	  completely	   in	  macaque	  cells.	   	  The	  role	  each	  of	   these	   isoforms	  
play	   in	  downstream	  events	  has	  not	  been	  reported	   in	  any	  system	  to	  date.	   	  FACS	  data	  of	  each	  
time	  point	  largely	  support	  western	  blot	  data,	  establishing	  that	  there	  are	  virus-­‐specific	  modula-­‐
tions	  of	  JNK	  activation,	  with	  clear	  differences	  in	  human	  versus	  macaque	  cells	  with	  the	  exception	  
of	  three	  hours	  post	  infection	  in	  human	  cells.	  	  No	  isoform	  studies	  could	  be	  performed	  with	  FACS	  
since	  antibodies	  for	  this	  technique	  were	  not	  commercially	  available.	  	  
Activation	  of	  p38	  was	  observed	  to	  occur	  in	  a	  virus-­‐specific	  manner	  at	  one	  hour	  through	  
three	  hours	  post	  infection	  in	  the	  foreign	  host	  cells	  (HFF),	  whereas	  in	  the	  natural	  host	  cells	  (RMF)	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there	  was	  a	  relative	  increase	  in	  virus-­‐induced	  phosphorylation	  of	  p38	  (pp38)	  only	  at	  three	  hours	  
post	   infection	  (Figure	  31).	  This	  monophasic	  activation	  pattern	   is	  similar	   to	  observations	  made	  
regarding	  JNK	  activation.	  	  Interestingly,	  macaque	  cells	  may	  be	  more	  sensitive	  at	  detecting	  and	  
repsonding	  to	  perturbations	  caused	  by	  exposing	  the	  cells	  to	  uninfected	  as	  well	  as	  infected	  cell	  
lysates	  as	  can	  be	  seen	  on	  western	  blot	  analysis.	  	  Human	  cells	  exposed	  to	  uninfected	  cell	  lysates	  
did	  not	  activate	  p38	  until	  five	  hours	  post	  infection.	  
MAPK	  phosphatase	  (MKP)	  is	  known	  to	  play	  a	  role	  by	  dephosphorylation	  to	  regulate	  the	  
MAPK	   responses	   influenced	   by	   pJNK	   and	   pp38.	   Our	   data	   showed	   that	   the	   activity	   of	  MAPK	  
phosphatase	  1	  (MKP1)	  decreases	  in	  both	  hosts	  at	  three	  hours	  post	  infection	  through	  five	  hours	  
post	   infection	   (Figure	   32)	   in	   a	   virus	   specific	   manner,	   whereas	   cells	   treated	   with	   uninfected	  
lysate	   continue	   to	   show	   realtively	   abundant	   levels	   of	   MAPK	   phosphatase.	   	   This	   decrease	   in	  
phosphatase	  activity	  may	  explain	  the	   increaed	   levels	  of	  activated	  p38	  and	  those	  JNK	   isoforms	  
that	  are	  activated,	  but	  it	  is	  clear	  that	  B	  virus	  is	  specifically	  regulating	  activation	  and	  perhaps	  de-­‐
activation.	  	  Interestingly,	  phosphatase	  activities	  appear	  to	  be	  similarly	  regulated	  in	  cells	  of	  both	  





Figure	  30.	  Activation	  (phosphorylation)	  of	  JNK	  after	  B	  virus	  infection	  
Human	  (HFF)	  and	  monkey	  (RMF)	  cells	  were	  either	   infected	  with	  B	  virus	  (BV)	  or	  mock	  infected	  
(MCL)	  at	  MOI	  5.	  At	  defined	  time	  points	  total	  cell	  lysate	  (a)	  for	  western	  blotting	  procedures	  were	  
collected	  from	  each	  cell	  line	  with	  SDS	  lysis	  buffer	  with	  added	  HALT	  phosphatase	  inhibitors.	  SDS-­‐	  
PAGE	  and	  Western	  blotting	  detection	  procedures	  were	  carried	  followed	  by	  ECL	  immunodetec-­‐
tion,	  (b)	  for	  FACS	  analysis	  all	  cells	  were	  removed	  by	  enzymatic	  digestion.	  This	  process	  was	  fol-­‐
lowed	  by	  a	  cold	  PBS	  wash	  and	  fixation	  in	  paraformaldehyde	  (PFA)	  4	  to	  8%.	  Fix	  was	  removed	  and	  
cells	  permeabilized	  and	  resuspended	  in	  100%	  methanol.	  Cells	  were	  equally	  aliquoted	  and	  incu-­‐
bated	  in	  blocking	  buffer;	  the	  blocking	  was,	  followed	  by	  primary	  antibody	  and	  the	  fluorochrome-­‐
conjugated	  secondary	  antibody	  prior	  to	  detection.	  FACS	  limits	  were	  for	  10000	  events	  and	  data	  
is	  representative	  of	  duplicate	  experiments	  and	  staining	  with	  defined	  primary	  and	  secondary	  an-­‐





Figure	  31.	  Activation	  (phosphorylation)	  of	  p38	  after	  B	  virus	  infection	  
Human	  (HFF)	  and	  monkey	  (RMF)	  cells	  were	  either	   infected	  with	  B	  virus	  (BV)	  or	  mock	  infected	  
(MCL)	  at	  MOI	  5.	  At	  defined	  time	  points	  total	  cell	  lysate	  (a)	  for	  western	  blotting	  procedures	  were	  
collected	  from	  each	  cell	  line	  with	  SDS	  lysis	  buffer	  with	  added	  HALT	  phosphatase	  inhibitors.	  SDS-­‐	  
PAGE	  and	  Western	  blotting	  detection	  procedures	  were	  carried	  followed	  by	  ECL	  immunodetec-­‐
tion,	  (b)	  for	  FACS	  analysis	  all	  cells	  were	  removed	  by	  enzymatic	  digestion.	  This	  process	  was	  fol-­‐
lowed	  by	  a	  cold	  PBS	  wash	  and	  fixation	  in	  paraformaldehyde	  (PFA)	  4	  to	  8%.	  Fix	  was	  removed	  and	  
cells	  permeabilized	  and	  resuspended	  in	  100%	  methanol.	  Cells	  were	  equally	  aliquoted	  and	  incu-­‐
bated	  in	  blocking	  buffer;	  the	  blocking	  was,	  followed	  by	  primary	  antibody	  and	  the	  fluorochrome-­‐
conjugated	  secondary	  antibody	  prior	  to	  detection.	  FACS	  limits	  were	  for	  10000	  events	  and	  data	  
is	  representative	  of	  duplicate	  experimentsand	  staining	  with	  defined	  primary	  and	  secondary	  an-­‐




Figure	  32.	  	  	  MAPK	  phosphatase	  (MKP)	  levels	  after	  B	  virus	  infection	  
Human	  (HFF)	  and	  monkey	  (RMF)	  cells	  were	  either	   infected	  with	  B	  virus	  (BV)	  or	  mock	  infected	  
(MCL)	  at	  MOI	  5.	  At	  defined	  time	  points	  total	  cell	   lysate	  for	  western	  blotting	  procedures	  were	  
collected	  from	  each	  cell	  line	  with	  SDS	  lysis	  buffer	  with	  added	  HALT	  phosphatase	  inhibitors.	  SDS-­‐	  











6.2.3 MAP3K-­‐ASK1	  and	  MAP3K-­‐TAK1	  activation	  after	  B	  virus	  infection	  
Verification	   that	   the	  MAPKs	   p38	   and	   JNK	  were	   differentially	   activated	   in	   host	   specific	  
and	  virus	   specific	  manners	  underscored	   the	  question	  of	  whether	  MAPK-­‐associated	   responses	  
(MAPK	  apoptotic	   response)	  were	   regulated	   in	   a	   host-­‐dependent	  manner.	   Therefore,	   the	   first	  
question	  I	  asked	  was	  “Do	  upstream	  MAP3K-­‐ASK1	  (a	  known	  MAPK-­‐associated	  apoptotic	  marker)	  
and	  TAK1	  become	  activated	  after	  infection	  and	  how	  is	  ASK1	  regulatory	  protein	  14-­‐3-­‐3	  affected	  
after	  B	  virus	   infection?”	  These	  are	  critical	  questions	  that	  when	  answered	  will	  ultimately	  drive	  
experiments	  to	  understand	  host	  and	  virus	  specific	  mechanisms	  of	  regulating	  disease	  outcome	  
that	  so	  distinctly	  separates	  these	  hosts	  during	  B	  virus	  infection.	  
	  Western	  blots	  were	  performed	  using	  cells	  collected	  at	  different	  time	  points	  post	  infec-­‐
tion	  in	  both	  human	  and	  macaque	  cells	  and	  probed	  with	  antibodies	  specifically	  reactive	  with	  ac-­‐
tivated	   TAK1,	   ASK1,	   and	   14-­‐3-­‐3.	   	   Data	   from	   replicate	   experiments	   shows	   that	   pTAK1	  
(Thr184/187)	  dramatically	  decreases	   through	  one	  hour	   to	   five	  hours	  post	   infection	   in	  human	  
cells	   relative	   to	   those	   cells	   treated	   with	   uninfected	   cell	   lysates,	   whereas	   it	   dramatically	   in-­‐
creases	  in	  macaque	  cells.	  In	  the	  human	  cells,	  pTAK1	  (Ser412)	  had	  decreased	  protein	  levels	  at	  5	  
hours	  post	   infection	  whereas	  after	   the	   same	  amount	  of	   time,	  protein	   levels	  had	   increased	   in	  
the	  macaque	  cells	  (Figure	  33).	  	  These	  are	  striking	  differences	  in	  the	  way	  which	  human	  and	  ma-­‐
caque	   cells	   respond	   to	   B	   virus	   infection.	   	   In	   the	   absence	   of	   TAK1	   activation,	   human	   cells	   in-­‐
fected	  with	  B	  virus	  will	  fail	  to	  mount	  a	  proinflammatory	  response	  and	  lacking	  this	  response,	  and	  
virus	   replication	   can	   proceed	   unhampered	   by	   host	   defense	   systems,	   allowing	   the	   virus	   to	  
spread	  at	  high	  levels	  through	  the	  sensory	  ganglia	  to	  the	  CNS.	  	  With	  respect	  to	  ASK1,	  if	  activation	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occurs	  cells	  can	  activate	  p53	  and	  apoptotic	  defenses	  can	  take	  place.	  	  Interestingly,	  ASK1	  is	  acti-­‐
vated	   immediately	   after	   infection	   in	   human	   cells	   (1	   hpi),	   and	   slightly	   later	   in	   macaque	   cells	  
(3hpi),	  but	  levels	  of	  activation	  are	  low	  and	  limited	  to	  these	  single	  time	  points,	  suggesting	  that	  
cells	  from	  both	  species	  can	  respond	  to	  B	  virus	  infection,	  but	  only	  for	  a	  very	  short	  interval	  and	  
weakly	  	  with	  respect	  to	  engaging	  in	  apoptosis	  defenses.	  The	  mechanism	  by	  which	  B	  virus	  sup-­‐
presses	  ASK1	  activation	  will	  be	  the	  topic	  of	  future	  studies.	  	  Limited	  activation	  of	  ASK1	  will	  also	  
result	  in	  limited	  intervals	  of	  MAP2K	  activation	  leading	  to	  dampening	  JNK	  and	  p38	  activation.	  
The	  regulation	  of	  MAPK-­‐dependent	  apoptosis	  can	  occur	  through	  the	  MAP3Ks	  to	  signal	  
pro-­‐apoptotically	  via	  a	  MAPK	  (p38,	  JNK),	  to	  influence	  inhibitory	  proteins	  such	  as	  the	  14-­‐3-­‐3	  or	  
to	   influence	  activation	  proteins	  such	  as	  p53	   (p53	  has	  been	   found	  to	  complex	  with	   JNK	   for	   its	  
sequestration	  and	  subsequent	  degradation).	  Our	  data	  show	  that	  in	  B	  virus	  infected	  human	  cells	  
the	  presence	  of	  activated	  ASK1	  (pASK1)	  can	  be	  observed	  at	  only	  one	  hour	  post	  infection	  (Figure	  
33)	  and	  only	  weakly	  at	  three	  hours	  post	  infection	  in	  macaque	  cells.	   	  As	  previously	  mentioned,	  
ASK-­‐1	  is	  a	  MAPK3K	  that	  can	  be	  regulated	  by	  the	  family	  of	  14-­‐3-­‐3	  proteins.	  Is	  14-­‐3-­‐3	  responsible	  
for	  the	  short,	  relatively	  weak	  activation	  of	  ASK-­‐1?	  	  This	  family	  of	  proteins	  have	  been	  shown	  to	  
diffusely	   spread	  within	   the	   cytoplasm	  of	   cells	   and	   be	   regulated	   by	  many	   factors	   such	   a	   p53,	  
which	  is	  also	  regulated	  by	  ASK1.	  The	  14-­‐3-­‐3-­‐	  proteins	  are	  considered	  to	  be	  regulators	  of	  the	  cell	  
and	  the	  cell	  cycle	  as	  they	  allow	  for:	  activation	  of	  MAPK,	  prevention	  of	  apoptosis,	  cells	  to	  arrest	  
in	  G2	  phase	  and	  bind	  to	  mitosis	  specific	  translation/initiation	  factors	  such	  as	  EIF4B,	  suppression	  
of	   cap-­‐dependent	   translation	   and	   stimulation	   of	   cap-­‐independent	   translation	   (thus	   imparing	  
mitotic	  exit).	  Therefore	  we	  examined	  by	  western	  blotting,	  the	  relative	  levels	  of	  14-­‐3-­‐3	  proteins	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after	  B	  virus	  infection.	  We	  observed	  that	  there	  were	  no	  differences	  in	  the	  relative	  levels	  of	  14-­‐











Figure	  33.	  	  MAP3K	  (ASK1	  and	  TAK1)	  activation	  and	  regulation	  by	  14-­‐3-­‐3	  proteins	  
Human	  (HFF)	  and	  monkey	  (RMF)	  cells	  were	  either	   infected	  with	  B	  virus	  (BV)	  or	  mock	  infected	  
(MCL)	  at	  MOI	  5.	  At	  defined	  time	  points	  total	  cell	   lysate	  for	  western	  blotting	  procedures	  were	  
collected	  from	  each	  cell	  line	  with	  SDS	  lysis	  buffer	  with	  added	  HALT	  phosphatase	  inhibitors.	  SDS-­‐	  





6.2.4 Induction	  of	  apoptotic	  events	  pp53	  and	  cleaved	  caspase	  3	  after	  B	  virus	  infection	  
From	  the	  data	  presented	  thus	  far,	  we	  know	  that	  a	  productive	  infection	  is	  established	  in	  
cells	  from	  each	  species,	  as	  seen	  in	  the	  kinetic	  anaysis	  of	  virus	  replication,	  albeit	  at	  with	  reduced	  
effiency	  in	  macaque	  cells.	  Thus,	  there	  is	  the	  potential	  for	  spread	  to	  neighboring	  cells	  however,	  
with	  the	  observed,	  different	  host	  outcomes	  (survival	  vs.	  death).	  	  	  We	  also	  know	  from	  the	  work	  
of	  a	  number	  of	   investigators	   that	   that	  herpesviruses	   (such	  as	  HSV1)	  are	  known	   to	   inhibit	   the	  
host	  apoptotic	  response	  within	  the	   initial	  three	  to	  five	  hours	  post	   infection.	   	  With	  this	  knowl-­‐
ededge,	   we	   next	   investigated	   whether	   downstream	   apoptotic	   events	   were	   influenced	   by	  
MAPKs	  (pp53	  and	  cleaved	  caspase	  3)	  after	  B	  virus	  infection.	  
Cells	   from	  each	  species	  were	   infected	  with	  B	  virus	  and	  harvested	  at	  7	  hpi.	   	  This	   time-­‐
point	  was	  selected	  to	  allow	  for	  the	  effects	  of	  events	  at	  5	  hpi	  to	  unfold.	   	  Cells	  were	  harvested	  
and	  p53	  mRNA	  was	  measured	  in	  cells	  from	  each	  species	  with	  levels	  expressed	  as	  	  a	  ratio	  of	  in-­‐
fected	  to	  uninfected	  cells.	   	  Replicate	  cultures	  were	  pooled	  for	  this	  analysis.	   	  The	  levels	  of	  p53	  
were	  two-­‐fold	  greater	  in	  human	  cells	  when	  compared	  to	  macaque	  cells,	  however	  differences	  in	  
the	  patterns	  of	  p53	  activation	  (pp53)	  were	  apparent	  in	  cells	  from	  each	  species	  as	  seen	  in	  Figure	  
34.	  	  Human	  cells	  infected	  with	  B	  virus	  do	  not	  show	  increased	  p53	  activation	  until	  5	  hpi,	  whereas	  
by	  this	  timepoint	  macaque	  cells	  have	  almost	  no	  serine	  phosphorylation	  of	  p53	  while	  maintain-­‐
ing	   serine	   46	   phosphorylation	   p53	   in	   cells	   exposed	   to	   either	   infected	   or	   uninfected	   lysates.	  	  
Thus,	  serine	  46	  appears	  to	  be	  phoshorylated	  regardless	  of	  the	  presence	  or	  absence	  of	  B	  virus	  in	  
macaque	  cells,	  whereas	  in	  human	  cells	  serine	  46	  is	  phosphorylated	  in	  what	  appears	  to	  be	  a	  B	  
virus	   specific	  manner.	   	  The	   implications	  of	   this	  differential	  phosphorylation	  are	  unclear,	  how-­‐
ever,	  it	  is	  remarkable	  that	  macaque	  cells	  appear	  to	  respond	  via	  p53	  activation	  when	  exposed	  to	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either	  B	  virus	  infected	  or	  uninfected	  cell	  lysate,	  suggesting	  that	  there	  are	  sensor	  differences	  be-­‐
tween	  human	  and	  macaque	  cells.	  The	  observation	  that	  B	  virus	   infected	  macaque	  cells	  do	  not	  
express	  high	  p53	  levels	  of	  serine-­‐15	  phosphorylation	  by	  5	  hpi,	  whereas	  human	  cells	  infected	  by	  
B	  virus	  show	  elevated	   levels	  begs	   further	  study.	   	   Interestingly,	  p53	   (ser15)	  may	  play	  a	   role	   in	  
epithelial	  cell	  responses	  to	  damage	  	  
To	  further	  investigate	  the	  apoptotic	  differences	  between	  B	  virus	  infected	  macaque	  and	  
human	  cells,	  with	   the	  knowledge	  that	  caspases	  play	  a	   role	   in	  viral	  protein	  processing,	  experi-­‐
ments	  were	  designed	  to	  examine	  executioner	  protein	  caspase	  3,	  which	  is	  cleaved	  when	  active	  
and	  is	  responsible	  for	  the	  proteolytic	  cleavage	  of	  many	  apoptotic	  proteins.	  Does	  virus	  infection	  
impact	  caspase	  3	  cleavage	  in	  a	  species-­‐specific	  manner?	  	  Human	  and	  macaque	  cells	  were	  each	  
infected	  with	  B	  virus	  at	  MOI	  5	  and	  harvested	  at	  30	  minutes,	  three	  hours	  and	  seven	  hours	  post	  
infection	  for	  FACS	  analysis	  to	  measure	  activated	  p53	  and	  cleaved	  caspase	  levels.	  	  The	  levels	  of	  
cleaved	   or	   activated	   caspase	   3	   in	   B	   virus	   infected	   cells	   compared	   to	   the	   relative	   levels	   of	  
cleaved	  caspase	  3	  in	  mock	  infected	  cells	   increase	  from	  one	  to	  seven	  hours	  post	  in	  the	  foreign	  
host	   (HFF)	   (Figure	   35).	  However,	   in	   the	  natural	   host	   (RMF),	   relative	  protein	   levels	   of	   cleaved	  
caspase	   3	   never	   exceed	   that	   of	   the	  macaque	   cells	   exposed	   to	   uninfected	   cells	   and	   at	   three	  
hours	  post	  infection	  relative	  protein	  levels	  of	  cleaved	  caspase	  3	  decrease	  to	  below	  those	  seen	  
in	  cells	  exposed	  in	  uninfected	  cell	  lysates	  (control).	  Caspase	  3	  cleavage	  is	  generally	  considered	  
one	  marker	   that	   apoptosis	   is	   in	   progress.	   Antibodies	   specific	   for	   activated	   caspase	   however	  
were	  not	  sufficiently	  sensitive	  for	  use	  in	  western	  blot	  (data	  not	  shown).	  	  	  Data	  from	  the	  accom-­‐
panying	  FACS	  analysis	  of	  activated	  p53	  support	  the	  conclusions	  drawn	  from	  data	  shown	  in	  Fig-­‐
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ure	  34.	  	  The	  	  increases	  in	  activated	  caspase	  3	  in	  human	  cells	  infeted	  with	  B	  virus	  correlate	  well	  
with	  the	  increased	  p53	  transcription	  and	  activation	  (both	  Ser15	  and	  Ser46).	  
	  
	  
Figure	  34.	  	  Analysis	  of	  markers	  of	  apoptosis	  p53	  and	  cleaved	  caspase	  3	  
Human	  (HFF)	  and	  monkey	  (RMF)	  cells	  were	  either	   infected	  with	  B	  virus	  (BV)	  or	  mock	  infected	  
(MCL)	  at	  MOI	  5.	  At	  defined	  time	  points	  total	  cell	  lysate	  for	  (a)	  western	  blotting	  procedures	  were	  
collected	  from	  each	  cell	  line	  with	  SDS	  lysis	  buffer	  with	  added	  HALT	  phosphatase	  inhibitors.	  SDS-­‐	  
PAGE	  and	  Western	  blotting	  detection	  procedures	  were	  carried	  followed	  by	  ECL	  immunodetec-­‐
tion,	  (b)	  RT-­‐PCR	  was	  collected	  with	  RLT	  buffer.	  Total	  RNA	  was	  isolated	  and	  purified,	  followed	  by	  







Figure	  35.	  	  	  FACS	  analysis	  of	  apoptotic	  events	  pp53	  and	  cleaved	  caspase	  3	  
Cells	  were	  mock-­‐infected	  or	  infected	  with	  B	  virus	  at	  MOI	  5,	  and,	  at	  defined	  time	  points,	  media	  
was	  removed	  and	  enzymatic	  digestion	  was	  used	  to	  remove	  adhered	  cells.	  This	  process	  was	  fol-­‐
lowed	  by	  a	  cold	  PBS	  wash	  and	  fixation	  in	  paraformaldehyde	  (PFA)	  4	  to	  8%.	  Fix	  was	  removed	  and	  
cells	  permeabilized	  and	  resuspended	  in	  100%	  methanol.	  Cells	  were	  equally	  aliquoted	  and	  incu-­‐
bated	  in	  blocking	  buffer;	  the	  blocking	  was,	  followed	  by	  primary	  antibody	  and	  the	  fluorochrome-­‐
conjugated	  secondary	  antibody	  prior	  to	  detection.	  FACS	  limits	  were	  for	  10000	  events	  and	  data	  




6.2.5 	  Role	  of	  MAPKs	  p38	  and	  JNK	  on	  the	  replication	  of	  B	  virus	  	  	  
MAPK	  are	  key	  drivers	  of	   the	   innate	   immune	  response	  to	   infection	   	  With	   the	  observed	  
results	  from	  the	  analyses	  covered	  at	  this	  point,	  	  I	  next	  investigated	  the	  role	  of	  p38	  and	  JNK	  on	  
the	  replication	  of	  B	  virus	  by	  inhibition	  or	  stimulation	  of	  the	  pathways	  prior	  to	  and	  after	   infec-­‐
tion.	   	   What	   are	   the	   functional	   consequences	   of	   the	   differences	   noted	   in	   the	   previously	   de-­‐
scribed	  experiments?	  	  My	  hypothesis	  was	  that	  virus	  replication	  was	  modulated	  differentially	  in	  
cells	  of	  each	  host,	   resulting	   in	  differences	   in	   the	  amount	  of	   replicated	  virus	  able	   to	  enter	   the	  
axons	  of	  the	  peripheral	  nerves.	  	  Failure	  to	  control	  virus	  load	  may	  underlie	  the	  differences	  in	  B	  
virus	  pathogenesis	  in	  macaques	  and	  humans.	  	  To	  test	  this	  hypothesis,	  we	  infected	  cells	  of	  each	  
species	   and	   evaluated	   the	   effects	   of	   blocking	   or	   enhancing	   the	   progression	   of	   the	  MAPK	   re-­‐
sponses	   via	   JNK	   and	  p38	   activation.	   	  We	   selected	  multiple	   inhibitors	   of	   either	   p38	  or	   JNK	   as	  
each	  group	  of	  inhibitors	  had	  different	  mechanisms	  of	  action.	  	  	  
Using	  each	  p38	  inhibitor,	  we	  observed	  that	  inhibition	  lead	  to	  a	  relative	  decrease	  in	  B	  vi-­‐
rus	   replication	   (pfu)	   in	  human	   fibroblasts,	  whereas	   there	   is	  was	  an	  observed	   increase	   in	  viral	  
replication	  in	  the	  macaque	  fibroblasts	  (Figure	  36).	   It	   is	  curious	  that	  p38	  in	  cells	  from	  two	  spe-­‐
cies,	   albeit	   closely	   related	   species,	   have	   such	   disparate	   effects	   on	   virus	   replication.	   	  We	   re-­‐
peated	  this	  experiment	  multiple	  times	  to	  establish	  confidence	   in	  these	  observations	   	   	  The	  es-­‐
sential	  nature	  of	  p38	  in	  human	  fibroblasts	  for	  B	  virus	  replication	  suggests	  that	  downstream	  ef-­‐
fects	   of	   this	   pathway	   are	   critical	   to	   some	   specific	   components	  of	   virus	   replication	   and/or	   as-­‐
sembly.	  ,	  whereas	  in	  macaque	  cells,	  p38	  actually	  may	  dampen	  the	  amount	  of	  B	  virus	  that	  is	  rep-­‐
licated	   and/or	   assembled,	   thus	   serving	   as	   a	   control	   or	   regulator	   of	   the	   amount	   of	   virus	   pro-­‐
duced.	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As	  with	  p38	  inhibition,	  JNK	  inhibition	  led	  to	  a	  relative	  decrease	  in	  viral	  replication	  (less	  
pfu)	  in	  human	  cell	   line,	  whereas	  viral	  replication	  was	  relatively	  increased	  in	  the	  macaque	  cells	  
depending	  on	  the	  JNK	  inhibitor	  used	  (Figure	  36).	  	  Manufacturers	  of	  each	  inhibitor	  supplied	  in-­‐
formation	  with	   respect	   to	   the	  mechanism	  of	  action	  of	  each,	  and	  because	  of	  differing	  mecha-­‐
nisms	  of	  action,	  we	  anticipated	  potential	  differences	   in	  experimental	  outcomes	  of	   treatment,	  
which	  in	  fact	  we	  observed.	  	  The	  differences	  in	  inhibitor	  effects,	  however,	  did	  not	  correlate	  with	  
the	   manufacturers’	   descriptions	   of	   mechanisms	   of	   actions,	   but	   emerging	   data	   suggests	   that	  
mechanisms	  of	  actions	  of	  these	  compounds	  may	  not	  be	  fully	  elucidated	  at	  present.	  	  Because	  of	  
the	  curious	  and	  disparate	  effects	  in	  human	  and	  macaque	  cells,	  we	  decided	  to	  confirm	  these	  ob-­‐
servations	  using	  a	  different	  approach,	  i.e.,	  treatment	  of	  cells	  with	  p38	  and	  JNK	  stimulators.	  	  	  
Activation	  of	  the	  SAPK	  (JNK	  and	  p38)	  has	  generally	  been	  accomplished	  with	  the	  use	  of	  
sorbitol	   and	   anisomycin,	   respectively.	   Sorbital	   is	   a	   sugar	   and	   induces	   an	  osmotic	   shift	   that	   is	  
stressful	  to	  cells,	  whereas	  anisomycin	  is	  an	  antibiotic	  that	  binds	  to	  the	  60S	  ribosomal	  sub-­‐units	  
and	  prevents	  protein	  synthesis	  by	  inhibiting	  the	  peptide	  bond	  formation.	  Though	  each	  reagent	  
has	  been	  used	   to	   target	  either	   JNK	  or	  p38,	  each	   induces	  a	   stress	   response	   in	   cells	   that	   influ-­‐





Figure	  36.	  	  B	  virus	  infection	  in	  the	  presence	  of	  MAPK	  (JNK,	  p38)	  inhibition	  
Human	  (HFF)	  and	  monkey	  (RMF)	  cells	  were	  either	  pretreated	  and	  infected	  with	  B	  virus	  (BV)	  at	  
an	  MOI	  5	  in	  the	  presence	  of	  the	  stated	  inhibitor	  at	  the	  shown	  concentration,	  or	  infected	  with	  B	  
BV	  only.	  At	  24	  hours	  post	  infection	  total	  cell	  lysate	  was	  collected,	  and	  freeze	  thawed.	  Samples	  
were	  then	  titrated	  in	  duplicate	  on	  Vero	  cells	  (plaque	  assay)	  and	  pfu/ml	  determined.	  Results	  are	  
the	  mean	  ±	  standard	  error	  of	  the	  samples.	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After	  stimulation	  of	  the	  MAPK	  pathways	  by	  the	  use	  of	  anisomycin	  and	  sorbitol,	  we	  see	  
relative	  increases	  in	  the	  levels	  of	  pJNK3	  in	  the	  human	  cells	  and	  relative	  decreases	  in	  the	  levels	  
of	  JNK1/2/3	  in	  the	  macaque	  cell	  line	  (Figure	  37),	  unlike	  what	  we	  predicted,	  i.e.,	  cells	  from	  each	  
species	  would	  respond	  similarly	  to	  asnisomycin	  and	  sorbital	  treatment.	  	  There	  is	  no	  data	  in	  the	  
literature	  than	  macaque	  cells	  may	  differentially	  utilize	   JNK.	   	  This	  observation	  will	  be	  explored	  
with	  additional	  studies	  in	  the	  near	  future.	  	  	  
Relative	  pp38	  levels	  increased	  to	  lesser	  extent	  in	  human	  cells	  when	  compared	  to	  the	  un-­‐
treated	   controls.	   Interestingly,	   the	   relative	   protein	   levels	   of	   pp38	   are	   increased	   in	   sorbitol	  
treated	  macaque	  cells	  when	  compared	  to	  controls	  and	  anisomycin	  treated	  cells.	  There	  were	  no	  
observed	  differences	  in	  relative	  pp53	  levels	  after	  anisomycin	  treatment	  in	  human	  cells,	  whereas	  
there	  was	  an	  observed	  relative	  decrease	  in	  pp53	  in	  macaque	  cells	  (Figure	  37).	  	  Consistent	  with	  
the	  effects	  of	  JNK	  on	  B	  virus	  replication	   in	  human	  cells,	  an	   increase	   in	  B	  virus	  was	  seen	  when	  
JNK	   levels	   were	   increased	   as	   a	   result	   of	   anisomycin	   treatment.	   	   Likewise,	   B	   virus	   levels	   de-­‐
creased.	   	   These	   observations	   provided	   support	   for	   the	   results	   observed	   in	   the	   inhibition	   ex-­‐












Figure	  37.	  B	  virus	  infection	  in	  the	  presence	  of	  MAPK	  (JNK,	  p38)	  stimulation	  
Human	   (HFF)	   and	  monkey	   (RMF)	   cells	  were	   either	   pretreated	  with	   stated	   stimulator	   and	   in-­‐
fected	  with	  B	  virus	  (BV)	  at	  an	  MOI	  5	  in	  the	  presence	  of	  the	  stated	  stimulator	  at	  the	  shown	  con-­‐
centration,	  or	   infected	  with	  BV	  only.	  At	  24	  hours	  post	   infection	  total	  cell	   lysate	  was	  collected,	  
and	   freeze-­‐thawed.	   Samples	  were	   then	   titrated	   in	  duplicate	  on	  Vero	   cells	   (plaque	  assay)	   and	  
pfu/ml	  determined.	  Results	  are	  the	  mean	  ±	  standard	  error	  of	  the	  samples.	  	  Anti-­‐phospho	  anti-­‐








6.3 Specific	  Aim	  3:	  Measure	  MAPK-­‐induced	  gene	  products	  and	  proinflammatory	  mediators	  
that	   are	   upregulated	   in	   response	   to	   MAPK-­‐adaptor	   molecule	   activation	   to	   establish	  
whether	  these	  events	  correlate	  with	  observed	  adaptive	  responses	  characteristic	  of	  each	  
host	  species	  defenses	  against	  B	  virus	  infection.	  
6.3.1 Transcription	  factors	  associated	  with	  JNK	  and	  p38	  signaling	  
The	  MAPK-­‐JNK	  can	  influence	  many	  downstream	  transcription	  factors	  involved	  in	  the	  in-­‐
nate	  immune	  response	  to	  infection	  such	  as	  the	  Jun,	  ATF	  and	  Fos	  family	  members.	  Members	  of	  
these	  families	  dimerize	  to	  form	  the	  AP1	  transcription	  factor	  for	  the	  expression	  and	  regulation	  of	  
several	   stress	   responsive	   genes.	   AP1	   has	   been	   shown	   to	   be	   upregulated	   after	   infection	  with	  
many	  DNA	  viruses	  and	  some	  viruses	  have	  also	  been	  shown	  to	  exploit	  AP1	  to	  enhance	  the	  tran-­‐
scription	  of	  their	  viral	  genes.	   	  The	  true	  test	  of	  whether	  the	  differences	  observed	  in	  human	  vs.	  
macaque	  cells	  impact	  the	  deployment	  of	  specific	  defenses	  is	  challenging	  to	  test	  in	  the	  absence	  
of	  a	  suitable	  animal	  model	  that	  mimics	  zoonotic	  B	  virus	  infection.	  	  To	  overcome	  this	  obstacle,	  
we	  chose	  to	  ask	  this	  question	  using	  the	  cell	  model	  systems	  representing	  cells	  derived	  from	  hu-­‐
mans	  and	  macaques.	  	  Experiments	  were	  designed	  to	  evaluate	  transcription	  factor	  levels	  and	  by	  
measuring	  the	  gene	  products	  that	  these	  factors	  upregulate	  via	  FACS	  analysis.	  
Human	  and	  macaque	  cells	  were	  each	  infected	  with	  B	  virus	  or	  treated	  with	  uninfected	  cell	  lysate	  
as	  a	  negative	  control.	   	  Cells	  were	  then	  harvested	  at	  one	  and	  five	  hpi	  by	  removal	  of	  media	  fol-­‐
lowed	  by	  trypsin	  treatment	  to	  remove	  cells	  that	  were	  then	  treated	  with	  paraformaldehyde	  fixa-­‐
tive	  and	  methanol	  to	  permeabilize	  cells	   for	  FACS	  analysis	  to	   investigate	  the	  relative	  transcrip-­‐
tion	  factor	  levels	  after	  infection.	  	  Histograms	  show	  that	  after	  B	  virus	  infection	  there	  was	  a	  virus-­‐
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specific	  shift	   in	  the	  activated	  cJun	   in	  human	  cell	   lines	  by	  five	  hpi	  times	  post	   infection	  (Figures	  
38)	  indicating	  that	  cJun	  transcription	  factor	  levels	  increased	  dramatically	  between	  one	  and	  five	  
hours	  post	  in	  B	  virus	  infected	  human	  cells	  (Figure	  39).	  Little-­‐to-­‐no	  significant	  increases	  in	  cJun	  
were	  noted	  in	  B	  virus	  infected	  macaque	  cells.	  Transcription	  factor	  cJun	  regulates	  cell	  cycle	  pro-­‐
gression	  through	  G1	  via	  cyclin	  D	  and	  cooperates	  with	  NF-­‐κB	  to	  prevent	  apoptosis.	  	  It	  is	  a	  com-­‐
ponent	  of	  AP-­‐1	   transcription	   factor.	   	   Interestingly,	  we	  know	  from	  previous	  data	   (Zao	  and	  Hil-­‐
liard,	  unpublished)	  that	  in	  spite	  of	  the	  translocation	  of	  virus-­‐induced	  transcription	  factors	  regu-­‐
lating	   proinflammatory	   responses,	   there	   is	   an	   absence	   of	   transcription	   of	   proinflammatory	  
genes	   in	  B	  virus	   infected	  human	  foreskin	  fibroblasts	  at	   five	  and	  24	  hpi,	   the	  reasons	  for	  which	  
are	  unclear	  at	  present.	  	  	  
	   We	   next	   investigated	   cFos	   activation	   since	   cJun	   and	   cFos	   can	   form	   heterodimers	   to	  
regulate	  specific	  genes.	  	  Both	  are	  associated	  with	  regulation	  of	  cell	  cycle	  and	  apoptosis	  via	  AP-­‐1	  
regulated	  genes.	   	   cFos	  does	  not	  bind	   to	  promoter	   regions	  of	   these	  genes	  alone,	  but	   through	  
binding	  with	  cJun.	  	  Again	  FACS	  analyses	  were	  performed	  to	  quantify	  changes	  in	  cFos	  levels	  and	  
to	  compare	  B	  virus	  infected	  human	  and	  macaque	  cells	  at	  one	  and	  five	  hpi.	  	  Representative	  data	  






Figure	  38.	  	  	  JNK-­‐associated	  transcription	  factor	  pcJun	  during	  B	  virus	  infection	  at	  one	  and	  seven	  
hours	  post	  infection	  
Human	  (HFF)	  and	  monkey	  (RMF)	  cells	  were	  either	  mock-­‐infected	  (MCL)	  or	  infected	  with	  B	  virus	  
(BV)	  at	  MOI	  5,	   and	  at	  defined	   time	  points,	  media	  was	   removed	  and	  enzymatic	  digestion	  was	  
used	   to	   remove	  adhered	   cells.	   This	   process	  was	   followed	  by	   a	   cold	  PBS	  wash	   and	   fixation	   in	  
paraformaldehyde	   (PFA)	   4	   to	   8%.	   Fixative	   was	   removed	   and	   cells	   permeabilized	   and	   resus-­‐
pended	   in	  100%	  methanol.	  Cells	  were	  equally	  aliquoted	  and	   incubated	   in	  blocking	  buffer;	  the	  
blocking	  was,	  followed	  by	  primary	  antibody	  and	  the	  fluorochrome-­‐conjugated	  secondary	  anti-­‐
body	  prior	   to	  detection.	   The	  denotation	  M:	   represents	  mock-­‐infected,	  BV:	   represents	  B	   virus	  
infected	   and	   Unstain:	   represents	   uninfected	   unstained	   cells.	   FACS	   limits	   were	   set	   for	   10000	  





Figure	  39.	  	  JNK-­‐associated	  transcription	  factor	  pcJun	  through	  5	  hours	  post	  infection	  
Human	  (HFF)	  and	  monkey	  (RMF)	  cells	  were	  either	  mock-­‐infected	  (MCL)	  or	  infected	  with	  B	  virus	  	  
(BV)	  at	  MOI	  5,	   and	  at	  defined	   time	  points,	  media	  was	   removed	  and	  enzymatic	  digestion	  was	  
used	   to	   remove	  adhered	   cells.	   This	   process	  was	   followed	  by	   a	   cold	  PBS	  wash	   and	   fixation	   in	  
paraformaldehyde	   (PFA)	   4	   to	   8%.	   Fixative	   was	   removed	   and	   cells	   permeabilized	   and	   resus-­‐
pended	   in	  100%	  methanol.	  Cells	  were	  equally	  aliquoted	  and	   incubated	   in	  blocking	  buffer;	  the	  
blocking	  was,	  followed	  by	  primary	  antibody	  and	  the	  fluorochrome-­‐conjugated	  secondary	  anti-­‐
body	  prior	   to	  detection.	   The	  denotation	  M:	   represents	  mock-­‐infected,	  BV:	   represents	  B	   virus	  
infected	  and	  Unstain:	  represents	  uninfected	  unstained	  cells.	  FACS	  limits	  were	  for	  10000	  events	  
and	   data	   is	   representative	   of	   duplicate	   experiments.	   Data	   represents	   fold-­‐variation	   between	  
infected	  and	  uninfected	  cells	  from	  each	  species.	  
Interestingly,	  cFos	  levels	  appear	  to	  be	  relatively	  low	  at	  one	  hour	  pi	  in	  both	  cell	  lines,	  but	  
by	  five	  hours	  post	  infection,	  levels	  of	  cFos	  are	  elevated	  in	  a	  virus-­‐specific	  manner	  in	  human	  cells	  
(Figure	   40A	  &	  B),	   similar	   to	  what	   is	   seen	   for	   cJun.	  Histograms	  of	   FosB	   shows	   a	   similar	   virus-­‐
specific	  pattern	  to	  that	  of	  cJun	  with	  both	  human	  and	  macaque	  cells	  expressing	  lower	  amounts	  
at	  one	  hours	  post	   infection	  and	  by	   five	  hours	  post	   infection	  there	   is	  a	  clear	   increase	   in	  virus-­‐
specific	  expression	  only	   in	  human	  cells	   (Figures	  40	  &	  41).	   	  Comparative	  analyses	  of	  macaques	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versus	  human	  cells	  can	  be	  seen	   in	  Figures	  40	  &41	  which	  shows	  the	  P/N	  values	  calculated	   for	  
each	  species	  using	  raw	  data	  from	  FACS	  analyses.	  
	  
A.	  
B.	   	  
Figure	  40.	  	  JNK-­‐associated	  transcription	  factor	  cFos	  after	  B	  virus	  infection.	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Human	  (HFF)	  and	  monkey	  (RMF)	  cells	  were	  either	  mock-­‐infected	  (MCL)	  or	  infected	  with	  B	  virus	  
(BV)	  at	  MOI	  5,	   and	  at	  defined	   time	  points,	  media	  was	   removed	  and	  enzymatic	  digestion	  was	  
used	   to	   remove	  adhered	   cells.	   This	   process	  was	   followed	  by	   a	   cold	  PBS	  wash	   and	   fixation	   in	  
paraformaldehyde	   (PFA)	   4	   to	   8%.	   Fixative	   was	   removed	   and	   cells	   permeabilized	   and	   resus-­‐
pended	   in	  100%	  methanol.	  Cells	  were	  equally	  aliquoted	  and	   incubated	   in	  blocking	  buffer;	  the	  
blocking	  was,	  followed	  by	  primary	  antibody	  and	  the	  fluorochrome-­‐conjugated	  secondary	  anti-­‐
body	  prior	   to	  detection.	   The	  denotation	  M:	   represents	  mock-­‐infected,	  BV:	   represents	  B	   virus	  
infected	  and	  Unstain:	  represents	  uninfected	  unstained	  cells.	  FACS	  limits	  were	  for	  10000	  events	  
and	  data	  is	  representative	  of	  duplicate	  experiments.	  A)	  Histograms	  of	  FosB	  shows	  a	  similar	  vi-­‐
rus-­‐specific	   pattern	   to	   that	   of	   cJun	   with	   both	   human	   and	   macaque	   cells	   expressing	   lower	  
amounts	  at	  one	  hours	  post	  infection	  and	  by	  five	  hours	  post	  infection	  there	  is	  a	  clear	  increase	  in	  
virus-­‐specific	   expression	  only	   in	   human	   cells	   (Figure	   40).	   	   Comparative	   analyses	  of	  macaques	  
versus	  human	  cells	  can	  be	  seen	   in	  B)	  which	  shows	  the	  P/N	  values	  calculated	  for	  each	  species	  
using	  raw	  data	  from	  FACS	  analyses.	  
	  
Analysis	  of	  FosB	  was	  performed	  in	  a	  similar	  approach	  to	  cJun	  and	  cFos.	  	  FosB	  plays	  a	  role	  
in	   transcriptional	   regulation	   as	   it	   seems	   that	   in	   its	   absence	   there	   is	   reduced	  AP-­‐1	   associated	  
transcriptional	  activity.	  	  Figure	  41A	  shows	  levels	  of	  FosB	  in	  B	  virus	  infected	  human	  and	  macaque	  
cells,	  while	  Figure	  41B	  shows	   the	  analysis	  of	   virus-­‐influenced	   levels	  of	  FosB	   in	  each	  cell	   type.	  	  
Again	  little	  increase	  of	  FosB	  is	  seen	  in	  B	  virus	  infected	  macaque	  cells	  while	  greater	  than	  a	  three-­‐
fold	  increase	  is	  seen	  in	  B	  virus	  infected	  human	  cells.	  	  The	  lack	  of	  transcriptional	  activity	  in	  B	  vi-­‐
rus	  infected	  macaque	  cells	  has	  to-­‐date	  never	  been	  observed	  and	  is	  curious.	  	  These	  data	  suggest	  
that	  B	   virus	  employs	  a	  mechanism	   to	  dampen	  activation	  of	   transcriptional	   activity	   via	  an	  up-­‐
stream	  block	  in	  transcriptional	  factor	  activation,	  while	  B	  virus	  fails	  to	  accomplish	  this	  blockade	  
in	  human	  cells.	  	  Data	  from	  Zao	  and	  Hilliard	  (submitted	  for	  publication)	  suggests	  that	  in	  B	  virus	  
infected	  human	  cells,	  transcriptional	  activity	  is	  suppressed	  by	  in	  the	  nucleus	  since	  transcription	  
factors	   are	   activated	   and	   translocate	   to	   the	   nucleus,	   but	   fail	   to	   transcribe	   proinflammatory	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genes.	   Data	   gathered	   for	   this	   dissertation	   show	   that	   there	   is	   a	   clear	   difference	   in	   species-­‐















Figure	  41.	  	  JNK-­‐associated	  transcription	  factor	  FosB	  after	  B	  virus	  infection	  
Human	  (HFF)	  and	  monkey	  (RMF)	  cells	  were	  either	  mock-­‐infected	  (MCL)	  or	  infected	  with	  B	  virus	  
(BV)	  at	  MOI	  5,	  and	  at	  defined	  timepoints,	  medium	  was	  removed	  and	  enzymatic	  digestion	  was	  
used	   to	   remove	  adhered	   cells.	   This	   process	  was	   followed	  by	   a	   cold	  PBS	  wash	   and	   fixation	   in	  
paraformaldehyde	   (PFA)	   4	   to	   8%.	   Fixative	   was	   removed	   and	   cells	   permeabilized	   and	   resus-­‐
pended	   in	  100%	  methanol.	  Cells	  were	  equally	  aliquoted	  and	   incubated	   in	  blocking	  buffer;	   the	  
blocking	  was	   followed	  by	  primary	  antibody	  and	   the	   fluorochrome-­‐conjugated	  secondary	  anti-­‐
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body	  prior	   to	  detection.	   The	  denotation	  M:	   represents	  mock-­‐infected,	  BV:	   represents	  B	   virus	  
infected	  and	  Unstain:	  represents	  uninfected	  unstained	  cells.	  FACS	  limits	  were	  for	  10000	  events	  
and	  data	  are	  representative	  of	  duplicate	  experiments.	  
We	  next	  evaluated	  ATF2	   levels	   in	  B	  virus	   infected	  human	  and	  macaque	  cells	  using	  the	  
same	  methodological	  approach.	  	  	  Figure	  42	  shows	  FACS	  data	  that	  suggests	  that	  in	  human	  cells	  
there	  is	  an	  early	  virus-­‐specific	  suppression	  of	  p38	  associated	  activated	  ATF2	  at	  one	  hpi,	  while	  by	  
five	  hpi	  there	  is	  a	  virus-­‐specific	  increase	  in	  activated	  ATF2,	  unlike	  the	  responses	  observed	  to	  oc-­‐
cur	  in	  macaque	  cells.	  	  B	  virus	  infected	  macaque	  cells	  show	  minimal	  ATF2	  activation	  at	  one	  hpi,	  
while	   at	   five	   hpi	   there	  was	   an	   increase,	   however,	   significantly	   less	   than	   that	   seen	   in	   human	  
cells.	  	  The	  implications	  of	  these	  observations	  will	  be	  explored	  by	  analysis	  of	  genes	  upregulated	  
by	  ATF2.	  	  Figures	  42	  &	  43	  shows	  the	  relative	  fold-­‐changes	  in	  activated	  ATF2	  in	  B	  virus	  infected	  






Figure	  42.	  	  The	  p38-­‐associated	  transcription	  factor	  pATF2	  after	  B	  virus	  infection	  
Human	  (HFF)	  and	  monkey	  (RMF)	  cells	  were	  either	  mock-­‐infected	  (MCL)	  or	  infected	  with	  B	  virus	  
(BV)	  at	  MOI	  5,	   and	  at	  defined	   time	  points,	  media	  was	   removed	  and	  enzymatic	  digestion	  was	  
used	   to	   remove	  adhered	   cells.	   This	   process	  was	   followed	  by	   a	   cold	  PBS	  wash	   and	   fixation	   in	  
paraformaldehyde	   (PFA)	   4	   to	   8%.	   Fixative	   was	   removed	   and	   cells	   permeabilized	   and	   resus-­‐
pended	   in	  100%	  methanol.	  Cells	  were	  equally	  aliquoted	  and	   incubated	   in	  blocking	  buffer;	  the	  
blocking	  was,	  followed	  by	  primary	  antibody	  and	  the	  fluorochrome-­‐conjugated	  secondary	  anti-­‐
body	  prior	   to	  detection.	   The	  denotation	  M:	   represents	  mock-­‐infected,	  BV:	   represents	  B	   virus	  
infected	  and	  Unstain:	  represents	  uninfected	  unstained	  cells.	  FACS	  limits	  were	  for	  10000	  events	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and	  data	  is	  representative	  of	  duplicate	  experiments.	  A.	  histogram	  analysis	  of	  temporal	  changes	  
in	  activation	  of	  ATF2	  in	  B	  virus	  infected	  human	  and	  macaque	  cells.	  	  B.	  Comparative	  analysis	  of	  
fold-­‐changes	  of	  activated	  ATF2	  in	  B	  virus	  infected	  macaque	  and	  humans	  cells.	  
	  
Figure	  43.	  	  The	  p38-­‐associated	  transcription	  factor	  pATF2	  through	  5hrs	  pi	  comparative	  analy-­‐
sis	  of	  levels	  at	  one	  and	  five	  hpi	  together	  for	  both	  B	  virus	  infected	  macaque	  and	  humans	  cells	  
Human	  (HFF)	  and	  monkey	  (RMF)	  cells	  were	  either	  mock-­‐infected	  (MCL)	  or	  infected	  with	  B	  virus	  
(BV)	  at	  MOI	  5,	   and	  at	  defined	   time	  points,	  media	  was	   removed	  and	  enzymatic	  digestion	  was	  
used	   to	   remove	  adhered	   cells.	   This	   process	  was	   followed	  by	   a	   cold	  PBS	  wash	   and	   fixation	   in	  
paraformaldehyde	   (PFA)	   4	   to	   8%.	   Fixative	   was	   removed	   and	   cells	   permeabilized	   and	   resus-­‐
pended	   in	  100%	  methanol.	  Cells	  were	  equally	  aliquoted	  and	   incubated	   in	  blocking	  buffer;	  the	  
blocking	  was,	  followed	  by	  primary	  antibody	  and	  the	  fluorochrome-­‐conjugated	  secondary	  anti-­‐
body	  prior	   to	  detection.	   The	  denotation	  M:	   represents	  mock-­‐infected,	  BV:	   represents	  B	   virus	  
infected	  and	  Unstain:	  represents	  uninfected	  unstained	  cells.	  FACS	  limits	  were	  for	  10000	  events	  
and	  data	  is	  representative	  of	  duplicate	  experiment	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   ATF2	  is	   important	  for	  the	  regulation	  of	  growth	  control	  functions	  particularly	  in	  concert	  
with	  cJun	  by	   forming	  homo-­‐or	  heterodimers.	   	   It	   is	  also	  a	   response	  transcription	   factor	   that	   is	  
activated	  particularly	  as	  a	   result	  of	  environmental	  changes	   in	   the	  cell’s	  microenvironment.	   	   It	  
appears	  from	  the	  data	  shown	  in	  Figures	  42	  &	  43	  reveal	  that	  activated	  ATF2	  is	  found	  at	  slighty	  
higher	   levels	   in	  B	  virus	   infected	  humans	  cells	   relative	   to	  B	  virus	   infected	  macaque	  cells,	  how-­‐
ever,	   analysis	   of	   data	   by	   Student	   T-­‐test	   reveals	   that	   there	   are	   no	   significant	   differences	   be-­‐
tween	  ATF2	  activation	   levels	  between	  B	  virus	   infected	  macaque	  and	  humans	  cells.	   	   This	  may	  
simplay	  suggest	  that	  ATF2	  does	  not	  play	  an	  important	  role	  in	  the	  cell	  response	  to	  B	  virus.	  
As	  part	  of	   the	  group	  of	   transcription	   factors	  analyzed,	   the	  next	  experiments	  were	  de-­‐
signed	  to	  measure	  activated	  p53,	  a	  key	  element	   in	   induction	  of	  apoptotic	  defense	  responses.	  	  	  
Although	  simplexviruses	  in	  general	  efficiently	  block	  apoptosis,	  there	  are	  essential	  components	  
of	   this	   pathway	   that	  play	   a	   role(s)	   of	   virus	   replication	  processes.	   	  We	  again	  observed	   that	   in	  
human	  cells	   that	   the	  relative	   levels	  of	  apoptotic	   transcription	   factor	  pp53	  were	  greater	  when	  
compared	  to	  macaque	  cells	  after	  B	  virus	  infection	  (Figure	  44A).	  The	  fold-­‐changes	  for	  each	  can	  
be	  seen	  in	  Figure	  44B	  which	  shows	  a	  three-­‐fold	  increase	  in	  activated	  p53,	  perhaps	  as	  a	  rush	  for	  
the	  cell	  to	  self-­‐destruct	  in	  response	  to	  B	  virus	  infection,	  however	  activated	  p53	  drops	  radically	  
by	  five	  hpi.	  	  B	  virus	  infected	  macaque	  cells	  show	  activated	  p53	  by	  five	  hpi.	  	  Later	  timepoints	  will	  
be	  examined	  in	  a	  separate	  study	  to	  determine	  if	  the	  activated	  p53	  results	  in	  effective	  apoptosis	  









Figure	  44.	  	  JNK-­‐	  and	  p38-­‐associated	  transcription	  factor	  pp53	  after	  B	  virus	  infection	  
Human	  (HFF)	  and	  monkey	  (RMF)	  cells	  were	  either	  mock-­‐infected	  (MCL)	  or	  infected	  with	  B	  virus	  
(BV)	  at	  MOI	  5,	   and	  at	  defined	   time	  points,	  media	  was	   removed	  and	  enzymatic	  digestion	  was	  
used	   to	   remove	  adhered	   cells.	   This	   process	  was	   followed	  by	   a	   cold	  PBS	  wash	   and	   fixation	   in	  
paraformaldehyde	   (PFA)	   4	   to	   8%.	   Fixative	   was	   removed	   and	   cells	   permeabilized	   and	   resus-­‐
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pended	   in	  100%	  methanol.	  Cells	  were	  equally	  aliquoted	  and	   incubated	   in	  blocking	  buffer;	  the	  
blocking	  was,	  followed	  by	  primary	  antibody	  and	  the	  fluorochrome-­‐conjugated	  secondary	  anti-­‐
body	  prior	   to	  detection.	   The	  denotation	  M:	   represents	  mock-­‐infected,	  BV:	   represents	  B	   virus	  
infected	  and	  Unstain:	  represents	  uninfected	  unstained	  cells.	  FACS	  limits	  were	  for	  10000	  events	  
and	  data	  is	  representative	  of	  duplicate	  experiments.	  A.	  Histograms	  resulting	  from	  FACS	  analysis	  
of	  B	  virus	   infected	  human	  and	  macaque	  cells.	  B.	   	   Fold-­‐changes	   in	  activated	  p53	   in	  B	  virus	   in-­‐
fected	  human	  and	  macaque	  cells.	  
	  
Comparative	  analysis	  of	  the	  selected	  transcription	  factors	  are	  shown	  in	  Figure	  46	  follow-­‐
ing	  (seven	  hpi)	  the	  observed	  increases	  seen	  in	  FACS	  analysis	  of	  B	  virus	  infected	  and	  uninfected	  
macaque	  and	  human	  cells	  were	  examined.	  	  Figure	  45	  shows	  the	  overall	  relative	  gene	  expression	  
mRNA	  levels	  of	  transcription	  factors	  at	  7	  hours	  post	  infection.	  At	  this	  time	  point,	  we	  observed	  in	  
B	  virus	  infected	  cells	  that	  there	  was	  a	  >3-­‐4-­‐fold	  increase	  in	  the	  levels	  of	  the	  investigated	  tran-­‐
scription	  factors	  	  cJun,	  cFos,	  and	  FosB,	  and	  two-­‐fold	  increases	  in	  cc3	  and	  p38	  	  whereas	  no	  sig-­‐
nificant	  increases	  were	  found	  in	  B	  virus	  infected	  macaque	  cells	  other	  than	  a	  two-­‐fold	  increase	  in	  
activated	  p53.	  	  Upregulation	  of	  these	  transcription	  factors	  are	  partially	  self-­‐regulated	  and	  thus,	  
increases	  reflect	   the	  drop	   in	  activated	  transcription	   factor	   to	  replenish	  the	  supply	  so	  that	   the	  




Figure	  45.	  The	  gene	  expression	  levels	  of	  transcription	  factors	  influenced	  by	  JNK	  and	  p38	  
Human	  (HFF)	  and	  monkey	  (RMF)	  cells	  were	  either	  mock-­‐infected	  (MCL)	  or	  infected	  with	  B	  virus	  
(BV)	  at	  MOI	  5	  and	  at	  defined	  time	  points,	  media	  was	  removed	  and	  RLT	  buffer	  (Qiagen)	  added	  
for	   total	   RNA.	   RNA	  was	   then	  purified	   using	  Qiagen	  RNeasy	   and	  RNeasy	   Plus	   Kit,	   followed	  by	  
cDNA	  conversion	  using	  SA	  Biosciences	  RT2	  First	  Strand	  Kit.	  Analysis	  was	  then	  done	  using	  by	  PCR.	  
Results	  are	  BV/MCL	  for	  the	  stated	  protein	  and	  bars	  represent	  the	  mean	  ±	  standard	  error	  of	  the	  
samples.	  
	  
6.3.2 Cytokines	  involved	  in	  shaping	  the	  innate	  and	  adaptive	  response	  
Each	  of	  the	  transcription	  factors	  evaluated	  play	  a	  key	  role	  in	  upregulation	  of	  specific	  cy-­‐
tokine	  responses	  that	  ultimately	  shape	  the	  type	  of	  adaptive	  responses	  of	  a	  host	  in	  response	  to	  
infection.	   	  Cytokine	   secretion	   is	   a	   key	  event	  of	   the	   innate	   immune	   response	   to	   infection	  and	  
plays	  an	  important	  role	  not	  only	  in	  shaping	  the	  adaptive	  response	  to	  infection,	  but	  also	  the	  re-­‐
cruitment	  of	  innate	  immune	  cells	  to	  the	  site	  of	  infection.	  The	  types	  and	  amounts	  of	  cytokines	  
secreted	  after	  infection	  differ	  among	  cell	  lines	  and	  cell	  types,	  for	  example	  cells	  of	  the	  lymphoid	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origin,	  once	  recruited,	  secrete	  abundant	  amounts	  of	  specific	  cytokines	  in	  response	  to	  infection.	  
However,	  this	  cell	  type	  dependant	  secretion	  includes	  cells	  within	  the	  region	  of	  the	  primary	  in-­‐
fection	  that	  play	  an	  important	  role	  in	  the	  initial	  secretion	  of	  cytokines	  to	  influence	  surrounding	  
tissue	  and	  circulating	  immune	  cells.	  	  
The	  following	  figures	  (Figure	  46	  through	  Figure	  47)	  show	  the	  relative	  kinetics	  of	  proin-­‐
flammatory	  cytokine	  secretion	  after	  B	  virus	  infection	  of	  human	  and	  macaque	  cells.	  	  Do	  cells	  of	  
either	  species	  successfully	  induce	  specific	  cytokines	  to	  control	  virus	  replication	  or	  the	  effects	  of	  
this	  replication.	  	  And	  in	  order	  to	  evaluate	  the	  effects	  of	  the	  MAPK	  pathway	  activation,	  experi-­‐
ments	  were	  designed	  to	  investigate	  whether	  B	  virus	  infection	  in	  the	  presence	  of	  MAPK	  inhibi-­‐
tors	   derailed	   the	   cytokine	   responses	  observed.	   	   	  Macaque	   and	  human	   cells	  were	   infected	   as	  
previously	  described	  and	  at	  different	   timepoints	   after	   infection,	   supernatant	   fluids	  were	  har-­‐
vested	  to	  measure.	  Luminex	  multiplex	  technology	  was	  used	  to	  perform	  supernatant	  evaluations	  
for	  specific	  cytokines	  measurements.	   	   	  Figure	  46	  shows	  the	  results	  of	   IL2	  that	  we	  observed	   in	  
the	  B	  virus	  infected	  human	  and	  macaque	  cells.	  	  By	  comparison,	  the	  same	  values	  are	  shown	  for	  
cells	   exposed	   to	  mock-­‐infected	   (uninfected)	   cell	   lysates.	   	   These	   results	   show	   that	   little-­‐to-­‐no	  
virus-­‐specific	  IL2	  is	  being	  produced	  at	  any	  timepoints	  (1,5,7	  hp)	  by	  either	  cell	  species	  following	  
infection	  with	  B	  virus.	  	  This	  was	  not	  an	  unexpected	  observation	  since	  previous	  experiments	  per-­‐
formed	  using	  microarray	  analyses	  of	  B	  virus	  infected	  human	  cells	  showed	  essentially	  the	  same	  
results.	   	   The	  experiments	  performed	  during	   the	   course	  of	   this	   dissertation	   show	   for	   the	   first	  




Figure	  46.	  Interleukin	  2	  (IL2)	  levels	  after	  B	  virus	  infection	  
Cells	  were	  either	  mock-­‐infected	  (MCL)	  or	  infected	  with	  B	  virus	  (BV)	  at	  MOI	  5.	  After	  1	  hour	  unad-­‐
sorbed	  virus	  was	   removed	  and	  media	   replaced	  with	  minimal	  volume.	  At	  defined	   time	  points,	  
supernatant	  was	   removed	   and	   10%	   Tween	   and	   10%	  DOC	   added.	   Supernatant	  was	   then	   vor-­‐
texed	   and	   cytokines	   read	   using	   the	   Luminex	   100™	   IS,	   200™/HTS	   by	   Luminex	   Corporation	   for	  
LiquiChip	  analysis	  or	  using	  the	  ELISA	  plate	  reader	  as	  specified	  by	  manufacturer	  for	  desired	  OD	  
readings.	  P/N	  values	  were	  calculated	  as	  a	  ratio	  of	  the	  optical	  density	  values	  of	  B	  virus	  infected	  
cell	  supernatants/	  cytokine	  specific	  negative	  control	  provided	  by	  the	  manufacturer.	  
Representative	  IL-­‐4	  measurements	  shown	  in	  Figure	  47	  suggested	  that	  in	  B	  virus	  infected	  
monkey	  cells	  there	  was	  a	  four-­‐fold	  change	  greater	  than	  that	  of	  the	  mock	  at	  5	  hours	  post	  infec-­‐
tion.	  Whereas	  in	  the	  human	  cells	  the	  relative	  levels	  of	  IL4	  were	  unchanged	  at	  all	  times	  post	  in-­‐
fection.	  	  This	  is	  an	  interesting	  finding	  that	  suggests	  that	  B	  virus	  infected	  macaque	  cells	  can	  re-­‐
cruit	  immune	  responder	  cells	  that	  may	  play	  a	  role	  in	  controlling	  infection	  at	  some	  level.	  	  Future	  
experiments	  will	  be	  performed	  to	  determine	  the	  effects	  of	   IL-­‐4	  on	  effector	  cell	  population	  re-­‐
cruitment	  and	  the	  effects	  of	  these	  cells	  on	  virus	  load.	  Whether	  the	  monophasic	  increase	  in	  IL4	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is	   enough	   to	   influence	   recruitment	   of	   additional	   innate	   response	   cells	   and/or	   adaptive	   re-­‐
sponders	  requires	  further	  study.	  
	  
	  
Figure	  47.	  Interleukin	  4	  (IL4)	  levels	  after	  B	  virus	  infection	  
Cells	  were	  either	  mock-­‐infected	  (MCL)	  or	  infected	  with	  B	  virus	  (BV)	  at	  MOI	  5.	  After	  1	  hour	  unad-­‐
sorbed	  virus	  was	   removed	  and	  media	   replaced	  with	  minimal	  volume.	  At	  defined	   time	  points,	  
supernatant	  was	   removed	   and	   10%	   Tween	   and	   10%	  DOC	   added.	   Supernatant	  was	   then	   vor-­‐
texed	   and	   cytokines	   read	   using	   the	   Luminex	   100™	   IS,	   200™/HTS	   by	   Luminex	   Corporation	   for	  
LiquiChip	  analysis	  or	  using	  the	  ELISA	  plate	  reader	  as	  specified	  by	  manufacturer	  for	  desired	  OD	  
readings.	  (See	  Materials	  and	  Methods)	  
In	  Figure	  48	  we	  observed	  that	  after	  B	  virus	  infection	  of	  human	  cells	  IL6	  was	  produced	  ,	  
albeit	  at	   low	   levels.	   	  Macaque	  cells	   showed	  no	  virus	   specific	   increase	   in	   IL6,	  but	   interestingly	  
levels	  of	  IL6	  were	  elevated	  relative	  to	  the	  manufacturer’s	  negative	  control,	  suggesting	  that	  IL6	  
levels	  were	  present	   in	   relatively	  high	   levels	   in	  macaque	   cells	   exposed	   to	   virus	  or	   simply	   cells	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lysates	  free	  of	  virus.	  	  Anecdotally,	  macaques	  appear	  to	  have	  high	  levels	  of	  serum	  IL6.	  	  The	  sig-­‐
nificance	  of	  this	  is	  unknown.	  These	  levels	  may	  be	  effective	  for	  recruitment	  of	  neutrophils,	  which	  
will	  be	  explored	  in	  later	  experiments.	  
	  
Figure	  48.	  Interleukin	  6	  (IL6)	  levels	  after	  B	  virus	  infection	  
Cells	  were	  either	  mock-­‐infected	  (MCL)	  or	  infected	  with	  B	  virus	  (BV)	  at	  MOI	  5.	  After	  1	  hour	  unad-­‐
sorbed	  virus	  was	   removed	  and	  media	   replaced	  with	  minimal	  volume.	  At	  defined	   time	  points,	  
supernatant	  was	   removed	   and	   10%	   Tween	   and	   10%	  DOC	   added.	   Supernatant	  was	   then	   vor-­‐
texed	   and	   cytokines	   read	   using	   the	   Luminex	   100™	   IS,	   200™/HTS	   by	   Luminex	   Corporation	   for	  
LiquiChip	  analysis	  or	  using	  the	  ELISA	  plate	  reader	  as	  specified	  by	  manufacturer	  for	  desired	  OD	  
readings.	  (See	  Materials	  and	  Methods)	  
In	   figure	   49	  we	   observed	   that	   there	  were	   no	   significant	   differences	   by	   Student	   t-­‐test	  
analysis	  between	  B	  virus	  infected	  human	  and	  macaque	  cells	  with	  respect	  to	  production	  of	  IL8.	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Again,	  this	  data	  supports	  data	  from	  microarray	  experiments	  using	  B	  virus	  infected	  human	  cells	  
and	  presents	  the	  first	  look	  at	  B	  virus	  infected	  macaque	  cells.	  	  Thus,	  far,	  B	  virus	  infected	  human	  
and	  macaque	  cells	  are	  not	  responding	  to	  recruit	  proactive	  defenses,	  even	  though	  we	  have	  ob-­‐
served	  that	  specific	  components	  of	  the	  MAPK	  pathways	  are	  engaged	  by	  the	  infection,	  albeit	  dif-­‐
ferently	  in	  each	  cell	  species.	  
	  
Figure	  49.	  Interleukin	  8	  (IL8)	  levels	  after	  B	  virus	  infection	  
Cells	  were	  either	  mock-­‐infected	  (MCL)	  or	  infected	  with	  B	  virus	  (BV)	  at	  MOI	  5.	  After	  1	  hour	  unad-­‐
sorbed	  virus	  was	   removed	  and	  media	   replaced	  with	  minimal	  volume.	  At	  defined	   time	  points,	  
supernatant	  was	   removed	   and	   10%	   Tween	   and	   10%	  DOC	   added.	   Supernatant	  was	   then	   vor-­‐
texed	   and	   cytokines	   read	   using	   the	   Luminex	   100™	   IS,	   200™/HTS	   by	   Luminex	   Corporation	   for	  
LiquiChip	  analysis	  or	  using	  the	  ELISA	  plate	  reader	  as	  specified	  by	  manufacturer	  for	  desired	  OD	  
readings.	  (See	  Materials	  and	  Methods)	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In	  figure	  50	  we	  observed	  that	  the	  levels	  of	  IL10	  were	  relatively	  unchanged	  in	  the	  human	  
and	   macaque	   cells	   after	   B	   virus	   infection	   when	   compared	   to	   their	   mock.	   Less	   than	   2-­‐fold	  
changes	  were	  observed	   in	   levels	  of	   IL10,	  which	   is	  unlikely	   to	   result	   in	  physiological	   response.	  	  
Failure	  of	  the	  immune	  response	  recruitment	  at	  this	  stage	  of	  infection	  is	  thus	  not	  due	  to	  produc-­‐
tion	  of	   IL-­‐10.	   	   In	  future	  experiments,	  other	  potential	   immunosuppressor	  molecules	  will	  be	  ex-­‐
amined.	  
	  
Figure	  50.	  	  Interleukin	  10	  (IL10)	  levels	  after	  B	  virus	  infection	  
Cells	  were	  either	  mock-­‐infected	  (MCL)	  or	  infected	  with	  B	  virus	  (BV)	  at	  MOI	  5.	  After	  1	  hour	  unad-­‐
sorbed	  virus	  was	   removed	  and	  media	   replaced	  with	  minimal	  volume.	  At	  defined	   time	  points,	  
supernatant	  was	   removed	   and	   10%	   Tween	   and	   10%	  DOC	   added.	   Supernatant	  was	   then	   vor-­‐
texed	   and	   cytokines	   read	   using	   the	   Luminex	   100™	   IS,	   200™/HTS	   by	   Luminex	   Corporation	   for	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LiquiChip	  analysis	  or	  using	  the	  ELISA	  plate	  reader	  as	  specified	  by	  manufacturer	  for	  desired	  OD	  
readings.	  (See	  Materials	  and	  Methods)	  
In	   figure	  51	  we	  observed	   that	   there	  was	  a	  2.5-­‐fold	   increase	   in	   the	   IL12	   (p70)	   levels	   in	  
mock-­‐infected	  human	   cells,	   but	   not	   in	   virus	   infected	  human	   cells.	   	   This	   observation	   suggests	  
that	   there	   is	   a	   potential	   virus	   down-­‐modulation	   of	   IL12	   (p70)	   that	  was	   less	   than	   that	   of	   the	  
mock	   at	   5	   and	  7	   hours	   post	   infection.	  However,	   in	   the	  monkey	   cells	   there	  was	   a	   relative	   in-­‐
crease	  in	  the	  IL12	  (p70)	  levels	  at	  5	  and	  7	  hours	  post	  infection.	   It	   is	  unlikely	  that	  these	  modest	  







Figure	  51.	  Interleukin	  12p70	  (IL12p70)	  levels	  after	  B	  virus	  infection	  
Cells	  were	  either	  mock-­‐infected	  (MCL)	  or	  infected	  with	  B	  virus	  (BV)	  at	  MOI	  5.	  After	  1	  hour	  unad-­‐
sorbed	  virus	  was	   removed	  and	  media	   replaced	  with	  minimal	  volume.	  At	  defined	   time	  points,	  
supernatant	  was	   removed	   and	   10%	   Tween	   and	   10%	  DOC	   added.	   Supernatant	  was	   then	   vor-­‐
texed	   and	   cytokines	   read	   using	   the	   Luminex	   100™	   IS,	   200™/HTS	   by	   Luminex	   Corporation	   for	  
LiquiChip	  analysis	  or	  using	  the	  ELISA	  plate	  reader	  as	  specified	  by	  manufacturer	  for	  desired	  OD	  
readings.	  (See	  Materials	  and	  Methods)	  
Interferon-­‐gamma	  is	  perhaps	  one	  of	  the	  most	  important	  antiviral	  proteins.	  	  In	  Figure	  52	  
we	  observed	  no	  significant	  differences	  between	  B	  virus	  infected	  macaque	  and	  human	  cells,	  nor	  	  
between	  these	  cells	  and	  cells	  treated	  with	  uninfected	  cell	   lysate,	   indicating	  that	  B	  virus	   infec-­‐
tion	  does	  not	  upregulate	  IFNα	  in	  either	  cell	  species.	  Again	  this	  observation	  corroborates	  previ-­‐
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ous	  observations	  made	  with	  B	  virus	  infected	  human	  cells	  and	  suggests	  that	  in	  this	  regard	  B	  virus	  
infected	  macaque	  cells	  show	  a	  similar	  absence	  of	  	  IFNα	  production.	  
	  
Figure	  52.	  	  Interferon	  	  alpha	  (IFNα)	  levels	  after	  B	  virus	  infection	  
Cells	  were	  either	  mock-­‐infected	  (MCL)	  or	  infected	  with	  B	  virus	  (BV)	  at	  MOI	  5.	  After	  1	  hour,	  un-­‐
adsorbed	  virus	  was	  removed	  and	  media	  replaced	  with	  minimal	  volume.	  At	  defined	  time	  points,	  
supernatant	  was	   removed	   and	   10%	   Tween	   and	   10%	  DOC	   added.	   Supernatant	  was	   then	   vor-­‐
texed	  and	  cytokines	   read	  using	   the	  Luminex	  100™	   IS,	  200™/HTS	  by	  Luminex	  Corporation	   for-­‐
LiquiChip	  analysis	  or	  using	  the	  ELISA	  plate	  reader	  as	  specified	  by	  manufacturer	  for	  desired	  OD	  
readings.(See	  Materials	  and	  Methods)	  
	   Analysis	  of	  B	  virus	   infected	  macaque	  and	  human	  cells	   for	   the	  production	  of	   IFNγ	   indi-­‐




Figure	  53.	  Interferon	  gamma	  (IFNγ)	  levels	  after	  B	  virus	  infection	  
Cells	  were	  either	  mock-­‐infected	  (MCL)	  or	  infected	  with	  B	  virus	  (BV)	  at	  MOI	  5.	  After	  1	  hour	  unad-­‐
sorbed	  virus	  was	   removed	  and	  media	   replaced	  with	  minimal	  volume.	  At	  defined	   time	  points,	  
supernatant	  was	   removed	   and	   10%	   Tween	   and	   10%	  DOC	   added.	   Supernatant	  was	   then	   vor-­‐
texed	   and	   cytokines	   read	   using	   the	   Luminex	   100™	   IS,	   200™/HTS	   by	   Luminex	   Corporation	   for	  
LiquiChip	  analysis	  or	  using	  the	  ELISA	  plate	  reader	  as	  specified	  by	  manufacturer	  for	  desired	  OD	  
readings.	  (See	  Materials	  and	  Methods)	  
MCP1	  plays	   an	   important	   role	   in	   the	   recruitment	  of	  monocyte	  defenses	   and	  previous	  
studies	   in	  our	   lab	  have	  shown	  that	  B	  virus	   infected	  human	  cells	   fail	   to	  recruit	  monocytes	   in	  a	  
transwell	   system.	   	  Data	   analysis	   shown	   in	   Figure	   54	   also	   shows	   that	   B	   virus	   infection	  of	  ma-­‐
caque	  cells	  induces	  no	  more	  MCP1	  that	  treatment	  of	  cells	  with	  uninfected	  cell	  lysates	  as	  seen	  
by	  barely	  a	  two-­‐fold	  increase	  in	  MCP1	  levels	  after	  the	  first	  hour	  post	  infection.	  	  B	  virus	  infected	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humans	  cells	  may	  actually	  downregulate	  MCP1,	  but	  further	  experiments	  must	  be	  done	  to	  verify	  
that	  this	  is	  significant.	  	  	  
	  
Figure	  54.	  Monocytic	  chemotactic	  protein	  1	  (MCP1)	  levels	  after	  B	  virus	  infection	  
Cells	  were	  either	  mock-­‐infected	  (MCL)	  or	  infected	  with	  B	  virus	  (BV)	  at	  MOI	  5.	  After	  1	  hour	  unad-­‐
sorbed	  virus	  was	   removed	  and	  media	   replaced	  with	  minimal	  volume.	  At	  defined	   time	  points,	  
supernatant	  was	   removed	   and	   10%	   Tween	   and	   10%	  DOC	   added.	   Supernatant	  was	   then	   vor-­‐
texed	   and	   cytokines	   read	   using	   the	   Luminex	   100™	   IS,	   200™/HTS	   by	   Luminex	   Corporation	   for	  
LiquiChip	  analysis	  or	  using	  the	  ELISA	  plate	  reader	  as	  specified	  by	  manufacturer	  for	  desired	  OD	  
readings.	  (See	  Materials	  and	  Methods)	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  Data	  shown	  in	  figure	  55	  reveal	  no	  significant	  changes	  in	  GM-­‐CSF	  levels.	  	  Cummulatively,	  
each	  data	  set	  is	  substantiating	  that	  there	  is	  a	  pattern	  in	  both	  B	  virus	  infected	  macaque	  and	  hu-­‐
man	  cells	  of	  no	  significant	  cell	  responses.	  	  Cells	  from	  either	  host	  appear	  to	  fail	  to	  recognize	  virus	  
invasion	  is	  progressing.	  	  The	  stealth	  nature	  of	  the	  infection	  is	  curious.	  	  What	  role(s)	  is	  induction	  
of	  the	  MAPK	  pathway	  playing?	  	  To	  address	  this	  question,	  the	  following	  experiments	  were	  con-­‐
ceived	  and	  performed.	  
	  
Figure	   55.	   Gramulocyte-­‐macrophage	   colony-­‐stimulating	   factor	   (GMCSF)	   levels	   after	   B	   virus	  
infection	  
Cells	  were	  either	  mock-­‐infected	  (MCL)	  or	  infected	  with	  B	  virus	  (BV)	  at	  MOI	  5.	  After	  1	  hour	  unad-­‐
sorbed	  virus	  was	   removed	  and	  media	   replaced	  with	  minimal	  volume.	  At	  defined	   time	  points,	  
supernatant	  was	   removed	   and	   10%	   Tween	   and	   10%	  DOC	   added.	   Supernatant	  was	   then	   vor-­‐
texed	   and	   cytokines	   read	   using	   the	   Luminex	   100™	   IS,	   200™/HTS	   by	   Luminex	   Corporation	   for	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LiquiChip	  analysis	  or	  using	  the	  ELISA	  plate	  reader	  as	  specified	  by	  manufacturer	  for	  desired	  OD	  
readings.	  Results	  are	  the	  mean	  ±	  standard	  error	  of	  the	  samples.	  (See	  Materials	  and	  Methods)	  
	  
6.3.3 Cytokine	  profile	  after	  infection	  in	  the	  presence	  of	  MAPK	  inhibitors	  
Having	  observed	  that	  the	  MAPK	  p38	  and	  JNK	  are	  activated,	  but	  fail	  to	  trigger	  significant	  
upregulation	  of	  defensive	  responses,	  i.e.,	  cytokine	  production	  in	  B	  virus	  infection,	  I	  investigated	  
how	  the	  inflammatory	  cytokine	  profile	  changed	  in	  the	  absence	  or	  the	  presence	  of	  the	  MAPK	  by	  
the	  use	  of	  inhibitors	  and	  stimulators	  of	  the	  MAPK	  pathway.	  
The	  results	  (Figures	  56	  and	  57)	  show	  that	  inhibition	  of	  the	  MAPK-­‐JNK	  led	  to	  a	  relative	  in-­‐
crease	  in	  secreted	  IL6	  in	  both	  cell	  lines.	  In	  contrast,	  p38	  inhibition	  led	  to	  a	  relative,	  but	  poor	  in-­‐
crease	  in	  the	  IL6	  levels	  in	  B	  virus	  infected	  human	  cells	  and	  barely	  a	  two-­‐fold	  increase	  in	  B	  virus	  
infected	  macaque	  cells.	  Stimulation	  of	  the	  p38	  and	  JNK	  pathways	  with	  sorbitol	  lead	  to	  relative	  






Figure	  56.	  	  Cytokine	  profile	  after	  B	  virus	  infection	  in	  the	  presence	  of	  JNK	  and	  p38	  inhibitors	  
Cells	  were	  infected	  with	  B	  virus	  (BV)	  at	  MOI	  5	  in	  the	  presence	  or	  absence	  of	  the	  stated	  inhibitor.	  
After	   1	   hour,	   unadsorbed	   virus	  was	   removed	   and	  media	   replaced	  with	  minimal	   volume	  with	  
stated	  inhibitor	  (JNKi	  L	  form	  for	  JNK	  inhibition	  and	  SB202190	  for	  p38	  inhibition)	  added	  to	  me-­‐
dia.	  At	  24	  hours	  post	  infection,	  supernatant	  was	  removed	  and	  10%	  Tween	  and	  10%	  DOC	  added.	  
Supernatant	  was	   then	  vortexed	  and	  cytokines	   read	  using	   the	  Luminex	  100™	   IS,	  200™/HTS	  by	  
Luminex	   Corporation	   for	   LiquiChip	   analysis	   or	   using	   the	   ELISA	   plate	   reader	   as	   specified	   by	  
manufacturer	  for	  desired	  OD	  readings.	  Results	  were	  calculated	  as:	  (BV	  +	  inhibitor)/BV	  only,	  for	  




6.3.4 Cytokine	  profile	  after	  infection	  in	  the	  presence	  of	  stimulators	  
	  
Figure	  57.	  	  Cytokine	  profile	  after	  B	  virus	  infection	  in	  the	  presence	  of	  JNK	  and	  p38	  stimulators	  
Cells	  were	  infected	  with	  B	  virus	  (BV)	  at	  MOI	  5	  in	  the	  presence	  or	  absence	  of	  the	  stated	  stimula-­‐
tor	   (Anisomycin	   for	  p38	   stimulation	  and	   sorbitol	   for	   JNK	   stimulation).	  Note	   that	   though	  each	  
stimulant	  is	  directed	  to	  a	  specified	  MAPK	  (p38	  or	  JNK)	  they	  have	  both	  been	  known	  to	  affect	  the	  
levels	  to	  p38	  and	  JNK	  in	  a	  stimulus	  and	  cell	  types	  dependant	  manner.	  After	  1	  hour,	  unadsorbed	  
virus	  was	  removed	  and	  media	  replaced	  with	  minimal	  volume	  with	  stated	  stimulator	  added	  to	  
media.	   At	   24	   hours	   post	   infection,	   supernatant	  was	   removed	   and	   10%	   Tween	   and	   10%	  DOC	  
added.	   Supernatant	   was	   then	   vortexed	   and	   cytokines	   read	   using	   the	   Luminex	   100™	   IS,	  
200™/HTS	   by	   Luminex	   Corporation	   for	   LiquiChip	   analysis	   or	   using	   the	   ELISA	   plate	   reader	   as	  
specified	  by	  manufacturer	   for	  desired	  OD	  readings.	  Results	  were	  calculated	  as:	   (BV	  +	  stimula-­‐








7 Discussion	  and	  summary	  
7.1 Host	  specific	  model	  of	  infection	  
The	  first	  anatomical	  site	  for	  virus	  replication	  -­‐	  prior	  to	  the	  retrograde	  transport	  of	  virus	  
by	  sensory	  neurons	  innervating	  the	  region	  	  -­‐	  is	  the	  skin.	  The	  skin	  functions	  as	  an	  external	  bar-­‐
rier,	  and	  one	  of	  its	  many	  layers	  is	  the	  dermis	  where	  fibroblasts	  comprise	  the	  majority	  of	  cells.	  
Fibroblasts	  play	  an	   important	  role	   in	  skin	   innate	   immunity	  and	  are	  capable	  of	  secreting	  many	  
cytokines,	  chemokines	  and	  antimicrobial	  peptides.	  The	  outcome	  of	  these	  responses	  direct	  the	  
recruitment	   of	   the	   cellular	   responders,	   e.g.,	   neutrophils,	  macrophage,	   dendritic	   cells,	   natural	  
killer	  cells	  and	  possibly	  others.	  The	  collective	   innate	  responses	  direct	  the	  specific	  adaptive	  re-­‐
sponses	  seen	  associated	  with	  disease	  pathogenesis	  in	  specific	  hosts.	  
	  By	  establishing	  a	  cell	  culture	  with	  cells	  representative	  of	  the	  majority	  cell	  type	  after	  in-­‐
fection	  in	  each	  host,	  we	  can	  investigate	  and	  dissect	  out	  the	  initial	  molecular	  sensing	  of	  B	  virus	  
and	  downstream	  factors	  associated	  with	  and	   involved	   in	  the	  activation	  of	  the	  MAPK	  pathway	  
which	  in	  turn	  upregulates	  specific	  genes	  putatively	  leading	  to	  cytokine	  secretion	  and	  the	  induc-­‐
tion	  of	  apoptotic	  events	  that	  can	  potentially	  be	  subverted	  for	  successful	  replication,	  assembly,	  
and	  egress	  of	  virus.	   	  A	  major	  benefit	  of	   the	  natural	  and	  foreign	  host	  cell	  model	  system	   is	   the	  
ability	  to	  infect	  both	  cell	  types	  with	  B	  virus	  and	  observe	  whether	  there	  are	  host	  specific	  differ-­‐
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ences	  or	  similarities	  that	  may	  correlate	  with	  the	  observed	  different	  outcomes	  in	  pathogenesis	  
(death	  in	  foreign	  host	  and	  survival	  in	  natural	  host).	  Thus,	  the	  model	  potentially	  allows	  for	  exam-­‐
ining	  early,	  local,	  host	  responses	  that	  influence	  the	  outcome	  of	  the	  infection	  after	  B	  virus-­‐host	  
interaction	  occurs.	  The	  virus	  (B	  virus)	  was	  my	  tool	  and	  allowed	  for	  a	  comparative	  investigation	  
of	  what	   host-­‐dependent	   changes	  were	   occurring	   at	   early	   times	   post	   infection.	   The	   ability	   of	  
both	  cell	  types	  to	  produce	  infectious	  virus	  though	  24	  hours	  as	  analyzed	  by	  plaque	  assay,	  and	  to	  
express	  US11	  and	  viral	  glycoproteins	  gC	  and	  gD,	  suggests	  that	  B	  virus	  is	  able	  to	  replicate	  during	  
the	   initial	   round	  of	   replication	   in	   these	  primary	  cells	   from	  different	  hosts.	  The	   levels	  of	   infec-­‐
tious	   virus	   and	   viral	   proteins	  with	   increased	   rounds	   of	   replication	   though	  not	   investigated	   in	  
this	  dissertation	  (as	  all	  times	  investigated	  were	  within	  one	  round	  of	  replication)	  may	  show	  dif-­‐
ferences	   in	   a	   cell-­‐type	   dependent	  manner	   and	  may	   become	  more	  magnified	   with	   increased	  
rounds	  of	   replication.	  This	  effect	   could	  also	  have	  an	   influence	  on	   the	  overall	  host-­‐dependent	  
responses	  observed	  as	  the	  levels	  of	  infectious	  virus	  present	  at	  the	  initial	  site	  of	  infection	  can	  be	  
directly	  related	  to	  the	  ability	  of	  the	  virus	  to	  evade	  host	  responses	  and	  enter	  the	  PNS	  or	  CNS,	  or	  
perhaps	  lower	  replication	  efficiency	  contributes	  to	  a	  temporal	  delay	  in	  neuroinvasion.	  With	  the	  
ability	  of	  B	  virus	  to	  replicate	  in	  both	  cell	  types	  albeit	  with	  different	  efficiencies	  of	  infection	  our	  
data	  suggest	  that	  the	  both	  B	  virus	  infected	  macaque	  and	  human	  cells	  fail	  to	  deploy	  innate	  de-­‐
fense	   responses	  unlike	   cells	   infected	  with	  HSV-­‐1.	   	   Perhaps	  most	   interesting,	   is	   that	  macaque	  
and	   human	   cells	   accomplish	   this	   by	   two	   distinct	  mechanisms.	   	  Macaque	   cells	   fail	   to	   activate	  
transcription	  factors,	  while	  humans	  cells	  fail	  to	  have	  activated	  transcription	  factors	  successfully	  
upregulate	  proinflammaory	  genes	  they	  regulate.	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7.2 Identification	  and	  analysis	  of	  differential	  signaling	  	  
This	  research	  was	  focused	  to	  investigate	  underlying	  reasons	  for	  different	  host	  outcomes	  
in	   response	   to	   infection	  and	  determining	  what	   role,	   if	  any,	   is	  played	  by	  one	  pathway	   (MAPK)	  
that	  is	  known	  to	  play	  an	  important	  role	  in	  the	  innate	  immune	  response	  to	  infection.	  	  To	  accom-­‐
plish	  the	  studies	  proposed	  at	  the	  outset	  of	  this	  research,	  a	  novel	  cell	  line	  from	  macaques	  had	  to	  
be	  established.	   	  These	  cells	  needed	  to	  be	  fibroblasts	   in	  order	  to	  perform	  studies	   in	  parallel	   in	  
cells	  from	  macaque	  and	  human	  sources.	  	  The	  establishment	  of	  macaque	  fibroblast	  cells	  was	  la-­‐
bor	  intensive,	  but	  ultimately	  successful	  and	  this	  success	  enabled	  a	  comparative	  analysis	  B	  virus	  
infection	  in	  the	  primary	  target	  cells	  of	  B	  virus	  when	  it	  infects	  either	  host.	  	  It	  is	  these	  target	  cells	  
that	   provide	   sufficient	   virus	   for	   populating	   dorsal	   root	   ganglia	   via	   retrograde	   travel	   through	  
sensory	  axons	  of	  the	  peripheral	  nervous	  system	  and	  it	  these	  cells	  that	  determine	  whether	  ef-­‐
fective	  innate	  and	  adaptive	  immune	  defenses	  are	  successfully	  engaged	  following	  B	  virus	  infec-­‐
tion.	   	  There	   is	  no	  animal	  model	  currently	  available	  to	  study	  B	  virus	  pathogenesis.	   	  One	  of	  the	  
goals	  of	  the	  studies	  described	  in	  this	  dissertation	  was	  to	  gain	  insight	  into	  molecular	  correlates	  
of	  infection	  that	  may	  lead	  to	  the	  establishment	  of	  susceptible	  transgenic	  mice	  that	  can	  serve	  as	  
in	  vivo	  model	  of	  B	  virus	  infection..	  	  	  But	  in	  the	  meantime,	  the	  question	  presenting	  at	  the	  onset	  
of	  this	  research	  is	  can	  we	  successfully	  establish	  a	  cell	  culture	  model	  of	  infection	  to	  gain	  under-­‐
standing	  about	  the	  dynamics	  of	  B	  virus	  infection	  (Figure	  28)	  in	  macaque	  and	  human	  cells?	  	  	  Our	  
results	   showed	   that	   each	   cell	   line	   supported	   B	   virus	   replication	   with	   kinetics	   previously	   de-­‐
scribed	  and	  published.	  	  With	  this	  data,	  we	  proceeded	  to	  analyze	  the	  initial	  events	  occurring	  in	  
each	  cell	  type	  following	  B	  virus	  infection.	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The	  established	  cell	  model	  system	  was	  subsequently	  used	  to	  evaluate	  the	  initial	  cellular	  
responses	  following	  attachment	  and	  adsorption	  of	  virus	  on	  target	  cells	  that	  would	  be	  the	  first	  
to	  encounter	  virus	  in	  vivo..	  	  Using	  the	  cells	  of	  macaque	  and	  human	  origin,	  we	  analyzed	  post	  ad-­‐
sorption	  signaling	  cascades,	  specifically	  the	  MAPK	  pathway.	  The	  pathway	  begins	  by	  assembly	  of	  
a	  complex	  of	  activated	  adaptor	  proteins	   that	  build	  a	  scaffold	   from	  with	   the	  signaling	  cascade	  
begins.	  They	  (adaptor	  proteins)	  also	  serve	  as	  points	  of	  convergence	  within	  a	  cell	  for	  signals	  to	  
be	  integrated	  prior	  to	  the	  divergent	  relay	  of	  the	  received	  signals	  to	  cellular	  signaling	  pathways,	  
such	  as	  the	  MAPK	  pathway.	  Their	  complex	  formation	  and	  targeted	  pathway	  differs	  with	  varied	  
cell	   types	   and	   pathogens	   encountered.	   Adaptors	   MyD88,	   TRIF	   and	   TRAF	   6	   represent	   three	  
adaptor	  proteins	   known	   to	  be	  play	  a	   role	   in	  upstream	  MAPK	  pathway	  activation.	  Our	   results	  
showed	  that	  the	  TRAF2	  was	  not	  activated	  in	  a	  virus-­‐specific	  manner,	  although	  TRAF6	  was	  acti-­‐
vated	  in	  human	  cells	  within	  30	  minutes	  post	  infection.	  	  No	  activation	  of	  TRAF6	  was	  seen	  to	  oc-­‐
cur	   in	  a	  virus-­‐specific	  manner	   in	  macaque	  cells,	  although	  exposure	  of	  macaque	  cells	   to	  either	  
virus	  infected	  cells	  lysates	  or	  uninfected	  cell	  lysates	  did	  result	  in	  activation	  of	  TRAF6	  and	  TRAF2.	  	  
It	  would	  appear	  that	  membrane	  perturbations	  are	  sufficient	  to	  initiate	  the	  signaling	  via	  TRAF2	  
and	  TRAF6.	  	  	  
As	  previously	  mentioned,	  the	  MAPK	  pathway	  represents	  one	  of	  several	  pathways	  known	  
to	  be	  activated	  in	  response	  to	  infection.	  We	  observed	  that	  virus-­‐independent	  activation	  of	  JNK1	  
and	  JNK2	  occurred	  in	  both	  species	  of	  cells.	  JNK3	  was	  also	  found	  to	  be	  activated	  which	  may	  be	  a	  
novel	   finding	   for	   fibroblasts	   as	   this	   isoform	  of	   JNK	   is	   usually	   found	   in	   heart,	   brain	   and	   testis	  
rather	  than	  in	  cells	  derived	  from	  skin.	  JNK	  is	  known	  to	  be	  associated	  with	  p53	  in	  cells,	  leading	  to	  
p53	  targeted	  degradation,	  the	  regulation	  of	  JNK1	  and	  JNK2	  have	  been	  shown	  to	  have	  opposing	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roles	  in	  a	  cell	  type	  dependent	  manner	  in	  fibroblasts	  and	  the	  stimulus	  and	  duration	  of	  JNK	  signal-­‐
ing	  determines	  whether	  it	  is	  a	  pro-­‐survival	  signal	  or	  an	  apoptotic	  inducing	  signal	  (Fuchs,	  Dolan	  
et	  al.	  1996;	  Fuchs,	  Adler	  et	  al.	  1998).	  JNK	  isoforms	  have	  also	  been	  shown	  to	  regulate	  the	  half-­‐
life	   and	   stability	   of	   cJun,	   whereby	   JNK1	   tends	   to	   activated	   cJun	   and	   JNK2	   tends	   to	   have	   a	  
greater	  affinity	  for	  cJun	  and	  thus	  target	  it	  for	  ubiquitination	  and	  degradation	  (Fuchs,	  Dolan	  et	  al.	  
1996).	  	  
Regarding	  p38,	  in	  the	  human	  cells	  there	  was	  a	  steady	  state	  of	  activation	  post	  infection,	  
that	  was	  virus-­‐dependent,	  whereas	  in	  the	  monkey	  cells	  a	  virus	  specific	  activation	  was	  noted	  to	  
occur	  only	  	  at	  three	  hpi.	  	  .	  Since	  both	  the	  JNK	  and	  p38	  pathway	  can	  be	  activated	  by	  similar	  up-­‐
stream	  adaptor	  complexes	  with	  areas	  of	  convergence	  and	  divergence	  to	  give	  specificity	  to	  the	  
signaling,	   it	   is	  plausible	   to	   think	   that	   the	  kinetically	  different	   times	  of	   JNK	  and	  p38	  activation	  
may	  be	  related	  to	  the	  kinetics	  of	  viral	  gene	  expression	  in	  each	  cell	   line,	  such	  that	  one	  class	  of	  
viral	  genes	  may	  trigger	  one	  pathway	  at	  an	  earlier	  time.	  It	  is	  also	  plausible	  that	  transcription	  fac-­‐
tors	  such	  as	  AP1,	  known	  to	  be	  regulated	  by	  the	  MAPK	  are	  being	  upregulated	  in	  the	  human	  cells	  
to	  allow	  for	  a	  productive	  infection	  as	  some	  viruses,	  inclusive	  of	  the	  herpesviruses	  are	  known	  to	  
have	  AP1	  binding	   sites	   in	   the	  promoter	   regions	   for	   some	  of	   their	   early	   genes	   (Xie,	   Pan	  et	   al.	  
2005).	  	  
Although	  we	  could	  not	  determine	  if	  the	  MAPK	  response	  was	  following	  a	  MyD88	  or	  TRIF	  
mediated	  path	  to	  activation,	  the	  use	  of	  inhibitors	  to	  either	  p38	  or	  to	  JNK	  showed	  that	  both	  p38	  
and	   JNK	  were	   influential	   in	   the	   relative	  amount	  of	   viral	   replication	   that	  occurred	   in	  each	   cell	  
line.	  MAPK	  p38	  and	  JNK	  were	  essential	  for	  B	  virus	  replication	  in	  the	  human	  cells,	  whereas	  pp38	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appeared	  to	  be	  dampening	  virus	  replication	  in	  the	  monkey	  cells.	  As	  shown	  in	  the	  results,	  these	  
inhibitors	  had	  varied	  mechanisms	  of	  action	  and	   it	   should	  be	  noted	   that	   those	   that	  competed	  
with	  the	  ATP	  binding	  sites	  had	  relatively	  larger	  effects	  on	  virus	  replication,	  suggesting	  that	  they	  
catalytic	  ATP	  binding	  site	  plays	  a	  primary	  role	   in	  p38	  and	  JNK	  activation.	   	  Regarding	  both	  JNK	  
and	  p38	  inhibition	  during	  virus	  replication,	  it	  may	  be	  that	  one	  of	  the	  pathways,	  p38	  or	  JNK,	  can	  
compensate	  for	  the	  other,	  or	  that	   it	   is	  the	  balance	  between	  these	  two	  factors	  that	  ultimately	  
determines	  the	  overall	  fate	  of	  the	  cell	  after	  infection	  in	  a	  host-­‐dependent	  manner	  (Hsu,	  Saffran	  
et	  al.	  2005).	  
The	  induction	  and	  stabilization	  of	  regulatory	  proteins,	  such	  as	  the	  inflammatory	  cytoki-­‐
nes,	  transcription	  factors	  and	  growth	  factors,	  that	  can	  act	  as	  cis	  signals	  to	  promote	  mRNA	  deg-­‐
radation	  and	  regulate	  translation	  are	  important	  events	  in	  host	  cells.	  These	  functionally	  diverse	  
proteins	  tend	  to	  have	  an	  AU-­‐rich	  instability	  element	  (ARE)	  in	  their	  3’	  untranslated	  region	  (UTR)	  
and	  ARE	   stabilization	  has	   been	   shown	   to	   be	   associated	  with	  MAPK	   (p38)	   induction,	  with	   the	  
regulation	  of	  cell	  death	  and	  with	  ND10	  domains	  (Chen,	  Del	  Gatto-­‐Konczak	  et	  al.	  1998;	  Corcoran,	  
Hsu	  et	  al.	  2006).	  Thus,	  the	  observed	  increased	  in	  p38	  activation	  after	  infection	  may	  also	  play	  a	  
role	   in	   gene	   regulation	   and	   stabilization	   by	   ARE	  mRNAs	   in	   a	   cell	   type	   dependent	  manner	   to	  
promote	  viral	  replication.	  
7.3 MAPK-­‐dependent	  apoptosis	  
The	   SAPKs	   JNK	   and	   p38	   are	   multifunctional	   kinases	   that	   influence	   numerous	   cellular	  
events	  in	  response	  to	  stress	  (viral	  infection)	  such	  as	  cell	  survival	  apoptosis	  and	  cytokine	  secre-­‐
tion.	  The	  MAP3K-­‐ASK1	  has	  been	  implicated	  in	  the	  stimulation	  of	  apoptosis	  via	  the	  JNK	  and	  p38	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pathways.	  This	  research	  not	  only	  showed	  that	  we	  have	  cell	  type	  specific	  responses	  that	  are	  not	  
only	  kinetically	  different	  but	  also	  some	  responses	  that	  are	  virus	  specific,	  such	  as	  ASK1	  induction.	  
The	   increased	   ASK1	   in	   human	   cells	   at	   earlier	   times	   that	   monkey	   cells	   suggests	   that	   ASK1	   a	  
MAP3K	  may	  be	  playing	  an	  early	  role	  in	  the	  induction	  of	  MAPK-­‐dependent	  apoptotic	  events.	  Be-­‐
cause	  PKR	  and	  ASK1	  are	  known	  to	   interact	  and	  their	   interaction	  can	   lead	  to	  p38	  and	   JNK	  de-­‐
pended	  cell	  death,	  it	  is	  plausible	  that	  though	  we	  see	  virus	  specific	  ASK1	  activation	  in	  both	  hosts,	  
the	  knowledge	  that	  PKR	  activation	  if	  inhibited	  by	  Υ34.5	  in	  B	  virus	  infected	  cells	  implies	  that	  this	  
association	  for	  ASK1	  mediatesd	  apoptosis	  is	  inhibited.	  	  
The	   roles	  of	   the	  MAPK	  p38	  and	   JNK	  have	  been	  varied	  one	   such	   role	  may	  be	   involved	  
with	  modulation	  of	  apoptosis.	  Typically,	  the	  activation	  of	  JNK	  is	  observed	  in	  conditions	  involving	  
cell	  survival	  and	  the	  inhibition	  of	  apoptosis.	  However,	  JNK	  has	  also	  been	  shown	  to	  be	  activated	  
in	  situations	  where	  the	  induction	  of	  apoptosis	  occurs	  and	  the	  interaction	  of	  active	  JNK	  with	  p53	  
leads	   to	   pp53	   being	   released	   from	   JNK	   allowing	   for	   downstream	   protein	   responses	   such	   as	  
caspase	  3	  activation	  to	  occur	  (Sumbayev	  and	  Yasinska	  2006).	  Regarding	  p38,	  most	  studies	  refer	  
to	  it	  as	  a	  pro-­‐apoptotic	  inducer	  of	  events	  prior	  to	  caspase	  activation,	  and	  p38	  has	  been	  shown	  
to	  destabilize	  the	  survival	  protein	  BCL2	  mRNA	  levels.	  However,	  it	  should	  also	  be	  noted	  that	  p38	  
activation	  has	  been	  linked	  to	  increased	  viral	  yields	  in	  the	  absence	  of	  p38-­‐mediated	  BCL2	  desta-­‐
bilization	  suggesting	  that	  the	  roles	  of	  p38	  and	  JNK	  in	  cells	  are	  dependent	  on	  stimulus-­‐duration	  
type,	  cell	   type	  and	  stimulus	   type	   (Zachos,	  Clements	  et	  al.	  1999).	  Our	  results	  also	  support	   this	  
notion	   as	   we	   observed	   a	   virus	   specific	   increased	   numbers	   of	   human	   cells	   expressing	   p53	  
whereas	   a	   non-­‐virus	   specific	   relative	   increase	  was	   observed	   in	   the	  monkey	   cells.	   The	   execu-­‐
tioner	   caspase,	   cleaved	   caspase	   3	   also	   showed	   a	   relative	   bi-­‐phasic	   increase	   after	   infection.	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However,	  as	  we	  know	  that	  a	  productive	  infection	  is	  established	  in	  both	  cell	  lines,	  this	  ability	  to	  
have	   successful	   replication	   must	   indicate	   that	   cell	   death/apoptosis	   is	   inhibited	   or	   limited	   at	  
some	  stage	  in	  the	  replicative	  cycle.	  	  
Overall	   the	  MAPK	   -­‐influenced	  events	   investigated	   in	   this	   study	  do	  not	  suggest	   that	   in-­‐
duction	  of	  apoptosis	   is	  not	  occurring,	   so	  where	   the	  block	  occurs	   is	  yet	   to	  be	  determined	  and	  
future	  investigates	  will	  look	  at	  DNA	  cleavage	  (Tunnel	  assay)	  and	  PARP	  levels,	  both	  events	  which	  
indicate	  terminal	  apoptosis.	  Recent	  work	  has	  shown	  that	  some	  viruses	  are	  able	  to	  use	  caspases	  
to	  cleave	  their	  viral	  proteins,	  to	  act	  as	  facilitators	  of	  protein	  nuclear	  transport	  and	  in	  the	  regula-­‐
tion	  of	  transcription	  (Bloom	  2004).	   	  However	  this	   is	  a	  host-­‐cell	   type	  and	  pathogen-­‐dependent	  
observation.	   	   The	   activation	  of	   caspase	   3	   cleavage	   even	  with	   virus	   replication	  may	   suggest	   a	  
role	  for	  it	  in	  the	  replication	  of	  B	  virus	  (though	  that	  has	  not	  been	  determined)	  in	  these	  cell	  lines.	  
Stimulation	  of	  the	  pathway	  in	  human	  cells	  also	  led	  to	  a	  JNK3	  isomeric	  protein	  level	   in-­‐
crease.	  This	  finding	  is	  important	  as	  knockout	  studies	  of	  each	  JNK	  isomer	  have	  shown	  that	  JNK3	  
plays	  an	   important	   role	   in	  neuronal	  cell	  death	   (Loss	  of	   JNK	   led	   to	  protection	  of	  brain-­‐derived	  
neurons)	   (Bogoyevitch	  MA	   2004).	   The	   role	   of	   the	   isomer	   in	   B	   virus	   infection	  was	   not	   deter-­‐
mined,	  but	  published	  studies	  have	   suggested	   that	   the	   JNK	   isomers	  can	  play	  different	   roles	   in	  
viral	  infection,	  and	  that	  the	  cross-­‐talk	  between	  the	  MAPK	  pathway	  and	  the	  NFkB	  pathway	  plays	  
an	  important	  role	  in	  determining	  cell	  fate	  (Wen-­‐Ming	  Chu	  1999;	  Salvatore	  Papa	  2004).	  All	  three	  
JNK	   isoforms	   have	   also	   been	   shown	   to	   regulate	   p53	   by	   phosphorylation	   and	   this	   post-­‐
translation	  modification	  by	  the	  JNK1	  isoforms	  can	  lead	  to	  different	  outcomes	  (Tafolla,	  Wang	  et	  
al.	  2005).	  Previous	  work	  in	  our	  laboratory	  has	  shown	  that	  the	  NFkB	  pathway	  is	  activated	  early	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after	   infection	   in	  human	  cells	   (foreign	  host),	   though	   transcription	   factors	   associated	  with	   the	  
pathway	  are	  unable	  to	  bind	  to	  promoter	  regions	  and	   influence	  gene	  transcription	  (Zao	  2007).	  
Thus,	   the	   overall	   suppression	   of	   the	   NFΚB	   pathway	  may	   be	   a	   contributing	   factor	   to	   the	   ob-­‐
served	   increase	   in	  MAPK	  activation	   (especially	   in	   the	  human	  cell	   line).	   JNK	  regulation	  of	  both	  
pro-­‐apoptotic	  and	  anti-­‐apoptotic	  proteins	  most	   likely	  has	  to	  do	  with	  a	  balance	  of	  the	  two	  op-­‐
posing	  signals	  after	  JNK	  activation.	  	  
7.4 Early	  innate	  cytokine	  correlates	  in	  response	  to	  B	  virus	  infection	  in	  both	  hosts	  
The	  modulation	  of	  gene	  transcription	  in	  the	  nucleus	  in	  response	  to	  changes	  occurring	  in	  
the	  cell	  due	  to	  viral	  infection	  allows	  for	  proteins	  involved	  in	  the	  innate	  immune	  response	  to	  be	  
upregulated.	   This	   upregulation	   of	   transcription	   factors	   regulated	   by	  MAPKs	   involves	   the	   Jun,	  
Fos	  and	  ATF	  family	  of	  proteins.	  The	  data	  showed	  that	  the	  for	  the	  human	  cells	  there	  was	  a	  gen-­‐
eral	   trend	  for	  a	  greater	  number	  of	  cells	   to	  express	  the	  FosB	  and	  ATF2	  transcription	  factors	  at	  
relatively	  greater	  levels	  when	  compared	  to	  the	  monkey	  cells.	  This	  observed	  expression	  may	  be	  
linked	  to	  transcription	  factors	  use	  by	  the	  virus	  to	  enhance	  its	  own	  replication	  as	  the	  promoter	  
regions	  of	   the	   immediate	  early	  or	  early	  genes	  of	   some	  viruses,	   inclusive	  of	  B	  virus,	  have	  AP1	  
binding	  sites	  (as	  mentioned	  previously).	  Thus,	  the	  overall	   initial	  upregulation	  of	  AP1	  factors	  in	  
both	  hosts	  can	  play	  an	  initial	  role	  in	  the	  regulation	  of	  genes	  involved	  in	  the	  innate	  immune	  re-­‐
sponse	  to	  the	  infection	  and	  also	  in	  virus	  replication	  as	  it	  manipulates	  cellular	  processes	  and	  ex-­‐
ploits	  upregulated	  transcription	  factors.	  	  
Of	  the	  many	  cytokines	  investigated	  at	  one	  through	  seven	  hours	  post	  infection,	  there	  ap-­‐
peared	  to	  be	  a	  greater	  potential	  for	  stimulation	  and	  development	  of	  a	  Th2	  mediated	  response	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versus	  a	  Th1	  mediated	  response	  in	  macaque	  cells,	  whereas	  the	  response	  in	  human	  cells	  did	  not	  
appear	  to	  lean	  to	  either	  a	  Th1	  or	  a	  Th2	  mediated	  response	  as	  very	  few	  cytokines	  were	  detected.	  
Members	  of	  the	  Th1	  interleukin	  (cytokines)	  family	  are	  IL2,	  Lymphotoxic	  protein	  (LP),	  IFNγ,	  TNFβ	  
and	  they	  are	  generally	  thought	  to	  activate	  macrophages	  to	  cell	  mediated	  immunity.	  This	  is	  dif-­‐
ferent	   to	   the	   Th2	   interleukin	   family	   whose	   prominent	   members	   are	   IL4,	   IL5,	   IL10	   and	   IL13.	  
These	   Th2	   cytokines	   play	   a	   role	   in	   host	   antibody-­‐mediated	   responses	   and	   can	   inhibit	  macro-­‐
phage	   function	   (Spruance,	  Evans	  et	  al.	  1995).	  Differentiation	  of	   cells	   involved	   in	   the	  early	   re-­‐
sponse	  to	  infection	  is	  guided	  by	  the	  cytokines	  found	  or	  secreted	  in	  the	  surrounding	  local	  envi-­‐
ronment.	  As	   such	   the	  early	   increase	   in	   IL2,	   IL6,	   IL7,	   IL8,	   IFNα,	   IFNγ,	  and	  MCP	   in	  monkey	  cells	  
suggests	  that	  though	  a	  proinflammatory	  response	  is	   initiated	  early	  after	   infection,	  key	  players	  
that	  directly	  shape	  the	  response	  to	  a	  Th1	  or	  a	  Th2	  response	  are	  also	  upregulated	  allowing	  for	  
CTL	  responses	  that	  include:	  PBMC	  induction	  to	  secret	  IFNγ;	  natural	  killer	  (NK)	  cell	  and	  T	  cell	  se-­‐
cretion	  of	  cytokines;	   increased	  NK	  cell	  activity;	  dendritic	  cell	  (DC)	  priming	  for	  IL12	  production;	  
macrophage	  activation,	  chemo-­‐attraction	  of	  monocytes,	  DC	  and	  NK	  cells	  and	  enhancement	  of	  
MHC	   expression	   in	   professional	   and	   non-­‐professional	   cells.	  With	   the	   upregulation	   of	   IL10,	   a	  
common	  damper	  of	  proinflammatory	  responses	  that	  has	  also	  been	  shown	  to	  have	  stimulatory	  
capabilities,	  occurring	  at	   late	  times	  post	   infection,	  this	  suggests	  that	   its	  upregulation	  could	  be	  
involved	  in	  not	  only	  decreasing	  the	  levels	  of	  proinflammatory	  cytokines	  but	  also	  limit	  antigen-­‐
presenting	  cell	  functions	  and	  the	  expression	  of	  chemotactic	  molecules	  for	  monocytes.	  	  	  	  
In	  the	  human	  cells,	  only	  small	  relative	  increases	  in	  the	  levels	  of	  	  IL2	  and	  IL4	  early	  after	  in-­‐
fection	  and	  GM-­‐CSF	  later	  in	  infection,	  could	  be	  seen.	  IL2	  and	  IL4	  have	  opposing	  roles	  such	  that	  
IL2	  drives	  a	  CTL	  response	  to	  promote	  Th1	  response,	  whereas	  IL4	  promotes	  a	  Th2	  response.	  GM-­‐
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CSF	   plays	   a	   role	   in	   stimulating	   antigen-­‐presenting	   DC	   to	   increase	   their	   functional	   capacity,	  
macrophages	  and	  granulocytes.	  The	   increased	   levels	   in	  GM-­‐CSF	   in	   conjunction	  with	  opposing	  
roles	  played	  by	  increased	  IL2	  and	  IL4	  levels	  suggest	  that	  the	  human	  cells	  are	  also	  able	  to	  mount	  
a	  response	  but	  it	  is	  not	  one	  that	  is	  committed	  or	  directed	  to	  a	  Th1	  or	  a	  Th2	  mediated	  response.	  
As	  such	  this	  delayed	  secretion	  of	  necessary	  cytokines	  to	  not	  only	  contain	  or	   inhibit	   the	   infec-­‐
tion,	  but	  also	  limit	  viral	  spread	  and	  shape	  the	  adaptive	  response	  can	  be	  responsible	  for	  the	  lack	  
of	  a	  response	  generally	  seen	  in	  human	  patients	  who	  have	  succumbed	  to	  the	  infection.	  	  
	  	  Noteworthy	   are	   the	   upregulation	   of	   IL7	   and	   IL12	   in	  macaque	   cells.	   IL7	   is	   capable	   of	  
down-­‐regulating	  an	  early	  critical	  repressor	  of	  cytokine	  signaling,	  SOCS3,	  allowing	  for	  amplified	  
cytokine	  production	   (IFNα/β),	   increased	   T	   cell	   effector	   function	   and	  numbers	   and	   viral	   clear-­‐
ance	  (Pellegrini,	  Calzascia	  et	  al.	  2011).	  SOCS3	  has	  been	  shown	  by	  previous	  work	  in	  our	  labora-­‐
tory	  to	  be	  downregulated	  after	  infection	  with	  B	  virus	  in	  human	  cells	  (Zao	  2007).	  Whether	  there	  
is	  a	  downregulation	  of	  SOCS3	  in	  macaque	  cells,	  and	  what	  the	  role	  (if	  any)	  is	  played	  by	  the	  ob-­‐
served	  increase	  of	   IL7	   levels	  post	  B	  virus	   infection	  in	  the	  macaque	  cell	   line	   is	  still	  to	  be	  deter-­‐
mined.	   The	   increase	   in	   IL12	   levels	   coincides	  with	   the	   increased	   levels	   of	   pro-­‐apototic	   factors	  
seen	  earlier	  and	  may	  be	  a	  late	  indicator	  that	  though	  the	  human	  cells	  are	  trying	  to	  induce	  apop-­‐
tosis	  as	  a	  survival	  mechanism	  for	  the	  host,	  this	  induction	  occurs	  beyond	  the	  3	  to	  5-­‐hour	  window	  
considered	  important	  for	  the	  prevention	  of	  apoptosis	  in	  herpesviruses	  (Aubert	  and	  Blaho	  1999).	  




Figure	  60.	  Host-­‐specific	  summary	  of	  cytokines	  and	  chemokies	  after	  B	  virus	  infection	  
	  
Collectively,	  these	  events	  allow	  for	  an	  early	  response	  that	  is	  not	  only	  mediated	  by	  early	  
proinflammatory	  mediators	  to	  occur	  but	  for	  early	  shaping	  of	  a	  long-­‐term	  adaptive	  response.	  As	  
the	  development	  of	  a	  Th1	  versus	  a	  Th2	  response	  leads	  to	  development	  of	  specific	  adaptive	  re-­‐
sponses	  and	  different	  pathological	  outcomes	  when	  disregulated,	   it	   is	   important	  to	  look	  at	  the	  
Th1/Th2	  paradigm	  of	  secreted	  cytokines	  after	  infection	  and	  how	  it	  play	  a	  roles	  in	  protection	  and	  
pathogenesis	  for	  vaccine	  development	  and	  therapeutic	  interventions.	  Generally	  Th1	  responses	  
function	  to	  drive	  cell-­‐mediated	  immunity	  whilst	  the	  Th2	  responses	  influence	  the	  IgM	  to	  IgG	  and	  
IgE	  antibody-­‐mediated	  response.	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The	  present	  study	  was	  not	  without	  its	  limitations	  and	  though	  each	  MAPK	  (JNK	  and	  p38)	  
has	  a	  role	  and	  can	  influence	  several	  events	  including	  the	  transcriptional	  program	  within	  the	  cell	  
after	  infection.	  The	  effect	  observed	  in	  the	  efficiency	  of	  viral	  replication	  and	  the	  levels	  and	  types	  
of	  cytokines	  secreted	  in	  response	  to	  the	  infection,	  suggests	  collectively	  the	  contribution	  of	  type	  
differences	  and	  other	  factors	  influence	  the	  overall	  outcome	  of	  the	  infection.	  It	  is	  plausible	  that	  
the	  effects	  of	   factors	   influenced	  by	  the	  pathway	  are	  being	   inhibited	  by	  the	   IE	  and	  E	  viral	  pro-­‐
teins	   that	  alternate	  downstream	  targets	  of	  p38	  and	   JNK	   for	  efficient	   replication	  are	  being	  af-­‐
fected;	   that	   the	   importance	   of	   the	   transcription	   factors	   upregulated	   in	   a	   cell-­‐type	   and	   time-­‐
dependent	  manner	  are	  masked	  by	  the	  culture	  system	  used	  and	  that	  the	  MAPK	  network,	  which	  
is	  known	  like	  other	  pathways	  to	  have	  areas	  of	  cross-­‐talk	  coupled	  with	  redundancy	  for	  regula-­‐
tion,	  is	  robust	  enough	  to	  mask	  the	  true	  effect	  of	  inhibition	  of	  a	  select	  arm	  of	  the	  pathway.	  Also,	  
though	  each	  inhibitor	  has	  specificty	  regarding	  their	  mechanism	  of	  action,	  care	  must	  be	  taken	  as	  
research	  has	  shown	  that	  p38	  inhibitors	  can	  activate	  or	  influence	  the	  levels	  of	  activated	  JNK	  and	  
as	  such	  care	  must	  be	  taken	  in	  extrapolating	  information	  from	  inhibition	  the	  studies.	  However,	  
with	  the	  development	  of	  peptide	  based	  inhibitors	  and	  allosteric	  modifiers	  of	  activated	  p38	  and	  
JNK	  (rather	  than	  ATP	  competitors)	  one	  may	  be	  able	  to	  not	  only	  have	  better	  targeting	  in	  inhibi-­‐
tion	  but	  also	  increase	  efficacy.	  
7.5 Potential	  benefit	  of	  the	  investigated	  events	  
Virus	   infection	   leads	   to	   defined	   responses	   that	   are	   host-­‐dependent	   and	   cell-­‐type-­‐
dependent.	  The	   infection	   leads	  to	  numerous	  manipulations	  within	  cells	  such	  that	  mRNA,	  pro-­‐
teins,	  metabolites,	  channel	  activity	  and	  potentials	  as	  well	  as	  cell	  scaffold	  structures	  and	  mem-­‐
branes	  are	  changed.	  All	  of	  theses	  changes	  can	  be	  characterized	  as	  a	  molecular	  signature.	  The	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changes	  are	  a	  biochemical	  signature	  of	  the	  infection	  and	  they	  will	  have	  certain	  alterations	  that	  
are	  restricted	  to	  the	  pathogen	   in	  a	  stated	  cell	   type.	  By	   investigating	  these	  signatures	  and	  dis-­‐
secting	  the	  role	  of	  the	  pathways	  involved,	  we	  will	  not	  only	  be	  able	  to	  develop	  technology	  that	  
can	  decipher	  what	  pathogen	  a	  cell	  type	  or	  person	  has	  come	  into	  contact	  with	  (diagnostic	  appli-­‐
cation)	  but	  also	  be	  able	  to	  define	  types	  of	  proteins	  involved	  in	  specific	  biochemical	  changes	  that	  
are	  either	  beneficial	  for	  the	  virus	  or	  lead	  to	  detrimental	  effects	  within	  the	  host.	  
Also	  this	  work	  highlights	  the	  importance	  of	  MAPK	  signaling	  post	  infection	  and	  the	  host	  
dependent	  role	  factors	  regulated	  by	  the	  MAPK	  have	  in	  B	  virus	  infection.	  More	  importantly,	  the	  
observed	  influence	  of	  inhibition	  on	  relative	  increases	  in	  proinflammatory	  cytokines	  IL6	  and	  IL8,	  
again	  suggests	  that	  the	  MAPK	  p38	  and	  JNK	  may	  either	  directly	  or	  indirectly	  influence	  cytokine	  
secretion	  and	  progression	  towards	  apoptosis	  in	  host	  cells.	  The	  observed	  p38	  dampening	  of	  the	  
replication	   in	   the	  natural	  host,	  and	   reduction	  of	   infectious	  virus	   in	   the	   foreign	  host	  after	  p38	  
inhibition	  points	  to	  a	  novel	  area	  not	  previously	  considered	  for	  therapeutics	  to	  B	  virus	  infection	  
to	  be	  investigated.	  The	  propagation	  of	  signals	  that	   lead	  to	  a	  TH1	  or	  a	  TH2	  mediated	  response	  
early	  after	   infection,	  can	  be	  a	  means	  for	  host	  survival	  and	  though	  we	  generally	  associate	  TH1	  
responses	  with	  antiviral	  clearance	  early	  after	   infection,	   it	  may	  be	  that	   the	  host	  survival	   is	  de-­‐
pendant	  on	  the	  TH1	  and	  TH2	  balance	  such	  that	  the	  monkey	  (as	  shown	   in	  the	  data)	   is	  able	  to	  
express	  factors	  associated	  with	  both	  responses	  and	  as	  such	  has	  cellular	  immunity	  and	  humoral	  
immunity	  to	  control/limit	  the	  infection	  and	  spread	  of	  B	  virus.	  
The	  overall	  induction	  of	  MAPKs	  and	  role	  of	  MAPKs	  in	  B	  virus	  infection	  has	  been	  shown	  in	  
this	   study	   to	  occur	   in	  a	  host	  dependent	  manner,	  and	   though	  not	  all	   induced	  events	  are	  virus	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specific,	  the	  study	  highlighted	  the	  importance	  of	  MAPK’s	  in	  virus	  replication	  and	  cytokine	  secre-­‐
tion,	  as	  summarized	  in	  Figure	  6.48.	  This	  regulation	  and	  modulation	  involves	  a	  constant	  shift	  in	  
the	  balance	  of	  transcription	  factors	  and	  cytokines	  such	  that	  their	  net	  effect	  is	  dependant	  on	  the	  
time	  of	  release,	  the	  location	  of	  the	  effect,	  the	  responsiveness	  of	  cell	  within	  the	  area	  of	  the	  in-­‐
fection,	  the	  density	  of	  receptors	  for	  the	  region	  of	  its	  effect	  and	  the	  overall	  composition	  of	  other	  
competing	  or	  synergistic	  cytokines	  within	  the	  defined	  area.	  As	  such,	  future	  studies	  to	  address	  
each	  of	  theses	  areas	  and	  how	  the	  interaction	  of	  primary	  fibroblast	  cells	  with	  other	  circulating	  
cells	  found	  in	  the	  area	  post	  infection	  to	  limit	  replication	  and	  spread	  will	  assist	  in	  dissecting	  the	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